-- dump date   	20140619_005819
-- class       	Genbank::CDS
-- table       	cds_function
-- id	function
YP_001202224.1	2.1.1 : DNA replication
YP_001202224.1	2.3.7 : Nucleoproteins, basic proteins
YP_001202224.1	3.1.2.5 : Action unknown
YP_001202224.1	3.3.2 : Regulon (a network of operons encoding related functions)
YP_001202224.1	7.1 : Cytoplasm
YP_001202225.1	2.1.1 : DNA replication
YP_001202225.1	7.1 : Cytoplasm
YP_001202226.1	2.1.1 : DNA replication
YP_001202226.1	2.1.3 : DNA recombination
YP_001202226.1	2.1.4 : DNA repair
YP_001202227.1	2.2.2 : Transcription related
YP_001202227.1	2.1.1 : DNA replication
YP_001202227.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001202227.1	7.1 : Cytoplasm
YP_001202228.1	1.6.7 : Peptidoglycan (murein)
YP_001202228.1	5.2 : Cell cycle physiology
YP_001202228.1	5.1 : Cell division
YP_001202228.1	6.2 : Peptidoglycan (murein)
YP_001202231.1	3.1.2 : Transcriptional level
YP_001202232.1	4.2.A.66 : The Multi Antimicrobial Extrusion (MATE) Family
YP_001202232.1	5.6.4 : Drug resistance/sensitivity
YP_001202236.1	3.1.2 : Transcriptional level
YP_001202238.1	1.5.2.1 : Purine biosynthesis
YP_001202239.1	3.1.2 : Transcriptional level
YP_001202243.1	1.1 : Carbon compound utilization
YP_001202244.1	1.5.1.3 : Arginine
YP_001202244.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001202244.1	1.1.3.3 : Arginine catabolism
YP_001202245.1	1.1.3.8 : Tryptophan utilization
YP_001202248.1	4.9.B :  uncharacterized transport protein
YP_001202248.1	4.S.174 : sulfate
YP_001202250.1	1.7.32 : Putrescine catabolism
YP_001202250.1	1.7.31 : Aminobutyrate catabolism
YP_001202252.1	5.6.4 : Drug resistance/sensitivity
YP_001202253.1	1.5.2 : Nucleotide
YP_001202254.1	5.13 : Virulence associated
YP_001202255.2	2.3.1 : Amino acid-activation
YP_001202255.2	7.1 : Cytoplasm
YP_001202256.1	5.5 : Adaptation to stress
YP_001202257.1	1.8.2 : Sulfur metabolism
YP_001202257.1	1.8.3 : Nitrogen metabolism
YP_001202258.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202259.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202260.1	2.3.3 : Posttranslational modification
YP_001202260.1	6.6 : Ribosome
YP_001202261.1	3.1.2 : Transcriptional level
YP_001202262.1	1.1 : Carbon compound utilization
YP_001202263.1	2.2.3 : RNA modification
YP_001202263.1	7.1 : Cytoplasm
YP_001202264.1	4.9.B :  uncharacterized transport protein
YP_001202266.1	6.1 : Membrane
YP_001202267.1	1.6.10 : Lipoprotein
YP_001202267.1	6.1 : Membrane
YP_001202267.1	7.3 : Inner membrane
YP_001202269.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202273.1	2.2.2 : Transcription related
YP_001202273.1	3.1.2 : Transcriptional level
YP_001202273.1	7.1 : Cytoplasm
YP_001202275.1	2.3.2 : Translation
YP_001202275.1	7.1 : Cytoplasm
YP_001202276.1	2.2.3 : RNA modification
YP_001202277.1	2.2.3 : RNA modification
YP_001202277.1	2.2.5 : tRNA
YP_001202277.1	7.1 : Cytoplasm
YP_001202278.1	2.3.2 : Translation
YP_001202278.1	2.3.8 : Ribosomal proteins
YP_001202278.1	6.6 : Ribosome
YP_001202278.1	7.1 : Cytoplasm
YP_001202279.1	1.2.1 : RNA
YP_001202279.1	2.2.4 : RNA degradation
YP_001202279.1	7.1 : Cytoplasm
YP_001202283.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202284.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202284.1	7.1 : Cytoplasm
YP_001202285.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202286.1	3.1.2 : Transcriptional level
YP_001202288.1	1.7.21 : Glyoxylate degradation
YP_001202288.1	1.1.1.2 : 2,5-ketogluconate metabolism
YP_001202289.1	3.1.2 : Transcriptional level
YP_001202291.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001202295.1	2.1.4 : DNA repair
YP_001202295.1	7.1 : Cytoplasm
YP_001202296.1	1.3.7 : Anaerobic respiration
YP_001202296.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001202296.1	1.3.6 : Aerobic respiration
YP_001202297.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001202298.1	1.5.3.5 : Coenzyme A
YP_001202298.1	2.1.1 : DNA replication
YP_001202298.1	7.1 : Cytoplasm
YP_001202299.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001202299.1	1.7.15 : 2'-deoxyribonucleotide/ribonucleoside metabolism
YP_001202299.1	2.1.4 : DNA repair
YP_001202299.1	2.1.1 : DNA replication
YP_001202300.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202303.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001202304.1	1.2.2 : DNA
YP_001202304.1	2.1.3 : DNA recombination
YP_001202304.1	2.1.5 : DNA degradation
YP_001202305.1	1.2.2 : DNA
YP_001202305.1	2.1.3 : DNA recombination
YP_001202305.1	2.1.5 : DNA degradation
YP_001202306.1	1.6.15.2 : Thioredoxin, glutaredoxin
YP_001202307.1	2.1.3 : DNA recombination
YP_001202307.1	2.1.4 : DNA repair
YP_001202307.1	2.1.1 : DNA replication
YP_001202309.1	1.5.3.2 : Folic acid
YP_001202309.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001202310.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202310.1	7.1 : Cytoplasm
YP_001202311.1	1.5.1.15 : Tryptophan
YP_001202311.1	7.1 : Cytoplasm
YP_001202312.1	1.5.1.15 : Tryptophan
YP_001202312.1	7.1 : Cytoplasm
YP_001202313.1	1.5.1.15 : Tryptophan
YP_001202315.1	2.1.3 : DNA recombination
YP_001202315.1	2.3.7 : Nucleoproteins, basic proteins
YP_001202315.1	7.1 : Cytoplasm
YP_001202316.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202317.1	2.3.2 : Translation
YP_001202317.1	2.3.8 : Ribosomal proteins
YP_001202317.1	6.6 : Ribosome
YP_001202317.1	7.1 : Cytoplasm
YP_001202318.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001202318.1	1.5.2.4 : Pyrimidine ribonucleotide/ribonucleoside biosynthesis
YP_001202318.1	7.1 : Cytoplasm
YP_001202319.1	1.5.1.20 : Chorismate
YP_001202321.1	2.1.4 : DNA repair
YP_001202322.1	3.1.2 : Transcriptional level
YP_001202322.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001202323.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001202325.1	1.3.6 : Aerobic respiration
YP_001202325.1	1.3.7 : Anaerobic respiration
YP_001202325.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202325.1	1.6.1 : Phospholipid
YP_001202325.1	1.7.6 : Glycerol metabolism
YP_001202325.1	4.3.A.1.p : periplasmic binding component
YP_001202325.1	7.2 : Periplasmic space
YP_001202326.1	1.3.6 : Aerobic respiration
YP_001202326.1	1.3.7 : Anaerobic respiration
YP_001202326.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202326.1	1.6.1 : Phospholipid
YP_001202326.1	1.7.6 : Glycerol metabolism
YP_001202326.1	4.3.A.1.m : membrane component
YP_001202326.1	6.1 : Membrane
YP_001202326.1	7.3 : Inner membrane
YP_001202327.1	1.3.6 : Aerobic respiration
YP_001202327.1	1.3.7 : Anaerobic respiration
YP_001202327.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202327.1	1.6.1 : Phospholipid
YP_001202327.1	1.7.6 : Glycerol metabolism
YP_001202327.1	4.3.A.1.m : membrane component
YP_001202327.1	6.1 : Membrane
YP_001202327.1	7.3 : Inner membrane
YP_001202328.1	1.3.7 : Anaerobic respiration
YP_001202328.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202328.1	1.6.1 : Phospholipid
YP_001202328.1	1.7.6 : Glycerol metabolism
YP_001202328.1	1.3.6 : Aerobic respiration
YP_001202328.1	4.3.A.1.a : ATP binding component
YP_001202328.1	7.1 : Cytoplasm
YP_001202329.1	5.5.2 : Temperature extremes
YP_001202329.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001202332.1	3 : Regulation
YP_001202333.1	2.2.2 : Transcription related
YP_001202333.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001202334.1	1.8.3 : Nitrogen metabolism
YP_001202334.1	2.2.2 : Transcription related
YP_001202334.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001202334.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001202334.1	8.1 : Prophage genes and phage related functions
YP_001202335.1	4.3.A.1.a : ATP binding component
YP_001202335.1	7.1 : Cytoplasm
YP_001202338.1	2 : Information transfer
YP_001202339.1	4.9.B :  uncharacterized transport protein
YP_001202339.1	7.2 : Periplasmic space
YP_001202340.1	4.9.A : Transporters of Unknown Classification
YP_001202340.1	4.S.34 : citrate/succinate
YP_001202341.1	4.9.B :  uncharacterized transport protein
YP_001202341.1	4.S.34 : citrate/succinate
YP_001202341.1	6.1 : Membrane
YP_001202341.1	7.3 : Inner membrane
YP_001202344.1	1.1.5.2 : Ethanol degradation
YP_001202344.1	4 : Transport
YP_001202348.1	1.6.7 : Peptidoglycan (murein)
YP_001202348.1	5.6.4 : Drug resistance/sensitivity
YP_001202348.1	6.1 : Membrane
YP_001202348.1	7.3 : Inner membrane
YP_001202352.1	2.3.2 : Translation
YP_001202352.1	7.1 : Cytoplasm
YP_001202354.1	2.3.2 : Translation
YP_001202354.1	2.3.8 : Ribosomal proteins
YP_001202354.1	6.6 : Ribosome
YP_001202354.1	7.1 : Cytoplasm
YP_001202355.1	2.3.2 : Translation
YP_001202355.1	2.3.8 : Ribosomal proteins
YP_001202355.1	3.1.4 : Regulation level unknown
YP_001202355.1	6.6 : Ribosome
YP_001202355.1	7.1 : Cytoplasm
YP_001202356.1	2.3.1 : Amino acid-activation
YP_001202356.1	7.1 : Cytoplasm
YP_001202358.1	2.3.1 : Amino acid-activation
YP_001202358.1	7.1 : Cytoplasm
YP_001202364.1	4.S.36 : Cu
YP_001202364.1	4.3.A.3 : The P-type ATPase (P-ATPase) Superfamily
YP_001202364.1	6.1 : Membrane
YP_001202364.1	7.3 : Inner membrane
YP_001202366.1	4 : Transport
YP_001202366.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001202366.1	5.6.4 : Drug resistance/sensitivity
YP_001202366.1	6.1 : Membrane
YP_001202366.1	7.3 : Inner membrane
YP_001202369.1	1.2.2 : DNA
YP_001202369.1	2.1.5 : DNA degradation
YP_001202369.1	5.6.1 : Radiation
YP_001202369.1	7.1 : Cytoplasm
YP_001202371.1	2.2.2 : Transcription related
YP_001202371.1	2.1.4 : DNA repair
YP_001202371.1	3.1.2.3 : Repressor
YP_001202371.1	3.1.2.2 : Activator
YP_001202374.1	1.3.1 : Glycolysis
YP_001202374.1	1.7.8 : Gluconeogenesis
YP_001202374.1	1.1.1.23 : Galactose degradation
YP_001202375.1	1.5.1.7 : Lysine, diaminopimelate
YP_001202375.1	6.2 : Peptidoglycan (murein)
YP_001202375.1	7.1 : Cytoplasm
YP_001202377.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001202377.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001202379.1	1.6.1 : Phospholipid
YP_001202380.1	2.3.4 : Chaperoning, folding
YP_001202380.1	5.5.1 : Osmotic pressure
YP_001202380.1	5.5.2 : Temperature extremes
YP_001202380.1	7.1 : Cytoplasm
YP_001202381.1	2.3.4 : Chaperoning, folding
YP_001202381.1	5.5.1 : Osmotic pressure
YP_001202381.1	5.5.2 : Temperature extremes
YP_001202387.1	2.3.4 : Chaperoning, folding
YP_001202387.1	5.1 : Cell division
YP_001202388.1	3.1.2.4 : Complex regulation
YP_001202388.1	5.5.2 : Temperature extremes
YP_001202389.1	1.2.1 : RNA
YP_001202389.1	2.2.4 : RNA degradation
YP_001202395.1	1.5.3.10 : Glutathione
YP_001202396.1	1.2.2 : DNA
YP_001202396.1	2.1.4 : DNA repair
YP_001202398.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202404.1	2.3.1 : Amino acid-activation
YP_001202404.1	7.1 : Cytoplasm
YP_001202407.1	8.1.2 : Replication
YP_001202408.1	8.1.2 : Replication
YP_001202409.1	8.1.2 : Replication
YP_001202412.1	2.2.2 : Transcription related
YP_001202412.1	3.1.2.3 : Repressor
YP_001202412.1	7.1 : Cytoplasm
YP_001202416.1	1.5.3.5 : Coenzyme A
YP_001202417.1	2.3.4 : Chaperoning, folding
YP_001202417.1	2.1.1 : DNA replication
YP_001202417.1	7.1 : Cytoplasm
YP_001202418.1	2.3.4 : Chaperoning, folding
YP_001202423.1	2.3.4 : Chaperoning, folding
YP_001202423.1	2.3.6 : Turnover, degradation
YP_001202423.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001202423.1	5.1 : Cell division
YP_001202423.1	5.5.2 : Temperature extremes
YP_001202423.1	7.1 : Cytoplasm
YP_001202424.1	5.6.4 : Drug resistance/sensitivity
YP_001202426.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202426.1	2.3.6 : Turnover, degradation
YP_001202426.1	2.3.4 : Chaperoning, folding
YP_001202426.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001202426.1	5.1 : Cell division
YP_001202426.1	7.1 : Cytoplasm
YP_001202427.1	1.5.1.16 : Histidine
YP_001202429.1	1.5.1.16 : Histidine
YP_001202430.1	1.5.1.16 : Histidine
YP_001202431.1	1.5.1.16 : Histidine
YP_001202432.1	1.5.1.16 : Histidine
YP_001202433.1	1.5.3.5 : Coenzyme A
YP_001202434.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202436.1	3.1.4 : Regulation level unknown
YP_001202439.1	4.9.A.16 : The Septal DNA Translocator (SDT) Family
YP_001202439.1	5.1 : Cell division
YP_001202439.1	5.8 : SOS response
YP_001202442.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202443.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001202445.1	1.3.6 : Aerobic respiration
YP_001202445.1	1.4.1 : Electron donor
YP_001202445.1	1.4.3 : Electron carrier
YP_001202445.1	1.6.15.1 : Cytochromes
YP_001202445.1	1.3.4 : Tricarboxylic acid cycle
YP_001202445.1	6.1 : Membrane
YP_001202445.1	7.3 : Inner membrane
YP_001202446.1	1.3.6 : Aerobic respiration
YP_001202446.1	1.4.1 : Electron donor
YP_001202446.1	1.3.4 : Tricarboxylic acid cycle
YP_001202447.1	1.3.6 : Aerobic respiration
YP_001202447.1	1.4.1 : Electron donor
YP_001202447.1	1.3.4 : Tricarboxylic acid cycle
YP_001202447.1	7.1 : Cytoplasm
YP_001202448.1	1.3.6 : Aerobic respiration
YP_001202448.1	1.4.1 : Electron donor
YP_001202448.1	1.3.4 : Tricarboxylic acid cycle
YP_001202448.1	7.1 : Cytoplasm
YP_001202449.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202450.1	4.3.A.1.am : ATP binding and membrane component
YP_001202455.1	1.5.1.3 : Arginine
YP_001202455.1	7.1 : Cytoplasm
YP_001202458.1	3.1.3.3 : Inhibition / activation of enzymes
YP_001202464.1	3.1.2.4 : Complex regulation
YP_001202477.1	2.2.2 : Transcription related
YP_001202477.1	3.1.2.2 : Activator
YP_001202477.1	3.1.2.3 : Repressor
YP_001202483.1	1.8.1 : Phosphorous metabolism
YP_001202483.1	1.7.1 : Unassigned reversible reactions
YP_001202483.1	7.1 : Cytoplasm
YP_001202484.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202484.1	4.S.152 : peptide
YP_001202485.1	1.5.3.2 : Folic acid
YP_001202485.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001202500.1	8.3.1 : transposases
YP_001202501.1	8.3 : Transposon related
YP_001202502.1	8.3.1 : transposases
YP_001202507.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202508.1	1.7.6 : Glycerol metabolism
YP_001202508.1	1.8.1 : Phosphorous metabolism
YP_001202508.1	1.1.1.23 : Galactose degradation
YP_001202508.1	7.1 : Cytoplasm
YP_001202510.1	4.2.A.49 : The Ammonium Transporter (Amt) Family
YP_001202510.1	6.1 : Membrane
YP_001202510.1	7.3 : Inner membrane
YP_001202512.1	4.2.A.49 : The Ammonium Transporter (Amt) Family
YP_001202512.1	6.1 : Membrane
YP_001202512.1	7.3 : Inner membrane
YP_001202513.1	1.8.3 : Nitrogen metabolism
YP_001202513.1	3.1.4 : Regulation level unknown
YP_001202515.1	1.7.1 : Unassigned reversible reactions
YP_001202524.1	1.4 : Energy production/transport
YP_001202526.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001202529.1	1.4.1 : Electron donor
YP_001202530.1	1.5.3.5 : Coenzyme A
YP_001202530.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001202532.1	8.3.1 : transposases
YP_001202536.1	1.5.3.10 : Glutathione
YP_001202538.1	1.5.3.10 : Glutathione
YP_001202540.1	1.5.2.1 : Purine biosynthesis
YP_001202540.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001202540.1	7.1 : Cytoplasm
YP_001202542.1	2.2.3 : RNA modification
YP_001202545.1	1.7.29 : Acetate catabolism
YP_001202545.1	1.1.2.3 : Propionate degradation
YP_001202550.1	1.4.3 : Electron carrier
YP_001202551.1	4.9.B :  uncharacterized transport protein
YP_001202552.1	1.5.1.19 : Leucine
YP_001202552.1	7.1 : Cytoplasm
YP_001202555.1	1.5.1.8 : Threonine
YP_001202555.1	1.5.1.9 : Methionine
YP_001202555.1	1.5.1.7 : Lysine, diaminopimelate
YP_001202556.1	6.1 : Membrane
YP_001202557.1	1.7 : Central intermediary metabolism
YP_001202558.1	1.7.1 : Unassigned reversible reactions
YP_001202558.1	7.1 : Cytoplasm
YP_001202562.1	1.5.1.19 : Leucine
YP_001202562.1	7.1 : Cytoplasm
YP_001202568.1	1.5.1.19 : Leucine
YP_001202568.1	7.1 : Cytoplasm
YP_001202569.1	2.3.2 : Translation
YP_001202569.1	2.3.8 : Ribosomal proteins
YP_001202569.1	6.6 : Ribosome
YP_001202569.1	7.1 : Cytoplasm
YP_001202570.1	2.2.3 : RNA modification
YP_001202570.1	7.1 : Cytoplasm
YP_001202571.1	2.2.3 : RNA modification
YP_001202572.1	2.3.2 : Translation
YP_001202572.1	2.3.8 : Ribosomal proteins
YP_001202572.1	6.6 : Ribosome
YP_001202572.1	7.1 : Cytoplasm
YP_001202573.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001202577.1	1.5.1.7 : Lysine, diaminopimelate
YP_001202580.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001202580.1	5.1 : Cell division
YP_001202580.1	6.1 : Membrane
YP_001202581.1	5.1 : Cell division
YP_001202581.1	6.1 : Membrane
YP_001202582.1	1.6.15.1 : Cytochromes
YP_001202582.1	1.6.15.2 : Thioredoxin, glutaredoxin
YP_001202582.1	2.3.4 : Chaperoning, folding
YP_001202582.1	7.2 : Periplasmic space
YP_001202583.1	1.6.15.1 : Cytochromes
YP_001202583.1	2.3.4 : Chaperoning, folding
YP_001202584.1	1.6.15.1 : Cytochromes
YP_001202584.1	2.3.4 : Chaperoning, folding
YP_001202584.1	6.1 : Membrane
YP_001202584.1	7.3 : Inner membrane
YP_001202585.1	1.6.15.1 : Cytochromes
YP_001202585.1	2.3.4 : Chaperoning, folding
YP_001202585.1	4.3.A.1.m : membrane component
YP_001202585.1	6.1 : Membrane
YP_001202585.1	7.3 : Inner membrane
YP_001202586.1	1.6.15.1 : Cytochromes
YP_001202586.1	1.5.3.12 : Heme, porphyrin
YP_001202586.1	2.3.4 : Chaperoning, folding
YP_001202586.1	4.3.A.1.a : ATP binding component
YP_001202586.1	7.1 : Cytoplasm
YP_001202587.1	1.3.7 : Anaerobic respiration
YP_001202587.1	1.3.4 : Tricarboxylic acid cycle
YP_001202587.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001202590.1	5.6.4 : Drug resistance/sensitivity
YP_001202591.1	4 : Transport
YP_001202591.1	6.1 : Membrane
YP_001202591.1	7.3 : Inner membrane
YP_001202592.1	4.3.A.1.m : membrane component
YP_001202593.1	4.3.A.1.a : ATP binding component
YP_001202593.1	7.1 : Cytoplasm
YP_001202594.1	1.7.1 : Unassigned reversible reactions
YP_001202594.1	7.2 : Periplasmic space
YP_001202596.1	1.7.1 : Unassigned reversible reactions
YP_001202597.1	1.3.4 : Tricarboxylic acid cycle
YP_001202597.1	1.3.6 : Aerobic respiration
YP_001202597.1	1.7.21 : Glyoxylate degradation
YP_001202597.1	1.7.8 : Gluconeogenesis
YP_001202597.1	1.1.1.20 : Glycol degradation
YP_001202598.1	1.3.6 : Aerobic respiration
YP_001202598.1	1.3.4 : Tricarboxylic acid cycle
YP_001202599.1	1.3.6 : Aerobic respiration
YP_001202599.1	1.3.4 : Tricarboxylic acid cycle
YP_001202600.1	1.3.6 : Aerobic respiration
YP_001202600.1	1.3.4 : Tricarboxylic acid cycle
YP_001202601.1	1.3.6 : Aerobic respiration
YP_001202601.1	1.3.4 : Tricarboxylic acid cycle
YP_001202603.1	1.1.3.5 : Glycine cleavage
YP_001202603.1	1.3.3 : Pyruvate dehydrogenase
YP_001202603.1	1.3.4 : Tricarboxylic acid cycle
YP_001202603.1	1.3.6 : Aerobic respiration
YP_001202603.1	1.3.7 : Anaerobic respiration
YP_001202603.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001202603.1	1.7.21 : Glyoxylate degradation
YP_001202603.1	1.1.1.20 : Glycol degradation
YP_001202603.1	7.1 : Cytoplasm
YP_001202606.1	2.1.3 : DNA recombination
YP_001202607.1	2.1.1 : DNA replication
YP_001202607.1	7.1 : Cytoplasm
YP_001202609.1	1.3.8 : ATP proton motive force interconversion
YP_001202609.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001202609.1	6.1 : Membrane
YP_001202609.1	7.3 : Inner membrane
YP_001202610.1	1.3.8 : ATP proton motive force interconversion
YP_001202610.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001202610.1	6.1 : Membrane
YP_001202610.1	7.3 : Inner membrane
YP_001202611.1	1.3.8 : ATP proton motive force interconversion
YP_001202611.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001202611.1	6.1 : Membrane
YP_001202611.1	7.3 : Inner membrane
YP_001202612.1	1.3.8 : ATP proton motive force interconversion
YP_001202612.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001202612.1	6.1 : Membrane
YP_001202612.1	7.3 : Inner membrane
YP_001202613.1	1.3.8 : ATP proton motive force interconversion
YP_001202613.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001202613.1	6.1 : Membrane
YP_001202613.1	7.3 : Inner membrane
YP_001202615.1	5.10 : Defense/survival
YP_001202616.1	5.10 : Defense/survival
YP_001202618.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001202622.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001202623.1	1.5.1.4 : Proline
YP_001202623.1	7.1 : Cytoplasm
YP_001202624.1	1.5.1.4 : Proline
YP_001202624.1	7.1 : Cytoplasm
YP_001202626.1	4.2.A.7 : The Drug/Metabolite Transporter (DMT) Superfamily
YP_001202628.1	2.3.2 : Translation
YP_001202628.1	2.3.8 : Ribosomal proteins
YP_001202628.1	6.6 : Ribosome
YP_001202628.1	7.1 : Cytoplasm
YP_001202629.1	2.3.2 : Translation
YP_001202629.1	2.3.8 : Ribosomal proteins
YP_001202629.1	6.6 : Ribosome
YP_001202634.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001202644.1	3.1. : Type of regulation
YP_001202649.1	5.4 : Genetic exchange, recombination
YP_001202649.1	8.1.4 : Integration, recombination
YP_001202665.1	3.1.2 : Transcriptional level
YP_001202673.1	5.4 : Genetic exchange, recombination
YP_001202679.1	4.3.A.1.m : membrane component
YP_001202680.1	4.3.A.1.m : membrane component
YP_001202681.1	4.3.A.1.a : ATP binding component
YP_001202682.1	4.3.A.1.a : ATP binding component
YP_001202683.1	4.3.A.1.p : periplasmic binding component
YP_001202686.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001202689.1	3 : Regulation
YP_001202691.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202693.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001202694.1	1.1.1.18 : Trehalose degradation, low osmolarity+
YP_001202697.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202698.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202699.1	4.3.A.1.a : ATP binding component
YP_001202700.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001202704.1	4.S.15 : antibiotic
YP_001202706.1	3.1.2 : Transcriptional level
YP_001202708.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202708.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001202708.1	5.5.2 : Temperature extremes
YP_001202708.1	7.1 : Cytoplasm
YP_001202709.1	4.3.A.1.p : periplasmic binding component
YP_001202710.1	4.3.A.1.p : periplasmic binding component
YP_001202712.1	1.8.3 : Nitrogen metabolism
YP_001202712.1	1.5.2.1 : Purine biosynthesis
YP_001202712.1	2.3.3 : Posttranslational modification
YP_001202713.1	4.3.A.1.p : periplasmic binding component
YP_001202713.1	4.S.5 : alkanesulfonate
YP_001202714.1	4.3.A.1.m : membrane component
YP_001202714.1	4.S.5 : alkanesulfonate
YP_001202715.1	4.3.A.1.a : ATP binding component
YP_001202719.1	2.1.4 : DNA repair
YP_001202719.1	7.1 : Cytoplasm
YP_001202720.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001202721.1	1.1.3.8 : Tryptophan utilization
YP_001202722.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001202723.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001202723.1	5.6.4 : Drug resistance/sensitivity
YP_001202724.1	3.1.2 : Transcriptional level
YP_001202725.1	2.2.2 : Transcription related
YP_001202725.1	3.1.2.3 : Repressor
YP_001202725.1	3.3.1 : Operon (regulation of one operon)
YP_001202727.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001202735.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001202735.1	7.1 : Cytoplasm
YP_001202736.1	1.6.7 : Peptidoglycan (murein)
YP_001202736.1	6.2 : Peptidoglycan (murein)
YP_001202737.1	2.3.2 : Translation
YP_001202737.1	2.3.8 : Ribosomal proteins
YP_001202737.1	6.6 : Ribosome
YP_001202737.1	7.1 : Cytoplasm
YP_001202742.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202743.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202743.1	7.1 : Cytoplasm
YP_001202747.1	1.7.28 : Pyruvate catabolism
YP_001202747.1	1.7.23 : Methylglyoxal metabolism
YP_001202750.1	2.3.2 : Translation
YP_001202751.1	2.3.2 : Translation
YP_001202752.1	4.4.A : Phosphotransferase Systems (PEP-dependent PTS)
YP_001202753.1	1.5.1.8 : Threonine
YP_001202753.1	1.5.1.9 : Methionine
YP_001202753.1	1.5.1.7 : Lysine, diaminopimelate
YP_001202755.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001202755.1	1.3.6 : Aerobic respiration
YP_001202755.1	6.1 : Membrane
YP_001202755.1	7.3 : Inner membrane
YP_001202756.1	2.1.4 : DNA repair
YP_001202760.1	1.8.3 : Nitrogen metabolism
YP_001202761.1	1.5.2 : Nucleotide
YP_001202761.1	1.6.15.2 : Thioredoxin, glutaredoxin
YP_001202762.1	2.1 : DNA related
YP_001202764.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001202767.1	1.5.1.3 : Arginine
YP_001202768.1	2.3.4 : Chaperoning, folding
YP_001202769.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001202770.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001202772.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202772.1	4.S.52 : fatty acid
YP_001202773.1	8.3.1 : transposases
YP_001202774.1	3.1.2 : Transcriptional level
YP_001202775.1	4.3.A.1.p : periplasmic binding component
YP_001202776.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202777.1	1.7.9 : Misc. glucose metabolism
YP_001202777.1	1.3 : Energy metabolism (carbon)
YP_001202782.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001202783.1	2.1.1 : DNA replication
YP_001202783.1	2.1.3 : DNA recombination
YP_001202785.1	1.5.1.20 : Chorismate
YP_001202789.1	1.7 : Central intermediary metabolism
YP_001202789.1	4.S.34 : citrate/succinate
YP_001202790.1	1.7 : Central intermediary metabolism
YP_001202790.1	4.S.34 : citrate/succinate
YP_001202792.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001202793.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001202795.1	1.4.3 : Electron carrier
YP_001202798.1	4.3.A.1.p : periplasmic binding component
YP_001202799.1	4.3.A.1.m : membrane component
YP_001202800.1	4.3.A.1.m : membrane component
YP_001202801.1	4.3.A.1.a : ATP binding component
YP_001202803.1	2.3.2 : Translation
YP_001202803.1	2.3.8 : Ribosomal proteins
YP_001202804.1	3.1.2 : Transcriptional level
YP_001202804.1	5.5.2 : Temperature extremes
YP_001202808.1	2.3.2 : Translation
YP_001202811.1	2.2 : RNA related
YP_001202812.1	1.4.3 : Electron carrier
YP_001202813.1	3.1.2 : Transcriptional level
YP_001202814.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202815.1	2.1 : DNA related
YP_001202815.1	2.2 : RNA related
YP_001202816.1	4.3.A.1.p : periplasmic binding component
YP_001202817.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202822.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202823.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202824.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202832.1	1.7.14 : Polyamine biosynthesis
YP_001202838.1	1.5.1.9 : Methionine
YP_001202839.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001202840.1	2.1.4 : DNA repair
YP_001202841.1	2.2.2 : Transcription related
YP_001202842.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001202843.1	1.6.15.1 : Cytochromes
YP_001202843.1	4.2.A.9 : The Cytochrome oxidase biogenesis (Oxa1) Family
YP_001202845.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202847.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202849.1	4.3.A.1.p : periplasmic binding component
YP_001202850.1	4.3.A.1.a : ATP binding component
YP_001202851.1	4.3.A.1.m : membrane component
YP_001202852.1	1.5.1.14 : Tyrosine
YP_001202853.1	1.5.1.14 : Tyrosine
YP_001202853.1	1.5.3.10 : Glutathione
YP_001202854.1	3.1.2 : Transcriptional level
YP_001202857.1	4.2.A.23 : The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family
YP_001202858.1	4.3.A.1.p : periplasmic binding component
YP_001202859.1	1.5.3.10 : Glutathione
YP_001202860.1	1.7.1 : Unassigned reversible reactions
YP_001202860.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001202862.1	1.5.1.2 : Glutamine
YP_001202863.1	4.3.A.1.a : ATP binding component
YP_001202864.1	4.3.A.1.m : membrane component
YP_001202869.1	4.3.A.1.p : periplasmic binding component
YP_001202870.1	4.3.A.1.a : ATP binding component
YP_001202871.1	4.3.A.1.m : membrane component
YP_001202876.1	3.1.2 : transcriptional level
YP_001202877.1	4 : transport
YP_001202879.1	2.2.2 : Transcription related
YP_001202879.1	3.1.2 : Transcriptional level
YP_001202880.1	2.1.1 : DNA replication
YP_001202880.1	2.1.4 : DNA repair
YP_001202886.1	2.3.4 : Chaperoning, folding
YP_001202888.1	4.2.A.36 : The Monovalent Cation:Proton Antiporter-1 (CPA1) Family
YP_001202888.1	5.5.1 : Osmotic pressure
YP_001202892.1	1.6.7 : Peptidoglycan (murein)
YP_001202892.1	5.6.4 : Drug resistance/sensitivity
YP_001202892.1	6.2 : Peptidoglycan (murein)
YP_001202894.1	3.1.2 : Transcriptional level
YP_001202896.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202898.1	2.3.2 : Translation
YP_001202900.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001202900.1	4.8.A.8 : The Phosphotransferase System HPr (HPr) Family
YP_001202903.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202904.1	2.2.2 : Transcription related
YP_001202904.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202906.1	1.7.8 : Gluconeogenesis
YP_001202908.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001202908.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001202908.1	7.1 : Cytoplasm
YP_001202911.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001202912.1	1.7.1 : Unassigned reversible reactions
YP_001202915.1	2.1.1 : DNA replication
YP_001202915.1	7.1 : Cytoplasm
YP_001202917.1	6.7 : Capsule (M and K antigens)
YP_001202918.1	2.1.1 : DNA replication
YP_001202918.1	7.1 : Cytoplasm
YP_001202919.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202920.1	1.6.2 : Colanic acid (M antigen)
YP_001202920.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001202920.1	5.5.5 : Dessication
YP_001202920.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001202920.1	6.7 : Capsule (M and K antigens)
YP_001202921.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202923.1	3.1.2 : Transcriptional level
YP_001202926.1	2.1.1 : DNA replication
YP_001202926.1	7.1 : Cytoplasm
YP_001202928.1	2.1.3 : DNA recombination
YP_001202928.1	2.1.4 : DNA repair
YP_001202928.1	7.1 : Cytoplasm
YP_001202930.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001202930.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001202930.1	6.2 : Peptidoglycan (murein)
YP_001202931.1	2.1.4 : DNA repair
YP_001202933.1	2.3.3 : Posttranslational modification
YP_001202934.1	2.2.3 : RNA modification
YP_001202934.1	7.1 : Cytoplasm
YP_001202935.1	2.3.1 : Amino acid-activation
YP_001202935.1	7.1 : Cytoplasm
YP_001202936.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202937.1	1.5.1.7 : Lysine, diaminopimelate
YP_001202938.1	1.5.1.7 : Lysine, diaminopimelate
YP_001202938.1	7.1 : Cytoplasm
YP_001202941.1	1.5.1.3 : Arginine
YP_001202941.1	7.1 : Cytoplasm
YP_001202943.1	5.2 : Cell cycle physiology
YP_001202944.1	4.2.A.9 : The Cytochrome oxidase biogenesis (Oxa1) Family
YP_001202944.1	6.1 : Membrane
YP_001202944.1	7.3 : Inner membrane
YP_001202945.1	1.2.1 : RNA
YP_001202945.1	2.2.3 : RNA modification
YP_001202946.1	2.3.2 : Translation
YP_001202946.1	2.3.8 : Ribosomal proteins
YP_001202946.1	6.6 : Ribosome
YP_001202947.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001202948.1	3.1.2 : Transcriptional level
YP_001202949.1	8.1 : Prophage genes and phage related functions
YP_001202950.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001202951.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001202952.1	8.1 : Prophage genes and phage related functions
YP_001202954.1	8.1 : Prophage genes and phage related functions
YP_001202956.1	2.1.3 : DNA recombination
YP_001202956.1	5.4 : Genetic exchange, recombination
YP_001202956.1	8.1 : Prophage genes and phage related functions
YP_001202957.1	2.1.3 : DNA recombination
YP_001202957.1	5.4 : Genetic exchange, recombination
YP_001202957.1	8.1 : Prophage genes and phage related functions
YP_001202959.1	8.1 : Prophage genes and phage related functions
YP_001202960.1	8.1 : Prophage genes and phage related functions
YP_001202961.1	8.1 : Prophage genes and phage related functions
YP_001202964.1	8.1 : Prophage genes and phage related functions
YP_001202965.1	8.1 : Prophage genes and phage related functions
YP_001202966.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001202966.1	8.1 : Prophage genes and phage related functions
YP_001202967.1	8.1 : Prophage genes and phage related functions
YP_001202968.1	8.1 : Prophage genes and phage related functions
YP_001202970.1	8.1 : Prophage genes and phage related functions
YP_001202971.1	8.1 : Prophage genes and phage related functions
YP_001202972.1	8.1 : Prophage genes and phage related functions
YP_001202973.1	8.1 : Prophage genes and phage related functions
YP_001202974.1	8.1 : Prophage genes and phage related functions
YP_001202975.1	8.1 : Prophage genes and phage related functions
YP_001202976.1	1.5.1.16 : Histidine
YP_001202977.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202978.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202979.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202980.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202981.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202982.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202983.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001202997.1	6.1 : Membrane
YP_001203006.1	1.1 : Carbon compound utilization
YP_001203010.1	1.5.2.1 : Purine biosynthesis
YP_001203010.1	1.5.1.1 : Glutamate
YP_001203011.1	4.9.B :  uncharacterized transport protein
YP_001203011.1	6.1 : Membrane
YP_001203013.1	3.1.2 : transcriptional level
YP_001203015.1	1.5.2.3 : Purine ribonucleotide biosynthesis
YP_001203015.1	1.5.1.1 : Glutamate
YP_001203016.1	1.5.1.6 : Asparagine
YP_001203018.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001203021.1	2.2.2 : Transcription related
YP_001203021.1	3.1.2.2 : Activator
YP_001203021.1	3.1.2.3 : Repressor
YP_001203022.1	4.9.A : Transporters of Unknown Classification
YP_001203024.1	2.3.1 : Amino acid-activation
YP_001203024.1	2.3.2 : Translation
YP_001203024.1	2.2.5 : tRNA
YP_001203025.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203026.1	4.9.A : Transporters of Unknown Classification
YP_001203027.1	4.3.A.1.m : membrane component
YP_001203028.1	4.3.A.1.m : membrane component
YP_001203028.1	7.3 : Inner membrane
YP_001203029.1	4.3.A.1.p : periplasmic binding component
YP_001203030.1	4.3.A.1.a : ATP binding component
YP_001203030.1	7.1 : Cytoplasm
YP_001203035.1	4.3.A.1.a : ATP binding component
YP_001203041.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203045.1	4.3.A.1.a : ATP binding component
YP_001203046.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203046.1	4.3.A.1.a : ATP binding component
YP_001203046.1	7.1 : Cytoplasm
YP_001203047.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203047.1	4.3.A.1.m : membrane component
YP_001203047.1	6.1 : Membrane
YP_001203047.1	7.3 : Inner membrane
YP_001203048.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203048.1	4.3.A.1.m : membrane component
YP_001203048.1	7.3 : Inner membrane
YP_001203049.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203049.1	4.3.A.1.p : periplasmic binding component
YP_001203050.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203051.1	3.1.2 : Transcriptional level
YP_001203052.1	5.6.4 : Drug resistance/sensitivity
YP_001203053.1	1.8.3 : Nitrogen metabolism
YP_001203056.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001203056.1	3 : Regulation
YP_001203057.1	4.3.A.1.p : periplasmic binding component
YP_001203058.1	4.3.A.1.p : periplasmic binding component
YP_001203059.1	4.3.A.1.m : membrane component
YP_001203060.1	4.3.A.1.m : membrane component
YP_001203061.1	4.3.A.1.a : ATP binding component
YP_001203063.1	2.3.1 : Amino acid-activation
YP_001203063.1	2.2.5 : tRNA
YP_001203064.1	4.3.A.1.a : ATP binding component
YP_001203065.1	6.1 : Membrane
YP_001203066.1	4.3.A.1.am : ATP binding and membrane component
YP_001203067.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001203069.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203070.1	1.1.3 : Amino acids
YP_001203070.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001203070.1	2.2.2 : Transcription related
YP_001203070.1	3.1.2.2 : Activator
YP_001203070.1	3.1.2.3 : Repressor
YP_001203070.1	3.3.1 : Operon (regulation of one operon)
YP_001203070.1	7.1 : Cytoplasm
YP_001203076.1	1.3.7 : Anaerobic respiration
YP_001203076.1	1.1.5.2 : Ethanol degradation
YP_001203076.1	1.3.5 : Fermentation
YP_001203078.1	1.4.3 : Electron carrier
YP_001203082.1	1.1.5 : Others
YP_001203083.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203084.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203085.1	3.1.2 : Transcriptional level
YP_001203086.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203087.1	1.1.5.1 : Phenylacetic acid degradation
YP_001203087.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203088.1	1.6.1 : Phospholipid
YP_001203088.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203089.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203089.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203090.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203090.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203091.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203091.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203094.1	3.1.2.4.4 : Quorum sensing
YP_001203095.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203095.1	3.1.2.4.4 : Quorum sensing
YP_001203096.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203107.1	3.1.2 : Transcriptional level
YP_001203108.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203109.1	4 : Transport
YP_001203110.1	4 : Transport
YP_001203111.1	4 : Transport
YP_001203118.1	1 : Metabolism
YP_001203120.1	1.5.1.20 : Chorismate
YP_001203121.1	1.1.3 : Amino acids
YP_001203121.1	1.5.1.18 : Isoleucine/valine
YP_001203121.1	1.5.1.19 : Leucine
YP_001203121.1	4.3.A.1.a : ATP binding component
YP_001203121.1	7.1 : Cytoplasm
YP_001203122.1	4.3.A.1.a : ATP binding component
YP_001203123.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001203124.1	3.1.2 : Transcriptional level
YP_001203125.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203126.1	4.3.A.1.p : periplasmic binding component
YP_001203127.1	4.3.A.1.p : periplasmic binding component
YP_001203128.1	1.5.1.18 : Isoleucine/valine
YP_001203128.1	1.5.1.19 : Leucine
YP_001203128.1	4.3.A.1.m : membrane component
YP_001203129.1	1.5.1.18 : Isoleucine/valine
YP_001203129.1	1.5.1.19 : Leucine
YP_001203129.1	4.3.A.1.m : membrane component
YP_001203130.1	1.5.1.18 : Isoleucine/valine
YP_001203130.1	1.5.1.19 : Leucine
YP_001203130.1	1.1.3 : Amino acids
YP_001203130.1	4.3.A.1.a : ATP binding component
YP_001203130.1	7.1 : Cytoplasm
YP_001203131.1	1.5.1.18 : Isoleucine/valine
YP_001203131.1	1.5.1.19 : Leucine
YP_001203131.1	1.1.3 : Amino acids
YP_001203131.1	4.3.A.1.a : ATP binding component
YP_001203131.1	7.1 : Cytoplasm
YP_001203132.1	2.2.2 : Transcription related
YP_001203133.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203134.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203135.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203136.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203136.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203137.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203137.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203139.1	1.7.6 : Glycerol metabolism
YP_001203139.1	1.1.1.23 : Galactose degradation
YP_001203146.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001203146.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001203146.1	1.7.20 : S-adenosyl methionine biosynthesis
YP_001203146.1	1.5.1.9 : Methionine
YP_001203147.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001203150.1	3.1.2 : Transcriptional level
YP_001203151.1	1.5.1.13 : Phenylalanine
YP_001203152.1	1.6.5 : K antigen
YP_001203152.1	1.6.3.3 : Lipid A
YP_001203152.1	6.2 : Peptidoglycan (murein)
YP_001203152.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001203152.1	6.7 : Capsule (M and K antigens)
YP_001203152.1	6.1 : Membrane
YP_001203152.1	7.1 : Cytoplasm
YP_001203153.1	1.4.3 : Electron carrier
YP_001203154.1	4.3.A.1.p : periplasmic binding component
YP_001203154.1	7.2 : Periplasmic space
YP_001203155.1	4.3.A.1.p : periplasmic binding component
YP_001203155.1	7.2 : Periplasmic space
YP_001203156.1	4.3.A.1.m : membrane component
YP_001203156.1	6.1 : Membrane
YP_001203156.1	7.3 : Inner membrane
YP_001203157.1	4.3.A.1.m : membrane component
YP_001203157.1	6.1 : Membrane
YP_001203157.1	7.3 : Inner membrane
YP_001203158.1	4.3.A.1.a : ATP binding component
YP_001203158.1	7.1 : Cytoplasm
YP_001203163.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203165.1	1.8.3 : Nitrogen metabolism
YP_001203165.1	1.1.3 : Amino acids
YP_001203166.1	6.5 : Pilus
YP_001203167.1	6.5 : Pilus
YP_001203168.1	5.4 : Genetic exchange, recombination
YP_001203168.1	6.5 : Pilus
YP_001203169.1	5.4 : Genetic exchange, recombination
YP_001203169.1	6.5 : Pilus
YP_001203170.1	6.5 : Pilus
YP_001203171.1	6.5 : Pilus
YP_001203172.1	6.5 : Pilus
YP_001203173.1	6.5 : Pilus
YP_001203174.1	6.5 : Pilus
YP_001203179.1	2.2.2 : Transcription related
YP_001203179.1	3.1.2 : transcriptional level
YP_001203179.1	3.1.2.2 : Activator
YP_001203179.1	3.3.1 : Operon (regulation of one operon)
YP_001203179.1	5.5.2 : temperature extremes
YP_001203179.1	7.1 : Cytoplasm
YP_001203180.1	2.3.2 : Translation
YP_001203180.1	7.1 : Cytoplasm
YP_001203181.1	2.2.3 : RNA modification
YP_001203182.1	4.3.A.1.p : periplasmic binding component
YP_001203183.1	4.3.A.1.m : membrane component
YP_001203183.1	7.3 : Inner membrane
YP_001203184.1	4.3.A.1.m : membrane component
YP_001203185.1	4.3.A.1.a : ATP binding component
YP_001203186.1	4.3.A.1.a : ATP binding component
YP_001203187.1	1.8.3 : Nitrogen metabolism
YP_001203188.1	1.8.3 : Nitrogen metabolism
YP_001203189.1	1.8.3 : Nitrogen metabolism
YP_001203190.1	2.2 : RNA related
YP_001203190.1	2.1 : DNA related
YP_001203192.1	1.8.3 : Nitrogen metabolism
YP_001203194.1	1.8.3 : Nitrogen metabolism
YP_001203195.1	1.8.3 : Nitrogen metabolism
YP_001203196.1	1.8.3 : Nitrogen metabolism
YP_001203198.1	2.2.2 : Transcription related
YP_001203200.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203208.1	3 : Regulation
YP_001203210.1	1.7.21 : Glyoxylate degradation
YP_001203210.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203212.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001203214.1	1.8.2 : Sulfur metabolism
YP_001203215.1	1.5.3.12 : Heme, porphyrin
YP_001203217.1	1.8.3 : Nitrogen metabolism
YP_001203219.1	1.8.2 : Sulfur metabolism
YP_001203220.1	1.8.2 : Sulfur metabolism
YP_001203220.1	4.3.A.1.p : periplasmic binding component
YP_001203220.1	7.2 : Periplasmic space
YP_001203221.1	1.8.2 : Sulfur metabolism
YP_001203221.1	4.3.A.1.m : membrane component
YP_001203221.1	6.1 : Membrane
YP_001203221.1	7.3 : Inner membrane
YP_001203222.1	1.8.2 : Sulfur metabolism
YP_001203222.1	4.3.A.1.m : membrane component
YP_001203222.1	6.1 : Membrane
YP_001203222.1	7.3 : Inner membrane
YP_001203223.1	1.8.2 : Sulfur metabolism
YP_001203223.1	4.3.A.1.a : ATP binding component
YP_001203226.1	1.7.1 : Unassigned reversible reactions
YP_001203234.1	1.3.6 : aerobic respiration
YP_001203234.1	1.3.9 : Entner-Doudoroff pathway
YP_001203234.1	1.7.9 : glucose metabolism
YP_001203234.1	1.1 : carbon utilization
YP_001203238.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203238.1	6.2 : Peptidoglycan (murein)
YP_001203239.1	1.7.7 : Galactose metabolism
YP_001203239.1	1.7.9 : Misc. glucose metabolism
YP_001203239.1	1.6.2 : Colanic acid (M antigen)
YP_001203239.1	5.5.5 : Dessication
YP_001203239.1	6.7 : Capsule (M and K antigens)
YP_001203240.1	3 : Regulation
YP_001203242.1	4.3.A.1.p : periplasmic binding component
YP_001203243.1	4.3.A.1.p : periplasmic binding component
YP_001203244.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203244.1	4.3.A.1.m : membrane component
YP_001203244.1	6.1 : Membrane
YP_001203244.1	7.3 : Inner membrane
YP_001203245.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001203245.1	4.3.A.1.m : membrane component
YP_001203245.1	6.2 : Peptidoglycan (murein)
YP_001203245.1	6.1 : Membrane
YP_001203245.1	7.3 : Inner membrane
YP_001203246.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001203246.1	4.3.A.1.a : ATP binding component
YP_001203246.1	6.2 : Peptidoglycan (murein)
YP_001203246.1	7.1 : Cytoplasm
YP_001203247.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001203247.1	4.3.A.1.a : ATP binding component
YP_001203247.1	6.2 : Peptidoglycan (murein)
YP_001203247.1	7.1 : Cytoplasm
YP_001203248.1	3 : Regulation
YP_001203249.1	1.6.1 : Phospholipid
YP_001203249.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203251.1	3 : Regulation
YP_001203255.1	2.3.8 : Ribosomal proteins
YP_001203256.1	4.3.A.1.am : ATP binding and membrane component
YP_001203259.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203262.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001203263.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001203263.1	5.6.4 : Drug resistance/sensitivity
YP_001203263.1	6.1 : Membrane
YP_001203263.1	7.3 : Inner membrane
YP_001203264.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001203264.1	5.6.4 : Drug resistance/sensitivity
YP_001203264.1	6.1 : Membrane
YP_001203264.1	7.3 : Inner membrane
YP_001203266.1	2.2.2 : Transcription related
YP_001203266.1	3.1.3.2 : Covalent modification, demodification, maturation
YP_001203267.1	1 : Metabolism
YP_001203268.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001203269.1	1.3 : Energy metabolism (carbon)
YP_001203271.1	1.3.1 : Glycolysis
YP_001203271.1	1.7.8 : Gluconeogenesis
YP_001203271.1	1.1.1.23 : Galactose degradation
YP_001203271.1	7.1 : Cytoplasm
YP_001203272.1	1.7.8 : Gluconeogenesis
YP_001203272.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001203272.1	7.1 : Cytoplasm
YP_001203273.1	2.1.3 : DNA recombination
YP_001203273.1	2.1.4 : DNA repair
YP_001203273.1	2.1.1 : DNA replication
YP_001203273.1	7.1 : Cytoplasm
YP_001203274.1	1.7.3 : Pentose phosphate shunt, non-oxidative branch
YP_001203274.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001203274.1	1.1.1.22 : Ribose degradation
YP_001203278.1	5.6.4 : Drug resistance/sensitivity
YP_001203279.1	1.5.3.10 : Glutathione
YP_001203282.1	5.6 : Protection
YP_001203285.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203286.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203288.1	2.1.4 : DNA repair
YP_001203288.1	2.1.3 : DNA recombination
YP_001203288.1	7.1 : Cytoplasm
YP_001203289.1	2.1.3 : DNA recombination
YP_001203289.1	2.1.4 : DNA repair
YP_001203289.1	5.8 : SOS response
YP_001203289.1	7.1 : Cytoplasm
YP_001203291.1	2.1.3 : DNA recombination
YP_001203291.1	2.1.4 : DNA repair
YP_001203291.1	5.8 : SOS response
YP_001203291.1	7.1 : Cytoplasm
YP_001203293.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203294.1	2.1.1 : DNA replication
YP_001203295.1	1.5.3.10 : Glutathione
YP_001203296.1	3.1.2 : Transcriptional level
YP_001203297.1	1.5.1.11 : Serine
YP_001203300.1	2.2.2 : Transcription related
YP_001203300.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001203302.1	1.5.3.10 : Glutathione
YP_001203304.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203306.1	3.1.2 : Transcriptional level
YP_001203307.1	1.5.2 : Nucleotide
YP_001203308.1	1.5.3.10 : Glutathione
YP_001203312.1	3.1.2 : Transcriptional level
YP_001203314.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001203314.1	5.5.7 : Fe aquisition
YP_001203314.1	6.1 : Membrane
YP_001203314.1	7.3 : Inner membrane
YP_001203314.1	8.1 : Prophage genes and phage related functions
YP_001203314.1	8.4 : Colicin related
YP_001203315.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001203315.1	8.4 : Colicin related
YP_001203316.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001203316.1	5.5.7 : Fe aquisition
YP_001203317.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001203317.1	7.2 : Periplasmic space
YP_001203317.1	8.1 : Prophage genes and phage related functions
YP_001203317.1	8.4 : Colicin related
YP_001203320.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001203320.1	6.1 : Membrane
YP_001203320.1	8.1 : Prophage genes and phage related functions
YP_001203320.1	8.4 : Colicin related
YP_001203323.1	2.2.5 : tRNA
YP_001203324.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203327.1	3.1.2 : Transcriptional level
YP_001203329.1	1.3.1 : Glycolysis
YP_001203335.1	3.1.2 : Transcriptional level
YP_001203335.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203336.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203337.1	3 : Regulation
YP_001203340.1	1.7.1 : Unassigned reversible reactions
YP_001203340.1	4.9.A : Transporters of Unknown Classification
YP_001203341.1	1.7.1 : Unassigned reversible reactions
YP_001203341.1	4.9.A : Transporters of Unknown Classification
YP_001203342.1	1.7.1 : Unassigned reversible reactions
YP_001203342.1	4.9.A : Transporters of Unknown Classification
YP_001203342.1	6.1 : Membrane
YP_001203342.1	7.3 : Inner membrane
YP_001203344.1	4 : Transport
YP_001203345.1	4 : Transport
YP_001203348.1	2.3.8 : Ribosomal proteins
YP_001203348.1	6.6 : Ribosome
YP_001203349.1	1.5.2.1 : Purine biosynthesis
YP_001203349.1	7.1 : Cytoplasm
YP_001203350.1	1.5.2.1 : Purine biosynthesis
YP_001203350.1	7.1 : Cytoplasm
YP_001203357.1	1.3.6 : Aerobic respiration
YP_001203357.1	1.4.1 : Electron donor
YP_001203357.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001203357.1	1.7.6 : Glycerol metabolism
YP_001203357.1	1.1.1.23 : Galactose degradation
YP_001203357.1	7.1 : Cytoplasm
YP_001203358.1	1.1.4 : Amines
YP_001203358.1	1.7.14 : Polyamine biosynthesis
YP_001203358.1	4.3.A.1.am : ATP binding and membrane component
YP_001203359.1	1.1.4 : Amines
YP_001203359.1	1.7.14 : Polyamine biosynthesis
YP_001203359.1	4.3.A.1.m : membrane component
YP_001203359.1	6.1 : Membrane
YP_001203359.1	7.3 : Inner membrane
YP_001203360.1	1.1.4 : Amines
YP_001203360.1	1.7.14 : Polyamine biosynthesis
YP_001203360.1	4.3.A.1.m : membrane component
YP_001203360.1	6.1 : Membrane
YP_001203360.1	7.3 : Inner membrane
YP_001203362.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001203363.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001203364.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001203365.1	6 : Cell structure
YP_001203366.1	1.6.3 : Lipopolysaccharide
YP_001203366.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203367.1	1.6.3 : Lipopolysaccharide
YP_001203367.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001203369.1	1.8.3 : Nitrogen metabolism
YP_001203370.1	1.8.3 : Nitrogen metabolism
YP_001203372.1	1.5.3.12 : Heme, porphyrin
YP_001203374.1	1.8.3 : Nitrogen metabolism
YP_001203374.1	3.1.2 : Transcriptional level
YP_001203376.1	3 : Regulation
YP_001203379.1	4.3.A.7 : The Type IV (Conjugal DNA-Protein Transfer) Secretory Pathway (IVSP) Family
YP_001203380.1	4.3.A.7 : The Type IV (Conjugal DNA-Protein Transfer) Secretory Pathway (IVSP) Family
YP_001203396.1	2.3.6 : Turnover, degradation
YP_001203397.1	2.3.6 : Turnover, degradation
YP_001203398.1	2.1.3 : DNA recombination
YP_001203398.1	5.4 : Genetic exchange, recombination
YP_001203398.1	8.1.4 : Integration, recombination
YP_001203399.1	3 : Regulation
YP_001203400.1	2.2.2 : Transcription related
YP_001203403.1	1.5.3.12 : Heme, porphyrin
YP_001203404.1	1.5.3.12 : Heme, porphyrin
YP_001203405.2	1.5.3.12 : Heme, porphyrin
YP_001203406.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203409.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203410.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203411.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203412.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203414.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203415.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203416.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203418.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203427.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203429.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203430.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203431.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203432.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203433.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203434.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203435.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203436.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203437.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001203443.1	4 : Transport
YP_001203444.1	3.1.1.2 : Methylation
YP_001203450.1	8.2.1 : replication and maintenance
YP_001203453.1	3.1.2 : Transcriptional level
YP_001203454.1	5 : Cell processes
YP_001203455.1	3.1.2 : Transcriptional level
YP_001203456.1	4 : Transport
YP_001203457.1	2.2.2 : Transcription related
YP_001203457.1	3.1.2 : Transcriptional level
YP_001203457.1	7.1 : Cytoplasm
YP_001203458.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001203458.1	1.5.1.3 : Arginine
YP_001203458.1	7.1 : Cytoplasm
YP_001203459.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203461.1	3.1.1.2 : Methylation
YP_001203463.1	4 : Transport
YP_001203465.1	3.1.2 : Transcriptional level
YP_001203467.1	3.1.2.3 : Repressor
YP_001203468.1	4.3.A.1.p : periplasmic binding component
YP_001203470.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001203470.1	1.5.1.3 : Arginine
YP_001203470.1	7.1 : Cytoplasm
YP_001203476.1	3.1.2 : Transcriptional level
YP_001203478.1	4.2.A.75 : The L-lysine exporter (LysE) family
YP_001203481.1	3.1.2 : Transcriptional level
YP_001203483.1	1.2 : Macromolecule degradation
YP_001203483.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203485.1	2.1.1 : DNA replication
YP_001203486.1	2.2.2 : Transcription related
YP_001203486.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001203486.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001203486.1	7.1 : Cytoplasm
YP_001203498.1	1.5.3.7 : nicotinamide adenine dinucleotide
YP_001203498.1	1.1.5 : other compounds
YP_001203499.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203503.1	2.2.2 : Transcription related
YP_001203503.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001203503.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001203503.1	5.5.2 : Temperature extremes
YP_001203503.1	7.1 : Cytoplasm
YP_001203504.1	2.2.3 : RNA modification
YP_001203504.1	7.1 : Cytoplasm
YP_001203508.1	1.4.3 : Electron carrier
YP_001203508.1	1 : Metabolism
YP_001203516.1	1.5.1.20 : Chorismate
YP_001203517.1	3.1.2 : Transcriptional level
YP_001203518.1	1.1.1.16 : Rhamnose catabolism
YP_001203518.1	1.7.23 : Methylglyoxal metabolism
YP_001203518.1	1.1.1.11 : Fucose catabolism
YP_001203523.1	4.3.A.1.p : periplasmic binding component
YP_001203524.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203524.1	4.3.A.1.m : membrane component
YP_001203524.1	6.1 : Membrane
YP_001203524.1	7.3 : Inner membrane
YP_001203525.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203525.1	4.3.A.1.a : ATP binding component
YP_001203525.1	7.1 : Cytoplasm
YP_001203526.1	1.1.1.19 : Xylose catabolism
YP_001203527.1	1.1 : Carbon compound utilization
YP_001203529.1	1.7.18 : Betaine biosynthesis
YP_001203530.1	1.5.3.10 : Glutathione
YP_001203531.1	1.1.3 : Amino acids
YP_001203535.1	1.5.1.7 : Lysine, diaminopimelate
YP_001203537.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203538.1	1.6.12 : Flagella
YP_001203538.1	2.2.2 : Transcription related
YP_001203538.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203538.1	3.1.2.4.4 : Quorum sensing
YP_001203538.1	3.3.1 : Operon (regulation of one operon)
YP_001203538.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203539.1	4.3.A.1.a : ATP binding component
YP_001203540.1	4.3.A.1.m : membrane component
YP_001203541.1	4.3.A.1.p : periplasmic binding component
YP_001203542.1	2.2.2 : Transcription related
YP_001203542.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203543.1	2.2.2 : Transcription related
YP_001203543.1	3.1.2.2 : Activator
YP_001203543.1	3.1.2.3 : Repressor
YP_001203543.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203543.1	3.3.1 : Operon (regulation of one operon)
YP_001203543.1	6.1 : Membrane
YP_001203543.1	7.1 : Cytoplasm
YP_001203550.1	1.2 : Macromolecule degradation
YP_001203550.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203550.1	1 : Metabolism
YP_001203551.1	3.1.2 : Transcriptional level
YP_001203558.1	1 : Metabolism
YP_001203559.1	2.2.2 : Transcription related
YP_001203559.1	3.1.2.2 : Activator
YP_001203559.1	5.5.2 : Temperature extremes
YP_001203560.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001203561.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203564.1	4 : Transport
YP_001203568.1	1.1.5.5 : Mandelate catabolism
YP_001203570.1	1.7.1 : Unassigned reversible reactions
YP_001203571.1	1.1.3.12 : Leucine degradation
YP_001203572.1	1.5.3 : Cofactor, small molecule carrier
YP_001203573.1	1.5.3 : Cofactor, small molecule carrier
YP_001203574.1	1.4.3 : Electron carrier
YP_001203575.1	1.4.3 : Electron carrier
YP_001203576.1	1.1.3.12 : Leucine degradation
YP_001203578.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203581.1	1.1.5.5 : Mandelate catabolism
YP_001203584.1	1.4.3 : Electron carrier
YP_001203586.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203587.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203588.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203589.1	1.7.37 : C1 assimilation, serine pathway
YP_001203590.1	1.7.37 : C1 assimilation, serine pathway
YP_001203592.1	2.1.1 : DNA replication
YP_001203592.1	5.8 : SOS response
YP_001203592.1	7.1 : Cytoplasm
YP_001203593.1	2.2.5 : tRNA
YP_001203594.1	4 : transport
YP_001203594.1	4.2.A.38 : The K+ Transporter (Trk) Family
YP_001203599.1	1.8.2 : Sulfur metabolism
YP_001203601.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203602.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203603.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203604.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203605.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203606.1	3.3.4 : Global
YP_001203606.1	3.1.2.4.2 : Regulons or multilayer component regulatory systems
YP_001203607.1	3.1.2.4.2 : Regulons or multilayer component regulatory systems
YP_001203607.1	3.3.4 : Global
YP_001203609.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203610.1	1.5.3.10 : Glutathione
YP_001203613.1	6.1 : Membrane
YP_001203614.1	3.1.2 : Transcriptional level
YP_001203615.1	4.3.A.1.p : periplasmic binding component
YP_001203616.1	4.3.A.1.m : membrane component
YP_001203617.1	4.3.A.1.a : ATP binding component
YP_001203620.1	1.2.2 : DNA
YP_001203622.1	1.4.3 : Electron carrier
YP_001203623.1	2.2.2 : Transcription related
YP_001203623.1	3.1.2.2 : Activator
YP_001203623.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203624.1	1.3.8 : ATP proton motive force interconversion
YP_001203624.1	6.4 : Flagellum
YP_001203625.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001203625.1	6.4 : Flagellum
YP_001203626.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001203629.1	1.6.12 : Flagella
YP_001203629.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203629.1	6.1 : Membrane
YP_001203629.1	6.4 : Flagellum
YP_001203629.1	7.3 : Inner membrane
YP_001203639.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203640.1	4.S.36 : Cu
YP_001203641.1	5.6.4 : Drug resistance/sensitivity
YP_001203642.1	4 : Transport
YP_001203642.1	4.S.36 : Cu
YP_001203642.1	5.6.4 : Drug resistance/sensitivity
YP_001203645.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203646.1	4 : Transport
YP_001203648.1	1.1.3.8 : Tryptophan utilization
YP_001203649.1	1.1.3.8 : Tryptophan utilization
YP_001203651.1	1.8.3 : Nitrogen metabolism
YP_001203651.1	1.1 : Carbon compound utilization
YP_001203652.1	1.1 : Carbon compound utilization
YP_001203653.1	3.1.2 : Transcriptional level
YP_001203654.1	1.5.3.10 : Glutathione
YP_001203658.1	4.3.A.1.am : ATP binding and membrane component
YP_001203659.1	4.3.A.1.p : periplasmic binding component
YP_001203660.1	4.3.A.1.m : membrane component
YP_001203661.1	4.3.A.1.a : ATP binding component
YP_001203662.1	4.3.A.1.p : periplasmic binding component
YP_001203663.1	4.3.A.1.m : membrane component
YP_001203664.1	1.1.3.11 : Histidine degradation
YP_001203665.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001203666.1	2.2.2 : Transcription related
YP_001203666.1	3.1.2 : Transcriptional level
YP_001203667.1	4.3.A.1.a : ATP binding component
YP_001203668.1	4.3.A.1.m : membrane component
YP_001203669.1	4.3.A.1.m : membrane component
YP_001203673.1	4.3.A.1.p : periplasmic binding component
YP_001203675.1	3.1.2 : Transcriptional level
YP_001203681.1	1.1.1.4 : D-galactarate catabolism
YP_001203682.1	1 : Metabolism
YP_001203683.1	1.1.1.6 : D-glucarate catabolism
YP_001203684.1	1.1.1.6 : D-glucarate catabolism
YP_001203685.1	3.1.2 : Transcriptional level
YP_001203686.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203686.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203686.1	6.1 : Membrane
YP_001203686.1	7.3 : Inner membrane
YP_001203687.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203688.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001203690.1	1.7.8 : Gluconeogenesis
YP_001203691.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001203692.1	1.3.1 : Glycolysis
YP_001203693.1	1.3.1 : Glycolysis
YP_001203694.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203695.1	4.3.A.1.m : membrane component
YP_001203696.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203696.1	4.3.A.1.m : membrane component
YP_001203696.1	6.1 : Membrane
YP_001203696.1	7.3 : Inner membrane
YP_001203697.1	4.3.A.1.a : ATP binding component
YP_001203698.1	4.3.A.1.a : ATP binding component
YP_001203699.1	4.3.A.1.p : periplasmic binding component
YP_001203703.1	4.3.A.1.m : membrane component
YP_001203704.1	4.3.A.1.m : membrane component
YP_001203705.1	4.3.A.1.a : ATP binding component
YP_001203706.1	4.3.A.1.a : ATP binding component
YP_001203707.1	4.3.A.1.p : periplasmic binding component
YP_001203714.1	4.3.A.1.a : ATP binding component
YP_001203715.1	4.3.A.1.m : membrane component
YP_001203716.1	4.3.A.1.p : periplasmic binding component
YP_001203717.1	3.1.2.3 : Repressor
YP_001203719.1	1.1.3.11 : Histidine degradation
YP_001203720.1	1.1.3.11 : Histidine degradation
YP_001203721.1	1.1.3.11 : Histidine degradation
YP_001203726.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001203727.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001203731.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001203731.1	7.1 : Cytoplasm
YP_001203743.1	8.3.1 : transposases
YP_001203744.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203745.1	3.1.2.4 : Complex regulation
YP_001203745.1	3.1.2.3 : Repressor
YP_001203746.1	1.3.6 : Aerobic respiration
YP_001203746.1	1.4.3 : Electron carrier
YP_001203751.1	3.1.2.4 : Complex regulation
YP_001203751.1	3.1.2.2 : Activator
YP_001203752.1	3 : Regulation
YP_001203760.1	1.4 : Energy production/transport
YP_001203766.1	1.5.3.12 : Heme, porphyrin
YP_001203769.1	1.3 : Energy metabolism (carbon)
YP_001203769.1	3.1.2 : Transcriptional level
YP_001203770.1	1.3.2 : Pentose phosphate shunt, oxidative branch
YP_001203770.1	1.3 : Energy metabolism (carbon)
YP_001203771.1	1.3 : Energy metabolism (carbon)
YP_001203772.1	1.7.3 : Pentose phosphate shunt, non-oxidative branch
YP_001203772.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001203772.1	1.1.1.22 : Ribose degradation
YP_001203773.1	1.3 : Energy metabolism (carbon)
YP_001203774.1	1.3 : Energy metabolism (carbon)
YP_001203775.1	1.3 : Energy metabolism (carbon)
YP_001203778.1	3.1.2 : Transcriptional level
YP_001203780.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001203781.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001203782.1	2.2.2 : Transcription related
YP_001203782.1	3.1.2.2 : Activator
YP_001203782.1	3.1.2.3 : Repressor
YP_001203782.1	3.3.2 : Regulon (a network of operons encoding related functions)
YP_001203782.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001203782.1	7.1 : Cytoplasm
YP_001203788.1	1.8.1 : Phosphorous metabolism
YP_001203788.1	4.3.A.1.p : periplasmic binding component
YP_001203788.1	7.2 : Periplasmic space
YP_001203789.1	1.8.1 : Phosphorous metabolism
YP_001203789.1	4.3.A.1.m : membrane component
YP_001203789.1	6.1 : Membrane
YP_001203789.1	7.3 : Inner membrane
YP_001203790.1	1.8.1 : Phosphorous metabolism
YP_001203790.1	4.3.A.1.m : membrane component
YP_001203790.1	6.1 : Membrane
YP_001203790.1	7.3 : Inner membrane
YP_001203791.1	1.8.1 : Phosphorous metabolism
YP_001203791.1	4.3.A.1.a : ATP binding component
YP_001203791.1	7.1 : Cytoplasm
YP_001203792.1	1.8.1 : Phosphorous metabolism
YP_001203792.1	3.1.4 : Regulation level unknown
YP_001203793.1	1.8.1 : Phosphorous metabolism
YP_001203793.1	2.2.2 : Transcription related
YP_001203793.1	3.1.2.2 : Activator
YP_001203793.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203793.1	3.3.2 : Regulon (a network of operons encoding related functions)
YP_001203793.1	7.1 : Cytoplasm
YP_001203795.1	4.S.143 : Ni++
YP_001203796.1	1.8 : Metabolism of other compounds
YP_001203797.1	1.8 : Metabolism of other compounds
YP_001203797.1	3 : Regulation
YP_001203798.1	1.4 : Energy production/transport
YP_001203798.1	1.8 : Metabolism of other compounds
YP_001203798.1	1.3.7 : Anaerobic respiration
YP_001203799.1	1.4 : Energy production/transport
YP_001203799.1	1.8 : Metabolism of other compounds
YP_001203799.1	1.3.7 : Anaerobic respiration
YP_001203800.1	1.8 : Metabolism of other compounds
YP_001203801.1	1.8 : Metabolism of other compounds
YP_001203802.1	1.8 : Metabolism of other compounds
YP_001203803.1	1.8 : Metabolism of other compounds
YP_001203804.1	1.8 : Metabolism of other compounds
YP_001203805.1	1.4.3 : Electron carrier
YP_001203805.1	1.8 : Metabolism of other compounds
YP_001203806.1	1.8 : Metabolism of other compounds
YP_001203807.1	1.8 : Metabolism of other compounds
YP_001203808.1	3.1.4 : Regulation level unknown
YP_001203810.1	2.3.4 : Chaperoning, folding
YP_001203811.1	2.3.4 : Chaperoning, folding
YP_001203812.1	2.3.4 : Chaperoning, folding
YP_001203813.1	1.8 : Metabolism of other compounds
YP_001203813.1	2.3.3 : Posttranslational modification
YP_001203814.1	2.3.4 : Chaperoning, folding
YP_001203815.1	1.8.3 : Nitrogen metabolism
YP_001203815.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203816.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203817.1	4.9.B :  uncharacterized transport protein
YP_001203817.1	6.1 : Membrane
YP_001203818.1	3 : Regulation
YP_001203819.1	3.1.2 : Transcriptional level
YP_001203821.1	1.4 : Energy production/transport
YP_001203821.1	1.1.5.2 : Ethanol degradation
YP_001203821.1	7.2 : Periplasmic space
YP_001203824.1	1.5.3 : Cofactor, small molecule carrier
YP_001203825.1	1.1 : Carbon compound utilization
YP_001203826.1	1.4 : Energy production/transport
YP_001203826.1	1.1 : Carbon compound utilization
YP_001203827.1	4.9.B :  uncharacterized transport protein
YP_001203827.1	4.S.34 : citrate/succinate
YP_001203827.1	7.2 : Periplasmic space
YP_001203828.1	4 : Transport
YP_001203828.1	4.9.B :  uncharacterized transport protein
YP_001203828.1	4.S.34 : citrate/succinate
YP_001203828.1	6.1 : Membrane
YP_001203829.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203830.1	4.2.A.69 : The Auxin Efflux Carrier (AEC) Family
YP_001203830.1	4.S.46 : dicarboxylate
YP_001203831.1	1.5.1.18 : Isoleucine/valine
YP_001203831.1	7.1 : Cytoplasm
YP_001203832.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001203832.1	7.3 : Inner membrane
YP_001203833.1	1.4.2 : electron acceptor
YP_001203833.1	1.3.6 : aerobic respiration
YP_001203833.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001203834.1	1.4.2 : Electron acceptor
YP_001203834.1	1.3.6 : Aerobic respiration
YP_001203834.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001203834.1	6.1 : Membrane
YP_001203834.1	7.3 : Inner membrane
YP_001203835.1	1.4.2 : Electron acceptor
YP_001203835.1	1.3.6 : Aerobic respiration
YP_001203835.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001203835.1	6.1 : Membrane
YP_001203835.1	7.3 : Inner membrane
YP_001203836.1	1.4.2 : Electron acceptor
YP_001203836.1	1.3.6 : Aerobic respiration
YP_001203836.1	6.1 : Membrane
YP_001203836.1	7.3 : Inner membrane
YP_001203838.1	3.1.2.2 : Activator
YP_001203839.1	3.1.2.2 : Activator
YP_001203839.1	8.1.3 : Regulation
YP_001203841.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001203841.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001203841.1	5.6.4 : Drug resistance/sensitivity
YP_001203842.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001203842.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001203842.1	5.6.4 : Drug resistance/sensitivity
YP_001203843.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001203843.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001203843.1	5.6.4 : Drug resistance/sensitivity
YP_001203844.1	2.2.2 : Transcription related
YP_001203849.1	4.2.A.40 : The Nucleobase:Cation Symporter-2 (NCS2) Family
YP_001203849.1	6.1 : Membrane
YP_001203849.1	7.3 : Inner membrane
YP_001203850.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001203850.1	1.5.2.1 : Purine biosynthesis
YP_001203852.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001203853.1	1.1.3 : Amino acids
YP_001203853.1	4.3.A.1.a : ATP binding component
YP_001203853.1	7.1 : Cytoplasm
YP_001203854.1	1.1.3 : Amino acids
YP_001203854.1	4.3.A.1.a : ATP binding component
YP_001203854.1	7.1 : Cytoplasm
YP_001203855.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203855.1	4.3.A.1.m : membrane component
YP_001203855.1	6.1 : Membrane
YP_001203855.1	7.3 : Inner membrane
YP_001203856.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203856.1	4.3.A.1.m : membrane component
YP_001203856.1	6.1 : Membrane
YP_001203856.1	7.3 : Inner membrane
YP_001203857.1	1.1.3 : Amino acids
YP_001203857.1	4.3.A.1.p : periplasmic binding component
YP_001203857.1	7.2 : Periplasmic space
YP_001203858.1	4.3.A.1.p : periplasmic binding component
YP_001203859.1	4.3.A.1.m : membrane component
YP_001203860.1	4.3.A.1.m : membrane component
YP_001203861.1	4.3.A.1.a : ATP binding component
YP_001203863.1	1.5.2 : Nucleotide
YP_001203864.1	4 : transport
YP_001203866.1	4.9.B :  uncharacterized transport protein
YP_001203867.1	1.1.1.13 : Galactonate catabolism
YP_001203868.1	1.1.1.13 : Galactonate catabolism
YP_001203869.1	3.1.2 : Transcriptional level
YP_001203872.1	1.5.1.11 : Serine
YP_001203872.1	7.1 : Cytoplasm
YP_001203874.1	2.2.2 : Transcription related
YP_001203877.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001203877.1	4.3.A.1.a : ATP binding component
YP_001203878.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001203878.1	4.3.A.1.m : membrane component
YP_001203878.1	6.1 : Membrane
YP_001203878.1	7.3 : Inner membrane
YP_001203879.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001203879.1	4.3.A.1.p : periplasmic binding component
YP_001203881.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001203881.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203885.1	1.3.7 : Anaerobic respiration
YP_001203887.1	1.4.3 : Electron carrier
YP_001203887.1	1.8.3 : Nitrogen metabolism
YP_001203887.1	1.3.7 : Anaerobic respiration
YP_001203888.1	1.4.3 : Electron carrier
YP_001203888.1	1.8.3 : Nitrogen metabolism
YP_001203888.1	1.3.7 : Anaerobic respiration
YP_001203889.1	1.3.7 : Anaerobic respiration
YP_001203889.1	1.8.3 : Nitrogen metabolism
YP_001203890.1	1.3.7 : Anaerobic respiration
YP_001203890.1	1.8.3 : Nitrogen metabolism
YP_001203893.1	1.8.3 : Nitrogen metabolism
YP_001203893.1	1.1.3 : Amino acids
YP_001203895.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001203898.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001203899.1	1.8.3 : Nitrogen metabolism
YP_001203899.1	1.5.1 : Amino acids
YP_001203900.1	1.5.1 : Amino acids
YP_001203901.1	1.7.1 : Unassigned reversible reactions
YP_001203901.1	1.1.3 : Amino acids
YP_001203902.1	1.7.7 : Galactose metabolism
YP_001203903.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001203904.1	3.1.2 : Transcriptional level
YP_001203905.1	1.4.3 : Electron carrier
YP_001203906.1	4.3.A.1.p : periplasmic binding component
YP_001203906.1	7.2 : Periplasmic space
YP_001203907.1	4.3.A.1.m : membrane component
YP_001203907.1	6.1 : Membrane
YP_001203907.1	7.3 : Inner membrane
YP_001203908.1	4.3.A.1.m : membrane component
YP_001203908.1	6.1 : Membrane
YP_001203908.1	7.3 : Inner membrane
YP_001203909.1	4.3.A.1.a : ATP binding component
YP_001203909.1	7.1 : Cytoplasm
YP_001203910.1	1.4.3 : Electron carrier
YP_001203910.1	1.7.35 : Lactate oxidation
YP_001203912.1	1.1.1.7 : D-glucuronate catabolism
YP_001203912.1	1.1.1.5 : D-galacturonate catabolism
YP_001203913.1	1.1.1.9 : L-idonate catabolism
YP_001203914.1	1.1.1.7 : D-glucuronate catabolism
YP_001203914.1	1.1.1.5 : D-galacturonate catabolism
YP_001203915.1	1.1.1.7 : D-glucuronate catabolism
YP_001203915.1	1.3.9 : Entner-Doudoroff pathway
YP_001203915.1	1.7.21 : Glyoxylate degradation
YP_001203915.1	1.1.1.20 : Glycol degradation
YP_001203915.1	1.1.1.5 : D-galacturonate catabolism
YP_001203915.1	7.1 : Cytoplasm
YP_001203916.1	4.3.A.1.p : periplasmic binding component
YP_001203916.1	7.2 : Periplasmic space
YP_001203917.1	4.3.A.1.a : ATP binding component
YP_001203918.1	4.3.A.1.m : membrane component
YP_001203918.1	6.1 : Membrane
YP_001203918.1	7.3 : Inner membrane
YP_001203919.1	4.3.A.1.m : membrane component
YP_001203919.1	7.3 : Inner membrane
YP_001203920.1	3.1.2 : Transcriptional level
YP_001203921.1	1.5.1.18 : Isoleucine/valine
YP_001203922.1	1.5.1.7 : Lysine, diaminopimelate
YP_001203922.1	7.1 : Cytoplasm
YP_001203923.1	1.1.1.23 : Galactose degradation
YP_001203923.1	7.1 : Cytoplasm
YP_001203924.1	1.7.7 : Galactose metabolism
YP_001203924.1	7.2 : Periplasmic space
YP_001203926.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203926.1	4.3.A.1.p : periplasmic binding component
YP_001203926.1	7.2 : Periplasmic space
YP_001203927.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203927.1	4.3.A.1.a : ATP binding component
YP_001203927.1	7.1 : Cytoplasm
YP_001203928.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001203928.1	4.3.A.1.m : membrane component
YP_001203928.1	6.1 : Membrane
YP_001203928.1	7.3 : Inner membrane
YP_001203930.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203931.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001203931.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203932.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203933.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203934.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203935.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203936.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001203940.1	3 : Regulation
YP_001203940.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001203945.1	1.8.2 : Sulfur metabolism
YP_001203952.1	1.5.3.10 : Glutathione
YP_001203959.1	1.1 : Carbon compound utilization
YP_001203961.1	1.1 : Carbon compound utilization
YP_001203962.1	3.1.2 : Transcriptional level
YP_001203964.1	3.1.2 : Transcriptional level
YP_001203970.1	1.4.3 : Electron carrier
YP_001203970.1	3.1.2 : Transcriptional level
YP_001203971.1	4 : Transport
YP_001203975.1	1 : Metabolism
YP_001203976.1	1.1.5 : Others
YP_001203976.1	3.1.2 : Transcriptional level
YP_001203979.1	1.7.20 : S-adenosyl methionine biosynthesis
YP_001203979.1	1.5.1.9 : Methionine
YP_001203980.1	1.7.28 : Pyruvate catabolism
YP_001203980.1	1.7.29 : Acetate catabolism
YP_001203980.1	1.1.3.7 : Threonine catabolism
YP_001203980.1	1.3.5 : Fermentation
YP_001203980.1	7.1 : Cytoplasm
YP_001203981.1	1.7.18 : Betaine biosynthesis
YP_001203981.1	5.5.1 : Osmotic pressure
YP_001203981.1	6.1 : Membrane
YP_001203981.1	7.3 : Inner membrane
YP_001203982.1	1.5.3.12 : Heme, porphyrin
YP_001203983.1	1.5.3.12 : Heme, porphyrin
YP_001203989.1	1.5.3.10 : Glutathione
YP_001203990.1	2.3.4 : Chaperoning, folding
YP_001203994.1	4.2.A.66 : The Multi Antimicrobial Extrusion (MATE) Family
YP_001203994.1	5.6.4 : Drug resistance/sensitivity
YP_001203997.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204001.1	3.1.2 : Transcriptional level
YP_001204004.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001204005.1	5.6.4 : Drug resistance/sensitivity
YP_001204006.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001204006.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001204006.1	5.6.4 : Drug resistance/sensitivity
YP_001204007.1	3.1.2 : Transcriptional level
YP_001204011.1	1.7.6 : Glycerol metabolism
YP_001204011.1	2.2.2 : Transcription related
YP_001204011.1	3.1.2 : Transcriptional level
YP_001204011.1	3.3 : Genetic unit regulated
YP_001204012.1	1.7.6 : Glycerol metabolism
YP_001204012.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001204015.1	4.3.A.1.m : membrane component
YP_001204016.1	4.3.A.1.m : membrane component
YP_001204018.1	4.3.A.1.p : periplasmic binding component
YP_001204019.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001204019.1	5.5.7 : Fe aquisition
YP_001204019.1	6.1 : Membrane
YP_001204019.1	7.3 : Inner membrane
YP_001204020.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001204020.1	5.5.7 : Fe aquisition
YP_001204021.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001204021.1	5.5.7 : Fe aquisition
YP_001204025.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204027.1	1.7.1 : Unassigned reversible reactions
YP_001204027.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001204028.1	7.2 : Periplasmic space
YP_001204029.1	4.3.A.1.a : ATP binding component
YP_001204037.1	1.7.9 : Misc. glucose metabolism
YP_001204037.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204037.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001204037.1	7.1 : Cytoplasm
YP_001204045.1	1.6.6 : Osmoregulated periplasmic glucan
YP_001204045.1	5.5.1 : Osmotic pressure
YP_001204045.1	6.1 : Membrane
YP_001204045.1	7.3 : Inner membrane
YP_001204046.1	1.6.6 : Osmoregulated periplasmic glucan
YP_001204046.1	5.5.1 : Osmotic pressure
YP_001204046.1	7.2 : Periplasmic space
YP_001204047.1	8.3.1 : transposases
YP_001204048.1	3.1.2 : Transcriptional level
YP_001204050.1	3.1.2 : Transcriptional level
YP_001204055.1	1.6.3 : Lipopolysaccharide
YP_001204056.1	1.1 : Carbon compound utilization
YP_001204058.1	4 : Transport
YP_001204058.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001204058.1	4.S.54 : Fe++
YP_001204063.1	3.1.2 : Transcriptional level
YP_001204067.1	2.2.3 : RNA modification
YP_001204067.1	7.1 : Cytoplasm
YP_001204069.1	3 : Regulation
YP_001204070.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204071.1	1.5.3.12 : Heme, porphyrin
YP_001204071.1	7.1 : Cytoplasm
YP_001204072.1	1.5.3.20 : Tetrahydrobiopterin biosynthesis
YP_001204074.1	2.2.3 : RNA modification
YP_001204075.1	1.3.7 : Anaerobic respiration
YP_001204075.1	1.4 : Energy production/transport
YP_001204075.1	1.4.3 : Electron carrier
YP_001204075.1	1.3.6 : Aerobic respiration
YP_001204076.1	1.3.6 : Aerobic respiration
YP_001204076.1	1.3.7 : Anaerobic respiration
YP_001204076.1	1.4 : Energy production/transport
YP_001204076.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001204076.1	1.6.15.1 : Cytochromes
YP_001204086.1	1.5.1.15 : Tryptophan
YP_001204086.1	1.5.1.2 : Glutamine
YP_001204086.1	1.5.1.1 : Glutamate
YP_001204087.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204087.1	2.3.6 : Turnover, degradation
YP_001204087.1	7.1 : Cytoplasm
YP_001204091.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204099.1	2.1.4 : DNA repair
YP_001204099.1	7.1 : Cytoplasm
YP_001204100.1	1.5.3.10 : Glutathione
YP_001204101.1	1.5.3.12 : Heme, porphyrin
YP_001204102.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204104.1	2.1.1 : DNA replication
YP_001204106.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001204107.1	3.1.2 : Transcriptional level
YP_001204108.1	1.3.1 : Glycolysis
YP_001204109.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204111.1	1.2.1 : RNA
YP_001204111.1	2.2.4 : RNA degradation
YP_001204111.1	7.1 : Cytoplasm
YP_001204113.1	2.1.1 : DNA replication
YP_001204114.1	1.4.3 : Electron carrier
YP_001204114.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001204114.1	1.4 : Energy production/transport
YP_001204116.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204116.1	7.1 : Cytoplasm
YP_001204117.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204117.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001204121.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204123.1	2.3.1 : Amino acid-activation
YP_001204125.1	2.3.1 : Amino acid-activation
YP_001204125.1	7.1 : Cytoplasm
YP_001204128.1	1.7.8 : Gluconeogenesis
YP_001204130.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001204131.1	4 : Transport
YP_001204132.1	1.4.3 : Electron carrier
YP_001204132.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001204135.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204136.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204140.1	2.1.4 : DNA repair
YP_001204140.1	7.1 : Cytoplasm
YP_001204141.1	1.1.3.5 : Glycine cleavage
YP_001204142.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001204151.1	1.7.35 : Lactate oxidation
YP_001204151.1	1.4.3 : Electron carrier
YP_001204153.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001204162.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001204163.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001204163.1	1.7.7 : Galactose metabolism
YP_001204163.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001204164.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204166.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001204167.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001204169.1	1.3.1 : Glycolysis
YP_001204173.1	3.1.2 : Transcriptional level
YP_001204181.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204183.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204187.1	1.5.1.12 : Cysteine
YP_001204187.1	1.1.3 : Amino acids
YP_001204192.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001204196.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001204196.1	7.1 : Cytoplasm
YP_001204197.1	1.1.3 : Amino acids
YP_001204199.1	1.1.4 : Amines
YP_001204199.1	4.3.A.1.a : ATP binding component
YP_001204199.1	4.S.163 : putrescine
YP_001204199.1	7.1 : Cytoplasm
YP_001204200.1	1.1.4 : Amines
YP_001204200.1	4.S.163 : putrescine
YP_001204200.1	7.2 : Periplasmic space
YP_001204201.1	1.1.4 : Amines
YP_001204201.1	4 : Transport
YP_001204201.1	4.S.163 : putrescine
YP_001204201.1	7.3 : Inner membrane
YP_001204202.1	1.1.4 : Amines
YP_001204202.1	4.S.163 : putrescine
YP_001204202.1	7.3 : Inner membrane
YP_001204203.1	2.2.2 : Transcription related
YP_001204209.1	1.1.3 : Amino acids
YP_001204209.1	4.3.A.1.p : periplasmic binding component
YP_001204209.1	7.2 : Periplasmic space
YP_001204210.1	1.1.3 : Amino acids
YP_001204210.1	4.3.A.1.m : membrane component
YP_001204210.1	7.3 : Inner membrane
YP_001204211.1	1.1.3 : Amino acids
YP_001204211.1	1.5.1.18 : Isoleucine/valine
YP_001204211.1	1.5.1.19 : Leucine
YP_001204211.1	4.3.A.1.a : ATP binding component
YP_001204211.1	7.1 : Cytoplasm
YP_001204212.1	1.1.3 : Amino acids
YP_001204212.1	1.5.1.18 : Isoleucine/valine
YP_001204212.1	1.5.1.19 : Leucine
YP_001204212.1	4.3.A.1.a : ATP binding component
YP_001204212.1	7.1 : Cytoplasm
YP_001204213.1	3.1.2 : Transcriptional level
YP_001204217.1	1.1.1.2 : 2,5-ketogluconate metabolism
YP_001204217.1	7.1 : Cytoplasm
YP_001204222.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001204223.1	1.1.3.8 : Tryptophan utilization
YP_001204223.1	1.1.3.10 : Lysine cleavage
YP_001204223.1	7.1 : Cytoplasm
YP_001204224.1	5.6.4 : Drug resistance/sensitivity
YP_001204224.1	7.2 : Periplasmic space
YP_001204227.1	4.3.A.1.p : periplasmic binding component
YP_001204228.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204231.1	4.2.A.45 : The Metal Ion Transporter (MIT) Family
YP_001204231.1	4.9.A.17 : The Metal Ion Transporter (MIT) Family
YP_001204231.1	4.S.120 : Mg++
YP_001204233.1	1.8.3 : Nitrogen metabolism
YP_001204234.1	1.7.27 : Pyridoxal 5'-phosphate salvage
YP_001204234.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001204236.1	2.3.4 : Chaperoning, folding
YP_001204236.1	5.5.2 : Temperature extremes
YP_001204236.1	7.1 : Cytoplasm
YP_001204238.1	2.2.2 : Transcription related
YP_001204238.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001204238.1	5.5.2 : Temperature extremes
YP_001204238.1	7.1 : Cytoplasm
YP_001204239.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001204239.1	7.1 : Cytoplasm
YP_001204240.1	1.3.1 : Glycolysis
YP_001204241.2	1.5.1.20 : Chorismate
YP_001204243.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204246.1	2.2.3 : RNA modification
YP_001204247.1	2.2.3 : RNA modification
YP_001204248.1	1.5.2 : Nucleotide
YP_001204249.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001204249.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001204249.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204250.1	2.1.5 : DNA degradation
YP_001204250.1	2.1.4 : DNA repair
YP_001204250.1	7.1 : Cytoplasm
YP_001204252.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001204253.1	5.6.4 : Drug resistance/sensitivity
YP_001204253.1	5.10 : Defense/survival
YP_001204254.1	1.7.1 : Unassigned reversible reactions
YP_001204255.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204258.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001204263.1	1.4.3 : Electron carrier
YP_001204267.1	1.6.2 : Colanic acid (M antigen)
YP_001204267.1	5.5.5 : Dessication
YP_001204267.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001204267.1	6.7 : Capsule (M and K antigens)
YP_001204267.1	7.1 : Cytoplasm
YP_001204268.1	1.6.2 : Colanic acid (M antigen)
YP_001204268.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001204268.1	5.5.5 : Dessication
YP_001204268.1	6.7 : Capsule (M and K antigens)
YP_001204268.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001204268.1	7.1 : Cytoplasm
YP_001204274.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001204274.1	4.9.B :  uncharacterized transport protein
YP_001204275.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001204275.1	4.9.B :  uncharacterized transport protein
YP_001204276.1	4.9.B :  uncharacterized transport protein
YP_001204277.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001204277.1	4.9.B :  uncharacterized transport protein
YP_001204278.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001204278.1	4.9.A : Transporters of Unknown Classification
YP_001204282.1	8.1 : Prophage genes and phage related functions
YP_001204283.1	1.6.3 : Lipopolysaccharide
YP_001204283.1	8.1 : Prophage genes and phage related functions
YP_001204284.1	8.1 : Prophage genes and phage related functions
YP_001204285.1	8.1 : Prophage genes and phage related functions
YP_001204286.1	8.1 : Prophage genes and phage related functions
YP_001204287.1	8.1 : Prophage genes and phage related functions
YP_001204289.1	8.1 : Prophage genes and phage related functions
YP_001204290.1	8.1 : Prophage genes and phage related functions
YP_001204291.1	4.S.105 : lipopolysaccharide
YP_001204291.1	8.1 : Prophage genes and phage related functions
YP_001204292.1	8.1 : Prophage genes and phage related functions
YP_001204293.1	8.1 : Prophage genes and phage related functions
YP_001204296.1	4.9.A.1 : The Polysaccharide Transporter (PST) Family
YP_001204296.1	8.1 : Prophage genes and phage related functions
YP_001204297.1	8.1 : Prophage genes and phage related functions
YP_001204301.1	2.2.2 : Transcription related
YP_001204301.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001204301.1	8.1 : Prophage genes and phage related functions
YP_001204303.1	4.1 : Channel-type Transporters
YP_001204304.1	4.1 : Channel-type Transporters
YP_001204308.1	2.3.4 : Chaperoning, folding
YP_001204309.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001204310.1	8.3.1 : transposases
YP_001204311.1	1.6.3 : Lipopolysaccharide
YP_001204312.1	8.1 : Prophage genes and phage related functions
YP_001204314.1	8.1 : Prophage genes and phage related functions
YP_001204315.1	8.1 : Prophage genes and phage related functions
YP_001204320.1	8.1 : Prophage genes and phage related functions
YP_001204321.1	8.1 : Prophage genes and phage related functions
YP_001204322.1	8.1 : Prophage genes and phage related functions
YP_001204323.1	8.1 : Prophage genes and phage related functions
YP_001204324.1	8.1 : Prophage genes and phage related functions
YP_001204325.1	3.1.2 : Transcriptional level
YP_001204325.1	8.1 : Prophage genes and phage related functions
YP_001204326.1	3.1.2 : Transcriptional level
YP_001204327.1	8.1 : Prophage genes and phage related functions
YP_001204328.1	1.3.6 : Aerobic respiration
YP_001204328.1	1.4 : Energy production/transport
YP_001204328.1	1.6.15.1 : Cytochromes
YP_001204329.1	1.3.6 : Aerobic respiration
YP_001204329.1	1.4 : Energy production/transport
YP_001204329.1	1.5.3.12 : Heme, porphyrin
YP_001204329.1	1.6.15.1 : Cytochromes
YP_001204331.1	1.4 : Energy production/transport
YP_001204331.1	1.3.6 : Aerobic respiration
YP_001204331.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001204332.1	1.4 : Energy production/transport
YP_001204332.1	1.5.3.12 : Heme, porphyrin
YP_001204332.1	1.6.15.1 : Cytochromes
YP_001204332.1	1.3.6 : Aerobic respiration
YP_001204333.1	1.3.6 : Aerobic respiration
YP_001204333.1	1.5.3.12 : Heme, porphyrin
YP_001204333.1	1.6.15.1 : Cytochromes
YP_001204335.1	3.1.2 : Transcriptional level
YP_001204336.1	1.1.3.8 : Tryptophan utilization
YP_001204338.1	1.1.3 : Amino acids
YP_001204339.1	4 : Transport
YP_001204340.1	1.1.3 : Amino acids
YP_001204340.1	1.5.1.18 : Isoleucine/valine
YP_001204340.1	1.5.1.19 : Leucine
YP_001204340.1	4.3.A.1.a : ATP binding component
YP_001204340.1	7.1 : Cytoplasm
YP_001204341.1	4 : Transport
YP_001204342.1	4 : Transport
YP_001204343.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001204344.1	1.1.3.8 : Tryptophan utilization
YP_001204345.1	1.3 : Energy metabolism (carbon)
YP_001204345.1	3.1.2 : Transcriptional level
YP_001204346.1	1.3 : Energy metabolism (carbon)
YP_001204347.1	1.3 : Energy metabolism (carbon)
YP_001204348.1	5 : Cell processes
YP_001204349.1	5 : Cell processes
YP_001204350.1	5 : Cell processes
YP_001204351.1	5 : Cell processes
YP_001204352.1	5 : Cell processes
YP_001204353.1	1.3 : Energy metabolism (carbon)
YP_001204353.1	5 : Cell processes
YP_001204356.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001204356.1	1.4.3 : Electron carrier
YP_001204356.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001204358.1	2.2.2 : Transcription related
YP_001204359.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204368.1	4.S.53 : Fe
YP_001204368.1	5.5.7 : Fe aquisition
YP_001204370.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204370.1	3.1.4 : Regulation level unknown
YP_001204370.1	4.2.A.23 : The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family
YP_001204370.1	6.1 : Membrane
YP_001204370.1	7.3 : Inner membrane
YP_001204371.1	1.4.1 : Electron donor
YP_001204371.1	1.3.6 : Aerobic respiration
YP_001204371.1	1.3.7 : Anaerobic respiration
YP_001204371.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001204371.1	7.3 : Inner membrane
YP_001204372.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204373.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204376.1	4.3.A.1.p : periplasmic binding component
YP_001204377.2	1.3.2 : pentose phosphate shunt, oxidative branch
YP_001204377.2	1.5.1.18 : isoleucine/valine
YP_001204377.2	1 : metabolism
YP_001204378.1	4.3.A.1.a : ATP binding component
YP_001204379.1	4.3.A.1.m : membrane component
YP_001204380.1	4.3.A.1.m : membrane component
YP_001204382.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204382.1	1.1.3 : Amino acids
YP_001204382.1	1.1 : Carbon compound utilization
YP_001204383.1	1.1.3.13 : Methionine degradation
YP_001204383.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001204383.1	1.1.3 : Amino acids
YP_001204384.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001204388.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204389.1	1.1.5 : Others
YP_001204390.1	1.1.5 : Others
YP_001204392.1	4.3.A.1.p : periplasmic binding component
YP_001204393.1	3.1.2 : Transcriptional level
YP_001204401.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001204402.1	1.1.5 : Others
YP_001204402.1	3.1.2 : Transcriptional level
YP_001204403.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204403.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001204404.1	1.1.5 : Others
YP_001204405.1	1.1 : Carbon compound utilization
YP_001204407.1	1.1.5 : Others
YP_001204408.1	1.1.5 : Others
YP_001204409.1	1.1 : Carbon compound utilization
YP_001204411.1	4.3.A.1.p : periplasmic binding component
YP_001204413.1	1.5.1.20 : Chorismate
YP_001204414.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204414.1	7.2 : Periplasmic space
YP_001204415.1	3.1.2 : Transcriptional level
YP_001204416.1	1.4.3 : Electron carrier
YP_001204417.1	1.4.3 : Electron carrier
YP_001204418.1	3.1.2 : Transcriptional level
YP_001204419.1	1.1.5 : Others
YP_001204421.1	8.3.1 : transposases
YP_001204424.1	3.1.2 : Transcriptional level
YP_001204425.1	1.1.1.19 : Xylose catabolism
YP_001204426.1	1.7.9 : Misc. glucose metabolism
YP_001204426.1	1.1.1.19 : Xylose catabolism
YP_001204426.1	7.1 : Cytoplasm
YP_001204427.1	4.3.A.1.a : ATP binding component
YP_001204427.1	4.S.10 : allose/ribose
YP_001204428.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204428.1	4.3.A.1.m : membrane component
YP_001204428.1	6.1 : Membrane
YP_001204428.1	7.3 : Inner membrane
YP_001204429.1	4.3.A.1.p : periplasmic binding component
YP_001204430.1	3.1.2 : Transcriptional level
YP_001204431.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001204435.1	1.1.5 : Others
YP_001204438.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001204439.1	1.8.3 : Nitrogen metabolism
YP_001204440.1	1 : Metabolism
YP_001204440.1	1.2.2 : DNA
YP_001204441.1	3.1.2 : Transcriptional level
YP_001204442.1	1.1 : Carbon compound utilization
YP_001204443.1	1.1.2.2 : 3-phenylpropionate and 3-(3-hydroxyphenyl)propionate degradation
YP_001204446.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001204447.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001204450.1	3.1.2 : Transcriptional level
YP_001204452.1	4.3.A.1.p : periplasmic binding component
YP_001204453.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204453.1	3.1.4 : Regulation level unknown
YP_001204453.1	4.2.A.23 : The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family
YP_001204453.1	6.1 : Membrane
YP_001204453.1	7.3 : Inner membrane
YP_001204457.1	4.1.A.11 : The Chloride Channel (ClC) Family
YP_001204458.1	1.1 : Carbon compound utilization
YP_001204459.1	1.4.2 : Electron acceptor
YP_001204459.1	1.3.6 : Aerobic respiration
YP_001204459.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001204459.1	6.1 : Membrane
YP_001204459.1	7.3 : Inner membrane
YP_001204460.1	1.4.2 : Electron acceptor
YP_001204460.1	1.3.6 : Aerobic respiration
YP_001204460.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001204460.1	6.1 : Membrane
YP_001204460.1	7.3 : Inner membrane
YP_001204461.1	1.3.6 : Aerobic respiration
YP_001204461.1	1.4.2 : Electron acceptor
YP_001204461.1	6.1 : Membrane
YP_001204461.1	7.3 : Inner membrane
YP_001204463.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204463.1	5.5.2 : Temperature extremes
YP_001204463.1	7.2 : Periplasmic space
YP_001204469.1	3.1.2 : Transcriptional level
YP_001204470.1	1.8.2 : Sulfur metabolism
YP_001204471.1	1.8.2 : Sulfur metabolism
YP_001204472.1	1.8.2 : Sulfur metabolism
YP_001204473.1	1.8.2 : Sulfur metabolism
YP_001204474.1	1.4.3 : Electron carrier
YP_001204475.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204477.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001204477.1	6.1 : Membrane
YP_001204477.1	7.3 : Inner membrane
YP_001204480.1	3.1.2 : Transcriptional level
YP_001204485.1	3.1.2 : Transcriptional level
YP_001204486.1	1.5.3.1 : Biotin
YP_001204490.1	4.3.A.1.am : ATP binding and membrane component
YP_001204494.1	1.8.3 : Nitrogen metabolism
YP_001204494.1	3.1.2 : Transcriptional level
YP_001204495.1	1.8 : Metabolism of other compounds
YP_001204495.1	1.8.3 : Nitrogen metabolism
YP_001204495.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204496.1	1.8.3 : Nitrogen metabolism
YP_001204496.1	3.1.2.2 : Activator
YP_001204497.1	1.8.3 : Nitrogen metabolism
YP_001204497.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204500.1	1.4.3 : Electron carrier
YP_001204501.1	1.4.3 : Electron carrier
YP_001204502.1	1.4.3 : Electron carrier
YP_001204503.1	1.4.3 : Electron carrier
YP_001204504.1	1.8.3 : Nitrogen metabolism
YP_001204505.1	1.8.3 : Nitrogen metabolism
YP_001204506.1	1.8.3 : Nitrogen metabolism
YP_001204507.1	1.8.3 : Nitrogen metabolism
YP_001204508.1	4.9.B :  uncharacterized transport protein
YP_001204511.1	3.1.2 : Transcriptional level
YP_001204514.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001204515.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001204515.1	7.1 : Cytoplasm
YP_001204516.1	1.1 : Carbon compound utilization
YP_001204517.1	1.1 : Carbon compound utilization
YP_001204518.1	1.5.1.19 : Leucine
YP_001204518.1	1.5.1 : Amino acids
YP_001204519.1	4 : transport
YP_001204520.1	1.2.2 : DNA
YP_001204520.1	1 : Metabolism
YP_001204521.1	3.1.2 : Transcriptional level
YP_001204523.1	3.1.2 : Transcriptional level
YP_001204524.1	3.1.2 : Transcriptional level
YP_001204526.1	1.4 : Energy production/transport
YP_001204527.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204528.1	5.6.4 : Drug resistance/sensitivity
YP_001204529.1	1.1 : Carbon compound utilization
YP_001204530.1	1.8.3 : Nitrogen metabolism
YP_001204530.1	4.3.A.1.p : periplasmic binding component
YP_001204531.1	1.8.3 : Nitrogen metabolism
YP_001204531.1	4.3.A.1.m : membrane component
YP_001204532.1	1.8.3 : Nitrogen metabolism
YP_001204532.1	4.3.A.1.am : ATP binding and membrane component
YP_001204533.1	1.8.3 : Nitrogen metabolism
YP_001204534.1	1.8.3 : Nitrogen metabolism
YP_001204535.1	1.8.3 : nitrogen metabolism
YP_001204536.1	1.1.1.2 : 2,5-ketogluconate metabolism
YP_001204540.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204541.1	1 : Metabolism
YP_001204543.1	3.1.2 : Transcriptional level
YP_001204544.1	1 : Metabolism
YP_001204545.1	1.1.3.2 : L-serine degradation
YP_001204545.1	1.1.3.5 : Glycine cleavage
YP_001204545.1	1.1.3.7 : Threonine catabolism
YP_001204545.1	1.1.3 : Amino acids
YP_001204546.1	1.1 : Carbon compound utilization
YP_001204547.1	1.1.1.23 : Galactose degradation
YP_001204547.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204548.1	1.5.1.18 : Isoleucine/valine
YP_001204549.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204551.1	1.1.1.22 : Ribose degradation
YP_001204551.1	7.1 : Cytoplasm
YP_001204552.1	3 : Regulation
YP_001204553.1	1.5.1.1 : glutamate
YP_001204553.1	7.1 : Cytoplasm
YP_001204557.1	1.4.3 : Electron carrier
YP_001204558.1	3.1.2 : Transcriptional level
YP_001204559.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001204560.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001204561.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204561.1	4.3.A.1.m : membrane component
YP_001204561.1	6.1 : Membrane
YP_001204561.1	7.3 : Inner membrane
YP_001204562.1	4.3.A.1.m : membrane component
YP_001204563.1	4.3.A.1.p : periplasmic binding component
YP_001204565.1	1.1.3 : Amino acids
YP_001204565.1	1 : Metabolism
YP_001204566.1	1.1.3 : Amino acids
YP_001204566.1	4.3.A.1.a : ATP binding component
YP_001204566.1	7.1 : Cytoplasm
YP_001204567.1	1.1.3 : Amino acids
YP_001204567.1	4.3.A.1.a : ATP binding component
YP_001204567.1	7.1 : Cytoplasm
YP_001204568.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204568.1	4.3.A.1.m : membrane component
YP_001204568.1	6.1 : Membrane
YP_001204568.1	7.3 : Inner membrane
YP_001204569.1	4.9.B :  uncharacterized transport protein
YP_001204569.1	6.1 : Membrane
YP_001204569.1	7.3 : Inner membrane
YP_001204570.1	4.3.A.1.p : periplasmic binding component
YP_001204572.1	1.1.5 : Others
YP_001204576.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204577.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204578.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204579.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204580.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204581.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204582.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204583.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204588.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204588.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001204588.1	6.1 : Membrane
YP_001204588.1	7.3 : Inner membrane
YP_001204591.1	1.3.5 : Fermentation
YP_001204591.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204592.1	1.5.1.11 : Serine
YP_001204593.1	1.8.3 : Nitrogen metabolism
YP_001204593.1	1.1.3 : Amino acids
YP_001204594.1	3.1.2 : Transcriptional level
YP_001204596.1	4.3.A.1.p : periplasmic binding component
YP_001204597.1	4.3.A.1.m : membrane component
YP_001204598.1	4.3.A.1.m : membrane component
YP_001204599.1	4.3.A.1.am : ATP binding and membrane component
YP_001204600.1	1.1.3 : Amino acids
YP_001204600.1	1.5.1.18 : Isoleucine/valine
YP_001204600.1	1.5.1.19 : Leucine
YP_001204600.1	4.3.A.1.a : ATP binding component
YP_001204600.1	7.1 : Cytoplasm
YP_001204601.1	4.3.A.1.m : membrane component
YP_001204602.1	4.3.A.1.m : membrane component
YP_001204603.1	4.3.A.1.p : periplasmic binding component
YP_001204604.1	4.3.A.1.a : ATP binding component
YP_001204607.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204609.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204611.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001204612.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001204628.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204631.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204632.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204635.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204639.1	1.1 : Carbon compound utilization
YP_001204643.1	1.5.1 : Amino acids
YP_001204644.1	1.6.7 : Peptidoglycan (murein)
YP_001204646.1	2.1.4 : DNA repair
YP_001204646.1	7.1 : Cytoplasm
YP_001204647.1	1.5.1 : Amino acids
YP_001204648.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204649.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204649.1	7.1 : Cytoplasm
YP_001204650.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204651.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204652.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204652.1	3.1.2 : Transcriptional level
YP_001204653.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204654.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204655.1	1.1.1.4 : D-galactarate catabolism
YP_001204667.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001204668.1	1.5 : Building block biosynthesis
YP_001204669.1	1.1.3 : Amino acids
YP_001204670.1	3.1.1 : DNA structure level
YP_001204670.1	3.1.2 : Transcriptional level
YP_001204672.1	4 : Transport
YP_001204673.1	4.3.A.1.m : membrane component
YP_001204674.1	4.3 : Primary Active Transporters
YP_001204675.1	4.3.A.1.a : ATP binding component
YP_001204675.1	7.1 : Cytoplasm
YP_001204679.1	4 : Transport
YP_001204682.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204683.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204684.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204687.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001204687.1	3.1.4 : Regulation level unknown
YP_001204687.1	5.6.4 : Drug resistance/sensitivity
YP_001204687.1	7.1 : Cytoplasm
YP_001204690.1	1.1.3.3 : Arginine catabolism
YP_001204692.1	3.1.2 : Transcriptional level
YP_001204696.1	1 : Metabolism
YP_001204697.1	1.1 : Carbon compound utilization
YP_001204697.1	1 : Metabolism
YP_001204698.1	2.1.4 : DNA repair
YP_001204701.1	2.1.1 : DNA replication
YP_001204702.1	2.1.4 : DNA repair
YP_001204702.1	2.1.1 : DNA replication
YP_001204706.1	4 : Transport
YP_001204707.1	4.3.A.1.a : ABC superfamily ATP binding cytoplasmic component
YP_001204708.1	4.3.A.1.a : ATP binding component
YP_001204711.1	1.1 : Carbon compound utilization
YP_001204713.1	3.1.4 : Regulation level unknown
YP_001204717.1	1.1.5.1 : Phenylacetic acid degradation
YP_001204717.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204719.1	2.2.2 : Transcription related
YP_001204719.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001204722.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204723.1	2.2.2 : Transcription related
YP_001204723.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001204729.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204732.1	1.7.1 : Unassigned reversible reactions
YP_001204732.1	1.1.2.3 : Propionate degradation
YP_001204735.1	1.7.1 : Unassigned reversible reactions
YP_001204735.1	1.1.2.3 : Propionate degradation
YP_001204736.1	1.5.3.20 : Tetrahydrobiopterin biosynthesis
YP_001204736.1	1.5.3.2 : Folic acid
YP_001204737.1	1.5.3.20 : Tetrahydrobiopterin biosynthesis
YP_001204737.1	1.5.3.2 : Folic acid
YP_001204738.1	1.5.3.2 : Folic acid
YP_001204741.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204742.1	3.1.2 : Transcriptional level
YP_001204745.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204746.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204746.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001204746.1	5.5.2 : Temperature extremes
YP_001204747.1	2.3.4 : Chaperoning, folding
YP_001204747.1	5.1 : Cell division
YP_001204747.1	7.1 : Cytoplasm
YP_001204748.1	2.3.4 : Chaperoning, folding
YP_001204748.1	5.1 : Cell division
YP_001204748.1	7.1 : Cytoplasm
YP_001204750.1	5.5.2 : Temperature extremes
YP_001204750.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001204755.1	3.1.2 : Transcriptional level
YP_001204756.1	1.7.19 : Incorporation of metal ions
YP_001204756.1	1.8.2 : Sulfur metabolism
YP_001204758.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204764.1	1.7.1 : Unassigned reversible reactions
YP_001204768.1	1.6.7 : Peptidoglycan (murein)
YP_001204768.1	6.2 : Peptidoglycan (murein)
YP_001204770.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001204774.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204775.1	6.5 : Pilus
YP_001204776.1	2.1.4 : DNA repair
YP_001204778.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204779.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204782.1	1.3.7 : Anaerobic respiration
YP_001204782.1	1.6.15.1 : Cytochromes
YP_001204782.1	2.3.4 : Chaperoning, folding
YP_001204783.1	1.3.7 : Anaerobic respiration
YP_001204783.1	1.6.15.1 : Cytochromes
YP_001204783.1	2.3.4 : Chaperoning, folding
YP_001204783.1	7.2 : Periplasmic space
YP_001204784.1	1.3.7 : Anaerobic respiration
YP_001204784.1	1.6.15.1 : Cytochromes
YP_001204784.1	2.3.4 : Chaperoning, folding
YP_001204785.1	1.3.7 : Anaerobic respiration
YP_001204785.1	1.6.15.1 : Cytochromes
YP_001204785.1	2.3.4 : Chaperoning, folding
YP_001204786.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001204787.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001204789.1	8.1 : Prophage genes and phage related functions
YP_001204790.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204790.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001204790.1	5.5.2 : Temperature extremes
YP_001204791.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204792.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204793.1	1.8.3 : Nitrogen metabolism
YP_001204793.1	1.5.1.2 : Glutamine
YP_001204793.1	2.3.3 : Posttranslational modification
YP_001204800.1	1.5.1.1 : Glutamate
YP_001204800.1	4.3.A.1.p : periplasmic binding component
YP_001204800.1	7.2 : Periplasmic space
YP_001204802.1	1.5.1.18 : Isoleucine/valine
YP_001204803.1	4.9.B :  uncharacterized transport protein
YP_001204803.1	5.6.4 : Drug resistance/sensitivity
YP_001204804.1	4.9.B :  uncharacterized transport protein
YP_001204804.1	5.6.4 : Drug resistance/sensitivity
YP_001204807.1	1.3.6 : Aerobic respiration
YP_001204807.1	1.3.4 : Tricarboxylic acid cycle
YP_001204812.1	4.3.A.1.am : ATP binding and membrane component
YP_001204813.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001204815.1	3.1.2 : Transcriptional level
YP_001204818.1	1.8.2 : Sulfur metabolism
YP_001204818.1	5.6 : Protection
YP_001204819.1	1.8.3 : Nitrogen metabolism
YP_001204819.1	4.3.A.1.p : periplasmic binding component
YP_001204820.1	1.8.3 : Nitrogen metabolism
YP_001204820.1	4.3.A.1.m : membrane component
YP_001204821.1	1.8.3 : Nitrogen metabolism
YP_001204821.1	4.3.A.1.a : ATP binding component
YP_001204822.1	1.8.3 : Nitrogen metabolism
YP_001204822.1	1.7.24 : Cyanate catabolism
YP_001204822.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001204824.1	1.5.2.1 : Purine biosynthesis
YP_001204824.1	7.1 : Cytoplasm
YP_001204825.1	1.5.2.1 : Purine biosynthesis
YP_001204827.1	1.5.2.1 : Purine biosynthesis
YP_001204832.1	1.5.2.1 : Purine biosynthesis
YP_001204837.1	5.5.2 : Temperature extremes
YP_001204840.1	1.4.3 : Electron carrier
YP_001204842.1	5.6.4 : Drug resistance/sensitivity
YP_001204843.1	1.5.1.10 : Glycine
YP_001204845.1	2.3.2 : Translation
YP_001204845.1	2.3.8 : Ribosomal proteins
YP_001204845.1	6.6 : Ribosome
YP_001204845.1	7.1 : Cytoplasm
YP_001204848.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204849.1	1.6.7 : Peptidoglycan (murein)
YP_001204849.1	6.2 : Peptidoglycan (murein)
YP_001204850.1	3.1.2 : Transcriptional level
YP_001204857.1	1.6.7 : Peptidoglycan (murein)
YP_001204857.1	6.2 : Peptidoglycan (murein)
YP_001204857.1	7.1 : Cytoplasm
YP_001204858.1	1.2.2 : DNA
YP_001204863.1	1.3.5 : Fermentation
YP_001204863.1	1.3.7 : Anaerobic respiration
YP_001204863.1	1.1.5.2 : Ethanol degradation
YP_001204865.1	4 : Transport
YP_001204866.1	1.1 : Carbon compound utilization
YP_001204870.1	5.6 : Protection
YP_001204870.1	6.1 : Membrane
YP_001204872.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204872.1	6.1 : Membrane
YP_001204872.1	7.3 : Inner membrane
YP_001204874.1	1.4.3 : Electron carrier
YP_001204875.1	1.4.3 : Electron carrier
YP_001204877.1	1.5.2.1 : Purine biosynthesis
YP_001204879.1	3.1.2 : Transcriptional level
YP_001204886.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204886.1	3.1.4 : Regulation level unknown
YP_001204886.1	4.2.A.23 : The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family
YP_001204886.1	6.1 : Membrane
YP_001204886.1	7.3 : Inner membrane
YP_001204888.1	1.8.3 : Nitrogen metabolism
YP_001204888.1	1.7.26 : Allantoin assimilation
YP_001204889.1	1.7.3 : Pentose phosphate shunt, non-oxidative branch
YP_001204889.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204892.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204893.1	3.1.2 : Transcriptional level
YP_001204893.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001204894.1	1.5.1.19 : Leucine
YP_001204894.1	4.3.A.1.p : periplasmic binding component
YP_001204894.1	7.2 : Periplasmic space
YP_001204895.1	1.5.1.18 : Isoleucine/valine
YP_001204895.1	1.5.1.19 : Leucine
YP_001204895.1	1.1.3 : Amino acids
YP_001204895.1	4.3.A.1.a : ATP binding component
YP_001204895.1	7.1 : Cytoplasm
YP_001204896.1	1.5.1.18 : Isoleucine/valine
YP_001204896.1	1.5.1.19 : Leucine
YP_001204896.1	1.1.3 : Amino acids
YP_001204896.1	4.3.A.1.a : ATP binding component
YP_001204896.1	7.1 : Cytoplasm
YP_001204897.1	1.5.1.18 : Isoleucine/valine
YP_001204897.1	1.5.1.19 : Leucine
YP_001204897.1	4.3.A.1.m : membrane component
YP_001204897.1	6.1 : Membrane
YP_001204897.1	7.3 : Inner membrane
YP_001204898.1	1.5.1.18 : Isoleucine/valine
YP_001204898.1	1.5.1.19 : Leucine
YP_001204898.1	4.3.A.1.m : membrane component
YP_001204898.1	6.1 : Membrane
YP_001204898.1	7.3 : Inner membrane
YP_001204901.1	1.1.1 : carbon compounds
YP_001204901.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001204902.1	1.3 : Energy metabolism (carbon)
YP_001204903.1	1.3 : Energy metabolism (carbon)
YP_001204904.1	1.3 : Energy metabolism (carbon)
YP_001204912.1	1.3.5 : Fermentation
YP_001204912.1	1.3.7 : Anaerobic respiration
YP_001204912.1	1.1.5.2 : Ethanol degradation
YP_001204913.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001204913.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001204914.1	3.1.2 : Transcriptional level
YP_001204916.1	4.3.A.1.a : ATP binding component
YP_001204917.1	4.3.A.1.am : ATP binding and membrane component
YP_001204918.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204929.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001204930.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001204932.1	2.1.2 : DNA restriction/modification
YP_001204932.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001204935.1	2.3.5 : Export, signal peptide cleavage
YP_001204935.1	6.1 : Membrane
YP_001204935.1	7.3 : Inner membrane
YP_001204937.1	3.1.2 : Transcriptional level
YP_001204938.1	2.3.4 : Chaperoning, folding
YP_001204938.1	5.1 : Cell division
YP_001204938.1	7.1 : Cytoplasm
YP_001204939.1	2.3.4 : Chaperoning, folding
YP_001204939.1	5.1 : Cell division
YP_001204939.1	7.1 : Cytoplasm
YP_001204940.1	1.5.1.15 : Tryptophan
YP_001204952.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001204953.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001204953.1	7.1 : Cytoplasm
YP_001204955.1	1.5.1.9 : Methionine
YP_001204956.1	1.7.1 : Unassigned reversible reactions
YP_001204959.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001204961.1	1.1 : Carbon compound utilization
YP_001204963.1	4.3.A.1.a : ATP binding component
YP_001204963.1	7.1 : Cytoplasm
YP_001204964.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204964.1	4.3.A.1.m : membrane component
YP_001204964.1	6.1 : Membrane
YP_001204964.1	7.3 : Inner membrane
YP_001204965.1	4.3.A.1.m : membrane component
YP_001204966.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001204967.1	4.3.A.1.p : periplasmic binding component
YP_001204968.1	4.3.A.1.p : periplasmic binding component
YP_001204969.1	4.3.A.1.p : periplasmic binding component
YP_001204971.1	3.1.2 : Transcriptional level
YP_001204973.1	1.5.3.10 : Glutathione
YP_001204976.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001204979.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001204984.1	1.5.1.12 : Cysteine
YP_001204984.1	1.1.3 : Amino acids
YP_001204984.1	7.1 : Cytoplasm
YP_001204995.1	8.3.1 : transposases
YP_001205008.1	8.3.1 : transposases
YP_001205009.1	8.3.1 : transposases
YP_001205010.1	3.1.2 : Transcriptional level
YP_001205015.1	2.3.1 : Amino acid-activation
YP_001205015.1	7.1 : Cytoplasm
YP_001205017.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205020.1	4.2.A.3 : The Amino Acid-Polyamine-Choline (APC) Family
YP_001205026.1	1.8.3 : Nitrogen metabolism
YP_001205027.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205027.1	1.5.3 : Cofactor, small molecule carrier
YP_001205028.1	1.5.1.16 : Histidine
YP_001205034.1	1.5.2 : Nucleotide
YP_001205034.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205052.1	1.6.3 : Lipopolysaccharide
YP_001205057.1	3.1.2 : Transcriptional level
YP_001205058.1	1.1.3.14 : Valine degradation
YP_001205059.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001205059.1	7.1 : Cytoplasm
YP_001205060.1	1.8.3 : Nitrogen metabolism
YP_001205061.1	4.3.A.1.p : periplasmic binding component
YP_001205062.1	4.3.A.1.m : membrane component
YP_001205063.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205063.1	4.3.A.1.m : membrane component
YP_001205063.1	6.1 : Membrane
YP_001205063.1	7.3 : Inner membrane
YP_001205064.1	4.3.A.1.a : ATP binding component
YP_001205065.1	4.3.A.1.a : ATP binding component
YP_001205073.1	1.7.22 : Carnitine metabolism
YP_001205075.1	3.1.2 : Transcriptional level
YP_001205085.1	4.3.A.1.p : periplasmic binding component
YP_001205087.1	2.2.2 : Transcription related
YP_001205087.1	7.1 : Cytoplasm
YP_001205088.1	2.3.2 : Translation
YP_001205088.1	6.6 : Ribosome
YP_001205089.1	2.3.2 : Translation
YP_001205089.1	2.3.8 : Ribosomal proteins
YP_001205089.1	3.1.3.1 : Translation attenuation and efficiency
YP_001205089.1	6.6 : Ribosome
YP_001205089.1	7.1 : Cytoplasm
YP_001205092.1	2.3.2 : Translation
YP_001205092.1	2.3.8 : Ribosomal proteins
YP_001205092.1	6.6 : Ribosome
YP_001205092.1	7.1 : Cytoplasm
YP_001205093.1	2.3.2 : Translation
YP_001205093.1	2.3.8 : Ribosomal proteins
YP_001205093.1	6.6 : Ribosome
YP_001205093.1	7.1 : Cytoplasm
YP_001205094.1	2.2.2 : Transcription related
YP_001205094.1	7.1 : Cytoplasm
YP_001205095.1	2.2.2 : Transcription related
YP_001205095.1	7.1 : Cytoplasm
YP_001205097.1	4.3.A.1.am : ATP binding and membrane component
YP_001205099.1	8.3.1 : transposases
YP_001205100.2	2.3.2 : Translation
YP_001205100.2	2.3.8 : Ribosomal proteins
YP_001205100.2	6.6 : Ribosome
YP_001205100.2	7.1 : Cytoplasm
YP_001205101.2	2.3.2 : Translation
YP_001205101.2	2.3.8 : Ribosomal proteins
YP_001205101.2	6.6 : Ribosome
YP_001205101.2	7.1 : Cytoplasm
YP_001205102.1	2.3.2 : Translation
YP_001205102.1	7.1 : Cytoplasm
YP_001205103.1	3.1.3 : Posttranscriptional
YP_001205103.1	6.6 : Ribosome
YP_001205104.1	2.3.2 : Translation
YP_001205104.1	2.3.8 : Ribosomal proteins
YP_001205104.1	6.6 : Ribosome
YP_001205104.1	7.1 : Cytoplasm
YP_001205105.1	2.3.2 : Translation
YP_001205105.1	2.3.8 : Ribosomal proteins
YP_001205105.1	6.6 : Ribosome
YP_001205105.1	7.1 : Cytoplasm
YP_001205106.1	2.3.2 : Translation
YP_001205106.1	2.3.8 : Ribosomal proteins
YP_001205106.1	3.1.2 : Transcriptional level
YP_001205106.1	3.1.3.1 : Translation attenuation and efficiency
YP_001205106.1	3.3.1 : Operon (regulation of one operon)
YP_001205106.1	6.6 : Ribosome
YP_001205106.1	7.1 : Cytoplasm
YP_001205107.1	2.3.2 : Translation
YP_001205107.1	2.3.8 : Ribosomal proteins
YP_001205107.1	6.6 : Ribosome
YP_001205107.1	7.1 : Cytoplasm
YP_001205108.1	2.3.2 : Translation
YP_001205108.1	2.3.8 : Ribosomal proteins
YP_001205108.1	6.6 : Ribosome
YP_001205108.1	7.1 : Cytoplasm
YP_001205109.1	2.3.2 : Translation
YP_001205109.1	2.3.8 : Ribosomal proteins
YP_001205109.1	6.6 : Ribosome
YP_001205109.1	7.1 : Cytoplasm
YP_001205110.1	2.3.2 : Translation
YP_001205110.1	2.3.8 : Ribosomal proteins
YP_001205110.1	6.6 : Ribosome
YP_001205110.1	7.1 : Cytoplasm
YP_001205111.1	2.3.2 : Translation
YP_001205111.1	2.3.8 : Ribosomal proteins
YP_001205111.1	6.6 : Ribosome
YP_001205111.1	7.1 : Cytoplasm
YP_001205112.1	2.3.2 : Translation
YP_001205112.1	2.3.8 : Ribosomal proteins
YP_001205112.1	6.6 : Ribosome
YP_001205112.1	7.1 : Cytoplasm
YP_001205113.1	2.3.2 : Translation
YP_001205113.1	2.3.8 : Ribosomal proteins
YP_001205113.1	6.6 : Ribosome
YP_001205113.1	7.1 : Cytoplasm
YP_001205114.1	2.3.2 : Translation
YP_001205114.1	2.3.8 : Ribosomal proteins
YP_001205114.1	6.6 : Ribosome
YP_001205114.1	7.1 : Cytoplasm
YP_001205115.1	2.3.2 : Translation
YP_001205115.1	2.3.8 : Ribosomal proteins
YP_001205115.1	6.6 : Ribosome
YP_001205115.1	7.1 : Cytoplasm
YP_001205116.1	2.3.2 : Translation
YP_001205116.1	2.3.8 : Ribosomal proteins
YP_001205116.1	6.6 : Ribosome
YP_001205116.1	7.1 : Cytoplasm
YP_001205117.1	2.3.2 : Translation
YP_001205117.1	2.3.8 : Ribosomal proteins
YP_001205117.1	6.6 : Ribosome
YP_001205117.1	7.1 : Cytoplasm
YP_001205118.1	2.3.2 : Translation
YP_001205118.1	2.3.8 : Ribosomal proteins
YP_001205118.1	3.1.3.1 : Translation attenuation and efficiency
YP_001205118.1	6.6 : Ribosome
YP_001205118.1	7.1 : Cytoplasm
YP_001205119.1	2.3.2 : Translation
YP_001205119.1	2.3.8 : Ribosomal proteins
YP_001205119.1	3.1.3.1 : Translation attenuation and efficiency
YP_001205119.1	6.6 : Ribosome
YP_001205119.1	7.1 : Cytoplasm
YP_001205120.1	2.3.2 : Translation
YP_001205120.1	2.3.8 : Ribosomal proteins
YP_001205120.1	6.6 : Ribosome
YP_001205120.1	7.1 : Cytoplasm
YP_001205121.1	2.3.2 : Translation
YP_001205121.1	2.3.8 : Ribosomal proteins
YP_001205121.1	6.6 : Ribosome
YP_001205121.1	7.1 : Cytoplasm
YP_001205122.1	2.3.2 : Translation
YP_001205122.1	2.3.8 : Ribosomal proteins
YP_001205122.1	6.6 : Ribosome
YP_001205122.1	7.1 : Cytoplasm
YP_001205123.1	2.3.2 : Translation
YP_001205123.1	2.3.8 : Ribosomal proteins
YP_001205123.1	6.6 : Ribosome
YP_001205123.1	7.1 : Cytoplasm
YP_001205124.1	2.3.2 : Translation
YP_001205124.1	2.3.8 : Ribosomal proteins
YP_001205124.1	6.6 : Ribosome
YP_001205124.1	7.1 : Cytoplasm
YP_001205125.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001205125.1	6.1 : Membrane
YP_001205125.1	7.3 : Inner membrane
YP_001205127.1	2.3.2 : Translation
YP_001205127.1	2.3.8 : Ribosomal proteins
YP_001205127.1	6.6 : Ribosome
YP_001205127.1	7.1 : Cytoplasm
YP_001205128.1	2.3.2 : Translation
YP_001205128.1	2.3.8 : Ribosomal proteins
YP_001205128.1	6.6 : Ribosome
YP_001205128.1	7.1 : Cytoplasm
YP_001205129.1	2.2.2 : Transcription related
YP_001205129.1	7.1 : Cytoplasm
YP_001205130.1	2.3.2 : Translation
YP_001205130.1	2.3.8 : Ribosomal proteins
YP_001205130.1	6.6 : Ribosome
YP_001205130.1	7.1 : Cytoplasm
YP_001205132.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205134.1	4 : Transport
YP_001205135.1	4.3.A.1.p : periplasmic binding component
YP_001205136.1	4.3.A.1.m : membrane component
YP_001205137.1	1.1.4 : Amines
YP_001205137.1	1.8.2 : Sulfur metabolism
YP_001205137.1	4.3.A.1.a : ATP binding component
YP_001205137.1	7.1 : Cytoplasm
YP_001205138.1	1.1.4 : Amines
YP_001205140.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205141.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205142.2	1.5.3.5 : Coenzyme A
YP_001205142.2	1.5.1.18 : Isoleucine/valine
YP_001205143.1	3.1.2 : Transcriptional level
YP_001205144.1	4.3.A.1.a : ATP binding component
YP_001205145.1	4.3.A.1.p : periplasmic binding component
YP_001205146.1	4.3.A.1.m : membrane component
YP_001205147.1	4.3.A.1.m : membrane component
YP_001205148.1	1.6.3 : Lipopolysaccharide
YP_001205148.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001205149.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205149.1	1.1.3 : Amino acids
YP_001205149.1	1.1 : Carbon compound utilization
YP_001205150.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205150.1	5.5 : Adaptation to stress
YP_001205159.1	1.1.3.1 : L-alanine degradation
YP_001205159.1	1.1.3.14 : Valine degradation
YP_001205159.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205164.1	2.2.2 : Transcription related
YP_001205165.1	1.1.3 : Amino acids
YP_001205166.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205167.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205167.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001205167.1	1.1.3 : Amino acids
YP_001205167.1	1.1 : Carbon compound utilization
YP_001205168.1	1.1.3 : Amino acids
YP_001205168.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205169.1	3.1.2 : Transcriptional level
YP_001205170.1	1.1.3.14 : Valine degradation
YP_001205170.1	1.1.3.12 : Leucine degradation
YP_001205171.1	1.1.3 : Amino acids
YP_001205171.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205172.1	1.1.3 : Amino acids
YP_001205172.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205173.1	1.1.3.14 : Valine degradation
YP_001205175.1	3 : Regulation
YP_001205176.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205179.1	4.3.A.1.a : ATP binding component
YP_001205182.1	1.3 : Energy metabolism (carbon)
YP_001205183.1	1.8.1 : Phosphorous metabolism
YP_001205184.1	5.1 : Cell division
YP_001205195.1	1.4.3 : Electron carrier
YP_001205196.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205198.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205198.1	1.5.2.1 : Purine biosynthesis
YP_001205198.1	7.1 : Cytoplasm
YP_001205201.1	2.2.3 : RNA modification
YP_001205201.1	3.1.1.2 : Methylation
YP_001205202.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205202.1	1.5.2.1 : Purine biosynthesis
YP_001205202.1	7.1 : Cytoplasm
YP_001205205.1	1.4 : Energy production/transport
YP_001205205.1	1.8.2 : Sulfur metabolism
YP_001205206.1	1.8.2 : Sulfur metabolism
YP_001205206.1	3.1.2 : Transcriptional level
YP_001205207.1	1.4 : Energy production/transport
YP_001205207.1	1.8.2 : Sulfur metabolism
YP_001205208.1	1.4 : Energy production/transport
YP_001205210.1	1.8.2 : Sulfur metabolism
YP_001205211.1	1.8.2 : Sulfur metabolism
YP_001205212.1	1.8.2 : Sulfur metabolism
YP_001205213.1	1.8.2 : Sulfur metabolism
YP_001205214.1	1.8.2 : Sulfur metabolism
YP_001205215.1	1.8.2 : Sulfur metabolism
YP_001205216.1	1.8.2 : Sulfur metabolism
YP_001205217.1	1.8.2 : Sulfur metabolism
YP_001205224.1	1.8.2 : Sulfur metabolism
YP_001205230.1	3.1.2 : Transcriptional level
YP_001205231.1	1.1 : Carbon compound utilization
YP_001205231.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001205233.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001205233.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001205234.1	3.1.2 : Transcriptional level
YP_001205235.1	1.4.3 : Electron carrier
YP_001205250.1	8.1.4 : Integration, recombination
YP_001205253.1	3.1.1 : DNA structure level
YP_001205254.1	5.6.1 : Radiation
YP_001205255.1	3.3.3 : Stimulon (ie. environmental stimulus)
YP_001205256.1	4.9.B :  uncharacterized transport protein
YP_001205257.1	4.9.B :  uncharacterized transport protein
YP_001205259.1	1.1.3 : Amino acids
YP_001205260.1	1.1.3 : Amino acids
YP_001205263.1	2.2.3 : RNA modification
YP_001205263.1	5.5 : Adaptation to stress
YP_001205263.1	5.5.2 : Temperature extremes
YP_001205265.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001205269.1	4 : Transport
YP_001205269.1	4.3.A. : Pyrophosphate Bond (ATP; GTP; P2) Hydrolysis-driven Active Transporters
YP_001205270.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205273.1	3.1.2 : Transcriptional level
YP_001205273.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205274.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205275.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205278.1	1.5.3.1 : Biotin
YP_001205278.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205281.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001205285.1	3.1.2 : Transcriptional level
YP_001205286.1	3.1.2 : Transcriptional level
YP_001205288.1	1.5.3.3 : Lipoate
YP_001205289.1	8.1.4 : Integration, recombination
YP_001205295.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205295.1	5.6.4 : Drug resistance/sensitivity
YP_001205299.1	3.1.2 : Transcriptional level
YP_001205307.1	1.5.2.1 : Purine biosynthesis
YP_001205307.1	7.1 : Cytoplasm
YP_001205308.1	8.4 : Colicin related
YP_001205309.1	5.6 : Protection
YP_001205312.1	3.1.2 : Transcriptional level
YP_001205315.1	1.2.2 : DNA
YP_001205315.1	2.1.5 : DNA degradation
YP_001205317.1	3.1.2 : Transcriptional level
YP_001205326.1	1.5.1.17 : Alanine
YP_001205326.1	1.1.3.1 : L-alanine degradation
YP_001205327.1	2.1.1 : DNA replication
YP_001205327.1	7.1 : Cytoplasm
YP_001205329.1	1.6.1 : Phospholipid
YP_001205331.1	2.3.2 : Translation
YP_001205331.1	2.3.8 : Ribosomal proteins
YP_001205331.1	6.6 : Ribosome
YP_001205333.1	2.3.2 : Translation
YP_001205333.1	2.3.8 : Ribosomal proteins
YP_001205333.1	6.6 : Ribosome
YP_001205333.1	7.1 : Cytoplasm
YP_001205334.1	2.3.2 : Translation
YP_001205334.1	2.3.8 : Ribosomal proteins
YP_001205334.1	6.6 : Ribosome
YP_001205335.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205335.1	7.1 : Cytoplasm
YP_001205336.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205336.1	7.1 : Cytoplasm
YP_001205338.1	1.6.15.4 : Acyl carrier protein
YP_001205339.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205339.1	7.1 : Cytoplasm
YP_001205342.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205342.1	1.5.2.3 : Purine ribonucleotide biosynthesis
YP_001205342.1	7.1 : Cytoplasm
YP_001205347.1	2.2.3 : RNA modification
YP_001205347.1	5.6.4 : Drug resistance/sensitivity
YP_001205347.1	7.1 : Cytoplasm
YP_001205348.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001205348.1	7.1 : Cytoplasm
YP_001205350.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001205351.1	4 : Transport
YP_001205352.1	4 : Transport
YP_001205353.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205353.1	2.2.2 : Transcription related
YP_001205353.1	2.1.3 : DNA recombination
YP_001205353.1	7.1 : Cytoplasm
YP_001205354.1	2.1.1 : DNA replication
YP_001205356.1	4.3.A.1.a : ATP binding component
YP_001205356.1	7.1 : Cytoplasm
YP_001205359.1	1.7.15 : 2'-deoxyribonucleotide/ribonucleoside metabolism
YP_001205359.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205359.1	1.5.2.3 : Purine ribonucleotide biosynthesis
YP_001205361.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001205362.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001205365.1	1.8.1 : Phosphorous metabolism
YP_001205366.1	1.8.1 : Phosphorous metabolism
YP_001205368.1	1.6.1 : Phospholipid
YP_001205369.1	1.5.2.1 : Purine biosynthesis
YP_001205369.1	7.1 : Cytoplasm
YP_001205370.1	1.5.2.1 : Purine biosynthesis
YP_001205370.1	7.1 : Cytoplasm
YP_001205371.1	2.2 : RNA related
YP_001205371.1	3.1.2 : Transcriptional level
YP_001205371.1	3.3.1 : Operon (regulation of one operon)
YP_001205371.1	5.5.2 : Temperature extremes
YP_001205372.1	3.1.2 : Transcriptional level
YP_001205377.1	1.2.1 : RNA
YP_001205377.1	2.2.3 : RNA modification
YP_001205380.1	2.3.1 : Amino acid-activation
YP_001205380.1	7.1 : Cytoplasm
YP_001205388.1	1.7.8 : Gluconeogenesis
YP_001205388.1	1.3.4 : Tricarboxylic acid cycle
YP_001205392.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001205397.1	4.3.A.1.am : ATP binding and membrane component
YP_001205398.1	1.4 : Energy production/transport
YP_001205398.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205399.1	4 : Transport
YP_001205403.1	1.1.3 : Amino acids
YP_001205414.1	1.5.1.2 : Glutamine
YP_001205414.1	3.1.4 : Regulation level unknown
YP_001205415.1	1.8.3 : Nitrogen metabolism
YP_001205415.1	1.5.1.2 : Glutamine
YP_001205417.1	4.3.A.1.a : ATP binding component
YP_001205419.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205424.1	1.8.2 : sulfur metabolism
YP_001205424.1	5.5.3 : starvation response
YP_001205425.1	1.5.1.18 : Isoleucine/valine
YP_001205425.1	1.5.1.19 : Leucine
YP_001205425.1	1.1.3 : Amino acids
YP_001205425.1	4.3.A.1.a : ATP binding component
YP_001205425.1	7.1 : Cytoplasm
YP_001205426.1	4.3.A.1.m : ABC superfamily, membrane component
YP_001205427.1	1.1.3 : amino acids
YP_001205427.1	4.3.A.1.m : ABC superfamily, membrane component
YP_001205428.1	4.3.A.1.p : periplasmic binding component
YP_001205429.1	1.5.1.18 : Isoleucine/valine
YP_001205429.1	1.5.1.19 : Leucine
YP_001205429.1	1.1.3 : Amino acids
YP_001205429.1	4.3.A.1.a : ATP binding component
YP_001205429.1	7.1 : Cytoplasm
YP_001205432.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001205434.1	3.1.2 : Transcriptional level
YP_001205435.1	1.7.31 : Aminobutyrate catabolism
YP_001205435.1	1.7.32 : Putrescine catabolism
YP_001205436.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205436.1	1.1.3.3 : Arginine catabolism
YP_001205436.1	1.1.3.4 : Glutamate degradation
YP_001205445.1	1.1 : Carbon compound utilization
YP_001205450.1	3.1.2 : Transcriptional level
YP_001205451.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205451.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001205455.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001205459.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001205469.1	4.S.7 : alklphosphonate
YP_001205471.1	1.4 : Energy production/transport
YP_001205473.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205473.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001205476.1	1.4.3 : Electron carrier
YP_001205483.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205483.1	1.7.15 : 2'-deoxyribonucleotide/ribonucleoside metabolism
YP_001205484.1	4 : Transport
YP_001205484.1	4.2.A.7 : The Drug/Metabolite Transporter (DMT) Superfamily
YP_001205485.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205486.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205488.1	1.3.6 : Aerobic respiration
YP_001205488.1	1.4 : Energy production/transport
YP_001205488.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001205490.1	3.1.2 : Transcriptional level
YP_001205494.1	1.1.3 : Amino acids
YP_001205495.1	4.3.A.1.m : ABC superfamily, membrane component
YP_001205500.1	1.8.3 : Nitrogen metabolism
YP_001205500.1	1.1.3 : Amino acids
YP_001205500.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001205500.1	1.5.1.5 : Aspartate
YP_001205500.1	7.1 : Cytoplasm
YP_001205504.1	2.3.6 : Turnover, degradation
YP_001205504.1	7.1 : Cytoplasm
YP_001205505.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205506.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205507.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205508.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205508.1	7.1 : Cytoplasm
YP_001205509.1	1.6.15.3 : Biotin carboxyl carrier protein
YP_001205509.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205510.1	1.5.1.13 : Phenylalanine
YP_001205510.1	1.5.1.14 : Tyrosine
YP_001205510.1	1.5.1.15 : Tryptophan
YP_001205510.1	1.5.1.20 : Chorismate
YP_001205512.1	4.S.34 : citrate/succinate
YP_001205513.1	1.3.4 : Tricarboxylic acid cycle
YP_001205514.1	3.1.2 : Transcriptional level
YP_001205517.1	1.8.3 : Nitrogen metabolism
YP_001205518.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001205518.1	3.1.4 : Regulation level unknown
YP_001205518.1	4.2.A.23 : The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family
YP_001205518.1	6.1 : Membrane
YP_001205518.1	7.3 : Inner membrane
YP_001205519.1	1.2.1 : RNA
YP_001205519.1	2.2.4 : RNA degradation
YP_001205519.1	7.1 : Cytoplasm
YP_001205520.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001205520.1	1.6.7 : Peptidoglycan (murein)
YP_001205520.1	6.2 : Peptidoglycan (murein)
YP_001205521.1	5.10 : Defense/survival
YP_001205521.1	5.6.4 : Drug resistance/sensitivity
YP_001205523.1	2.3.2 : Translation
YP_001205523.1	7.1 : Cytoplasm
YP_001205524.1	1.4.3 : Electron carrier
YP_001205525.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205525.1	1.2.1 : RNA
YP_001205526.1	4.2.A.37 : The Monovalent Cation:Proton Antiporter-2 (CPA2) Family
YP_001205526.1	4.S.157 : potassium
YP_001205529.1	3.1.2 : Transcriptional level
YP_001205530.1	1.8.3 : Nitrogen metabolism
YP_001205531.1	1.5.1.9 : Methionine
YP_001205531.1	7.1 : Cytoplasm
YP_001205534.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205535.1	4.S.53 : Fe
YP_001205535.1	4.S.85 : heme
YP_001205535.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001205538.1	2.3.1 : Amino acid-activation
YP_001205538.1	7.1 : Cytoplasm
YP_001205540.1	1.5.3.10 : Glutathione
YP_001205545.1	1.8.3 : Nitrogen metabolism
YP_001205545.1	1.5.1.17 : Alanine
YP_001205546.1	1.8.2 : Sulfur metabolism
YP_001205546.1	2.3.4 : Chaperoning, folding
YP_001205548.1	1.8.2 : Sulfur metabolism
YP_001205548.1	4.3.A.1.a : ATP binding component
YP_001205548.1	7.1 : Cytoplasm
YP_001205549.1	1.7.19 : Incorporation of metal ions
YP_001205549.1	1.8.2 : Sulfur metabolism
YP_001205550.1	1.7.19 : Incorporation of metal ions
YP_001205550.1	1.5.1.17 : Alanine
YP_001205552.1	1.7.19 : Incorporation of metal ions
YP_001205552.1	1.8.2 : Sulfur metabolism
YP_001205552.1	2.3.4 : Chaperoning, folding
YP_001205555.1	2.3.2 : Translation
YP_001205555.1	2.2.3 : RNA modification
YP_001205558.1	1.7.1 : Unassigned reversible reactions
YP_001205561.1	2.2.2 : Transcription related
YP_001205561.1	2.1.1 : DNA replication
YP_001205561.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001205561.1	7.1 : Cytoplasm
YP_001205564.1	1.5.1.3 : Arginine
YP_001205564.1	7.1 : Cytoplasm
YP_001205565.1	1.1.3.7 : Threonine catabolism
YP_001205566.1	2.2 : RNA related
YP_001205567.1	4.3.A.1.p : periplasmic binding component
YP_001205568.1	4.3.A.1.m : membrane component
YP_001205569.1	4.3.A.1.m : membrane component
YP_001205572.1	3.1.2 : Transcriptional level
YP_001205574.1	1.3 : Energy metabolism (carbon)
YP_001205576.1	1.7.13 : Amino acid conversion
YP_001205576.1	1.8.3 : Nitrogen metabolism
YP_001205576.1	3.1.4 : Regulation level unknown
YP_001205577.1	1.5.1.7 : Lysine, diaminopimelate
YP_001205577.1	1.5.1.8 : Threonine
YP_001205577.1	1.5.1.9 : Methionine
YP_001205577.1	1.5.1.18 : Isoleucine/valine
YP_001205578.1	1.7.8 : Gluconeogenesis
YP_001205578.1	1.7.6 : Glycerol metabolism
YP_001205578.1	7.1 : Cytoplasm
YP_001205582.1	1.2.2 : DNA
YP_001205582.1	2.1.5 : DNA degradation
YP_001205582.1	2.1.1 : DNA replication
YP_001205582.1	8.1.4 : Integration, recombination
YP_001205585.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205585.1	5 : Cell processes
YP_001205585.1	6.2 : Peptidoglycan (murein)
YP_001205586.1	3.1.2 : Transcriptional level
YP_001205591.1	2.3.2 : Translation
YP_001205591.1	7.1 : Cytoplasm
YP_001205592.1	2.3.1 : Amino acid-activation
YP_001205593.1	1.1.3.10 : Lysine cleavage
YP_001205593.1	1.7.1 : Unassigned reversible reactions
YP_001205593.1	1.8.3 : Nitrogen metabolism
YP_001205595.1	1.5.1.20 : Chorismate
YP_001205595.1	1.5.1.13 : Phenylalanine
YP_001205598.1	1.5.3.12 : Heme, porphyrin
YP_001205602.1	1.4.3 : Electron carrier
YP_001205604.1	8.1.4 : Integration, recombination
YP_001205624.1	3.1.2 : Transcriptional level
YP_001205668.1	1.7.23 : Methylglyoxal metabolism
YP_001205668.1	1.5.3.10 : Glutathione
YP_001205669.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001205669.1	5.5.2 : Temperature extremes
YP_001205672.1	2.1 : DNA related
YP_001205672.1	3.1.2 : Transcriptional level
YP_001205672.1	5.2 : Cell cycle physiology
YP_001205673.1	2.3.2 : Translation
YP_001205673.1	2.3.4 : Chaperoning, folding
YP_001205673.1	5.5 : Adaptation to stress
YP_001205673.1	5.5.2 : Temperature extremes
YP_001205676.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001205676.1	1.3.6 : Aerobic respiration
YP_001205676.1	1.4.3 : Electron carrier
YP_001205677.1	3.1.2 : Transcriptional level
YP_001205678.1	3.1.2 : Transcriptional level
YP_001205679.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205680.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205680.1	1.5.3.1 : Biotin
YP_001205681.1	1.1.3.12 : Leucine degradation
YP_001205681.1	1.5.1.7 : Lysine, diaminopimelate
YP_001205682.1	4 : Transport
YP_001205682.1	4.2.A.13 : The C4-Dicarboxylate Uptake (Dcu) Family
YP_001205683.1	4.2.A.13 : The C4-Dicarboxylate Uptake (Dcu) Family
YP_001205693.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205695.1	3.1.2 : Transcriptional level
YP_001205697.1	1.7.21 : Glyoxylate degradation
YP_001205700.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205702.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001205705.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205707.1	4.S.20 : benzoate
YP_001205708.1	3.1.2 : Transcriptional level
YP_001205710.1	1.8.1 : Phosphorous metabolism
YP_001205717.1	1.5.3.10 : Glutathione
YP_001205717.1	1.7.1 : Unassigned reversible reactions
YP_001205722.1	3.1.2 : Transcriptional level
YP_001205722.1	5.6.4 : Drug resistance/sensitivity
YP_001205726.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205727.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001205727.1	4.3.A.1.a : ATP binding component
YP_001205728.1	4.3.A.1.a : ATP binding component
YP_001205729.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001205730.1	4.3.A.1.m : membrane component
YP_001205731.1	4.3.A.1.m : membrane component
YP_001205732.1	4 : Transport
YP_001205732.1	4.S.155 : phosphate
YP_001205733.1	4 : Transport
YP_001205733.1	4.S.155 : phosphate
YP_001205734.1	2.3.2 : Translation
YP_001205734.1	7.1 : Cytoplasm
YP_001205735.1	3.1.2 : Transcriptional level
YP_001205736.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205740.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001205743.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205744.1	3.1.2 : Transcriptional level
YP_001205745.1	1.3.6 : Aerobic respiration
YP_001205745.1	1.3.4 : Tricarboxylic acid cycle
YP_001205747.1	4.2.A.76 : The Resistance to Homoserine/Threonine (RhtB) Family
YP_001205747.1	6.1 : Membrane
YP_001205751.1	1.6.6 : Osmoregulated periplasmic glucan
YP_001205752.1	1.6.6 : Osmoregulated periplasmic glucan
YP_001205753.1	1.6.6 : Osmoregulated periplasmic glucan
YP_001205753.1	6.1 : Membrane
YP_001205753.1	7.3 : Inner membrane
YP_001205756.1	1.6.4 : Enterobacterial common antigen (surface glycolipid)
YP_001205756.1	1.6.7 : Peptidoglycan (murein)
YP_001205756.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001205756.1	1.7.12 : Amino sugar conversions
YP_001205756.1	1.1.4 : Amines
YP_001205756.1	1.6.3.1 : O antigen
YP_001205756.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001205756.1	6.1 : Membrane
YP_001205756.1	6.2 : Peptidoglycan (murein)
YP_001205756.1	7.1 : Cytoplasm
YP_001205759.1	1.6.7 : Peptidoglycan (murein)
YP_001205759.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001205759.1	1.7.12 : Amino sugar conversions
YP_001205759.1	1.6.3.1 : O antigen
YP_001205759.1	6.2 : Peptidoglycan (murein)
YP_001205759.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001205759.1	6.1 : Membrane
YP_001205759.1	7.1 : Cytoplasm
YP_001205760.1	4 : Transport
YP_001205760.1	4.2.A.75 : The L-lysine exporter (LysE) family
YP_001205765.1	2.1.4 : DNA repair
YP_001205765.1	2.1.1 : DNA replication
YP_001205765.1	7.1 : Cytoplasm
YP_001205767.1	2.1.4 : DNA repair
YP_001205770.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205771.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001205771.1	4.3.A.1.p : periplasmic binding component
YP_001205774.1	4 : Transport
YP_001205774.1	4.S.46 : dicarboxylate
YP_001205775.1	1.4.3 : Electron carrier
YP_001205776.1	1.6.1 : Phospholipid
YP_001205778.1	1.4.3 : Electron carrier
YP_001205782.1	1.1.3.3 : Arginine catabolism
YP_001205785.1	1.8.3 : Nitrogen metabolism
YP_001205785.1	4.S.125 : molybdenum
YP_001205785.1	4.S.145 : nitrite
YP_001205786.1	4 : Transport
YP_001205786.1	4.3.A.1.p : periplasmic binding component
YP_001205787.1	1.8.3 : Nitrogen metabolism
YP_001205787.1	4.S.145 : nitrite
YP_001205788.1	1.8.2 : Sulfur metabolism
YP_001205788.1	1.5.1.12 : Cysteine
YP_001205789.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001205789.1	5.6.4 : Drug resistance/sensitivity
YP_001205795.1	1.1.3 : Amino acids
YP_001205795.1	1.5 : Building block biosynthesis
YP_001205795.1	3.1.2 : Transcriptional level
YP_001205796.1	4.S.14 : ammonium
YP_001205797.1	2.3.2 : Translation
YP_001205797.1	7.1 : Cytoplasm
YP_001205799.1	4.3.A.1.p : periplasmic binding component
YP_001205799.1	4.S.143 : Ni++
YP_001205800.1	4.S.143 : Ni++
YP_001205801.1	1.5.1.14 : Tyrosine
YP_001205801.1	1.5.1.15 : Tryptophan
YP_001205801.1	1.5.1.13 : Phenylalanine
YP_001205804.1	1.5.1.11 : Serine
YP_001205804.1	1.5.1.8 : Threonine
YP_001205804.1	1.5.1.10 : Glycine
YP_001205805.1	1.3.6 : Aerobic respiration
YP_001205805.1	1.3.7 : Anaerobic respiration
YP_001205805.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001205805.1	1.6.1 : Phospholipid
YP_001205805.1	1.7.6 : Glycerol metabolism
YP_001205805.1	4.3.A.1.a : ATP binding component
YP_001205805.1	7.1 : Cytoplasm
YP_001205806.1	4.3.A.1.m : membrane component
YP_001205806.1	4.S.173 : sugar
YP_001205807.1	4.3.A.1.m : membrane component
YP_001205807.1	4.S.173 : sugar
YP_001205808.1	4.3.A.1.p : periplasmic binding component
YP_001205816.1	1.6.7 : Peptidoglycan (murein)
YP_001205817.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205817.1	1.7.15 : 2'-deoxyribonucleotide/ribonucleoside metabolism
YP_001205818.1	2.1.1 : DNA replication
YP_001205819.1	2.3.1 : Amino acid-activation
YP_001205820.1	2.1 : DNA related
YP_001205824.1	4 : Transport
YP_001205824.1	4.9.B :  uncharacterized transport protein
YP_001205824.1	4.S.34 : citrate/succinate
YP_001205824.1	6.1 : Membrane
YP_001205825.1	4.9.B :  uncharacterized transport protein
YP_001205825.1	7.2 : Periplasmic space
YP_001205827.1	4.3.A.1.a : ATP binding component
YP_001205828.1	4.3.A.1.m : membrane component
YP_001205829.1	4.3.A.1.m : membrane component
YP_001205830.1	4.3.A.1.p : periplasmic binding component
YP_001205834.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001205835.1	1.8.3 : Nitrogen metabolism
YP_001205836.1	1.8.3 : Nitrogen metabolism
YP_001205843.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205844.1	2.2.3 : RNA modification
YP_001205845.1	1.8.3 : Nitrogen metabolism
YP_001205845.1	3.1.2 : Transcriptional level
YP_001205845.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205846.1	1.8.3 : Nitrogen metabolism
YP_001205846.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205847.1	3.1.2 : transcriptional level
YP_001205848.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001205849.1	1.5.1.11 : Serine
YP_001205849.1	1.5.1.8 : Threonine
YP_001205849.1	1.5.1.10 : Glycine
YP_001205850.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205852.1	4.S.69 : gluconate
YP_001205854.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001205855.1	1.8.3 : Nitrogen metabolism
YP_001205855.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205856.1	1.8.3 : Nitrogen metabolism
YP_001205856.1	2.3.3 : Posttranslational modification
YP_001205856.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205858.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001205859.1	5.5 : Adaptation to stress
YP_001205866.1	1.5.3.3 : Lipoate
YP_001205866.1	7.1 : Cytoplasm
YP_001205867.1	2.1.4 : DNA repair
YP_001205868.1	2.3.1 : Amino acid-activation
YP_001205868.1	7.1 : Cytoplasm
YP_001205871.1	2.3.6 : Turnover, degradation
YP_001205871.1	3.1.3.2 : Covalent modification, demodification, maturation
YP_001205879.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205880.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205882.1	1.3.7 : Anaerobic respiration
YP_001205887.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001205887.1	5.6.4 : Drug resistance/sensitivity
YP_001205888.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001205888.1	5.6.4 : Drug resistance/sensitivity
YP_001205889.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001205889.1	5.6.4 : Drug resistance/sensitivity
YP_001205889.1	6.1 : Membrane
YP_001205889.1	7.3 : Inner membrane
YP_001205890.1	4.1.B.17 : The Outer Membrane Factor (OMF) Family
YP_001205890.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001205893.1	1.6.1 : Phospholipid
YP_001205894.1	1.5.1.12 : Cysteine
YP_001205895.1	4.3.A.1.a : ATP binding component
YP_001205895.1	7.1 : Cytoplasm
YP_001205896.1	4.3.A.1.m : membrane component
YP_001205897.1	4.3.A.1.m : membrane component
YP_001205897.1	6.1 : Membrane
YP_001205897.1	7.3 : Inner membrane
YP_001205898.1	4.3.A.1.p : periplasmic binding component
YP_001205899.1	1.5.1.9 : Methionine
YP_001205899.1	1.5.1.12 : Cysteine
YP_001205900.1	4.S.130 : Na+
YP_001205900.1	4.S.155 : phosphate
YP_001205902.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001205903.1	1.6.1 : Phospholipid
YP_001205905.1	1.6.7 : Peptidoglycan (murein)
YP_001205905.1	5.6.4 : Drug resistance/sensitivity
YP_001205905.1	6.2 : Peptidoglycan (murein)
YP_001205928.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205929.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205930.1	1.7.1 : Unassigned reversible reactions
YP_001205930.1	5.5.4 : pH response
YP_001205931.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001205931.1	2.3.6 : Turnover, degradation
YP_001205931.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001205935.1	1.7.12 : Amino sugar conversions
YP_001205937.1	2.2.2 : Transcription related
YP_001205937.1	3.1.2.2 : Activator
YP_001205937.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205937.1	7.1 : Cytoplasm
YP_001205938.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001205939.1	4.3.A.1.p : periplasmic binding component
YP_001205940.1	4.3.A.1.m : membrane component
YP_001205941.1	4.3.A.1.m : membrane component
YP_001205942.1	4.3.A.1.a : ATP binding component
YP_001205942.1	7.1 : Cytoplasm
YP_001205947.1	4.3.A.1.a : ATP binding component
YP_001205948.1	4 : Transport
YP_001205953.1	2.3.1 : Amino acid-activation
YP_001205961.1	3.3.4 : Global
YP_001205961.1	3.1.2.4 : Complex regulation
YP_001205962.1	3.1.2.3 : Repressor
YP_001205962.1	3.1.2.4.2 : Regulons or multilayer component regulatory systems
YP_001205965.1	1.5.1.12 : Cysteine
YP_001205965.1	7.1 : Cytoplasm
YP_001205967.1	2.2.3 : RNA modification
YP_001205967.1	7.1 : Cytoplasm
YP_001205969.1	1.5.1.8 : Threonine
YP_001205969.1	1.5.1.9 : Methionine
YP_001205969.1	1.5.1.7 : Lysine, diaminopimelate
YP_001205970.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001205970.1	2.2.3 : RNA modification
YP_001205970.1	7.1 : Cytoplasm
YP_001205972.1	1.1.3.6 : Proline utilization
YP_001205972.1	1.1.3 : Amino acids
YP_001205973.1	1.1.3.6 : Proline utilization
YP_001205973.1	1.1.3 : Amino acids
YP_001205974.1	1.5.3.5 : Coenzyme A
YP_001205976.1	2.2.2 : Transcription related
YP_001205976.1	2.1.1 : DNA replication
YP_001205976.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001205976.1	7.1 : Cytoplasm
YP_001205977.1	3.1.2 : Transcriptional level
YP_001205979.1	2.1.3 : DNA recombination
YP_001205979.1	5.8 : SOS response
YP_001205979.1	7.1 : Cytoplasm
YP_001205980.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001205982.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001205984.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001205987.1	2.1.4 : DNA repair
YP_001205987.1	5.6.1 : Radiation
YP_001205987.1	5.8 : SOS response
YP_001205987.1	7.1 : Cytoplasm
YP_001205988.1	1.7.25 : Glycolate metabolism
YP_001205994.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001205994.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001206007.1	4.S.174 : sulfate
YP_001206007.1	5.5.3 : Starvation response
YP_001206009.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001206011.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001206011.1	6.1 : Membrane
YP_001206011.1	7.3 : Inner membrane
YP_001206012.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001206012.1	6.1 : Membrane
YP_001206012.1	7.3 : Inner membrane
YP_001206013.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001206016.1	1.6.7 : Peptidoglycan (murein)
YP_001206016.1	2.3.6 : Turnover, degradation
YP_001206017.1	2.3.3 : Posttranslational modification
YP_001206018.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206019.1	1.2.2 : DNA
YP_001206019.1	1.2.1 : RNA
YP_001206019.1	5.6 : Protection
YP_001206021.1	2.3.1 : Amino acid-activation
YP_001206021.1	7.1 : Cytoplasm
YP_001206022.1	4.2.A.64 : The Type V Secretory Pathway or Twin Arginine Targeting (Tat) Family
YP_001206022.1	6.1 : Membrane
YP_001206023.1	4 : Transport
YP_001206024.1	4 : Transport
YP_001206024.1	4.2.A.64 : The Type V Secretory Pathway or Twin Arginine Targeting (Tat) Family
YP_001206027.1	1.7.12 : Amino sugar conversions
YP_001206027.1	1.6.7 : Peptidoglycan (murein)
YP_001206029.1	2.3.1 : Amino acid-activation
YP_001206029.1	2.2.5 : tRNA
YP_001206030.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001206033.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206035.1	3.1.2 : Transcriptional level
YP_001206039.1	2.1.4 : DNA repair
YP_001206040.1	5.6.4 : Drug resistance/sensitivity
YP_001206041.1	1.8.3 : Nitrogen metabolism
YP_001206042.1	1.8.3 : Nitrogen metabolism
YP_001206043.1	1.8.3 : Nitrogen metabolism
YP_001206044.1	1.8.3 : Nitrogen metabolism
YP_001206045.1	1.8.3 : Nitrogen metabolism
YP_001206046.1	1.8.3 : Nitrogen metabolism
YP_001206048.1	1.8.3 : Nitrogen metabolism
YP_001206048.1	1.1 : Carbon compound utilization
YP_001206049.1	4.3.A.1.a : ATP binding component
YP_001206050.1	4.3.A.1.a : ATP binding component
YP_001206051.1	4.3.A.1.m : membrane component
YP_001206052.1	4.3.A.1.m : membrane component
YP_001206053.1	4.3.A.1.p : periplasmic binding component
YP_001206054.1	4.3.A.1.p : periplasmic binding component
YP_001206056.1	3.1.4 : Regulation level unknown
YP_001206057.1	1.3.2 : pentose phosphate shunt, oxidative branch
YP_001206057.1	1.5.1.18 : isoleucine/valine
YP_001206057.1	1 : metabolism
YP_001206059.1	1.5.1.8 : Threonine
YP_001206060.1	1.3.4 : Tricarboxylic acid cycle
YP_001206060.1	1.7.35 : Lactate oxidation
YP_001206060.1	1.3.3 : Pyruvate dehydrogenase
YP_001206061.1	1.3.4 : Tricarboxylic acid cycle
YP_001206061.1	1.7.35 : Lactate oxidation
YP_001206061.1	1.3.3 : Pyruvate dehydrogenase
YP_001206063.1	1.3.4 : Tricarboxylic acid cycle
YP_001206063.1	1.7.35 : Lactate oxidation
YP_001206063.1	1.3.3 : Pyruvate dehydrogenase
YP_001206064.1	1.3.4 : Tricarboxylic acid cycle
YP_001206064.1	1.7.35 : Lactate oxidation
YP_001206064.1	1.3.3 : Pyruvate dehydrogenase
YP_001206071.1	1.3.1 : Glycolysis
YP_001206071.1	1.3.7 : Anaerobic respiration
YP_001206071.1	1.7.8 : Gluconeogenesis
YP_001206071.1	1.1.1.23 : Galactose degradation
YP_001206071.1	7.1 : Cytoplasm
YP_001206074.1	8.3.1 : transposases
YP_001206075.1	8.3.1 : transposases
YP_001206077.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206077.1	5.6.4 : Drug resistance/sensitivity
YP_001206078.1	1.6.5 : K antigen
YP_001206078.1	6.2 : Peptidoglycan (murein)
YP_001206078.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001206078.1	6.7 : Capsule (M and K antigens)
YP_001206078.1	6.1 : Membrane
YP_001206078.1	7.1 : Cytoplasm
YP_001206080.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001206081.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001206082.1	3.1.2 : Transcriptional level
YP_001206084.1	1.1.1.23 : Galactose degradation
YP_001206084.1	1.3.1 : Glycolysis
YP_001206084.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206085.1	2.3.4 : Chaperoning, folding
YP_001206086.1	1.5.1.15 : Tryptophan
YP_001206087.1	1.5.1.15 : Tryptophan
YP_001206088.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001206089.1	3 : Regulation
YP_001206090.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001206091.1	1.3 : Energy metabolism (carbon)
YP_001206096.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001206097.1	2.2.2 : Transcription related
YP_001206097.1	2.1.4 : DNA repair
YP_001206097.1	3.3.2 : Regulon (a network of operons encoding related functions)
YP_001206097.1	3.1.2.3 : Repressor
YP_001206097.1	5.8 : SOS response
YP_001206101.1	2.3.1 : Amino acid-activation
YP_001206101.1	7.1 : Cytoplasm
YP_001206102.1	1.5.3.12 : Heme, porphyrin
YP_001206102.1	2.3.1 : Amino acid-activation
YP_001206102.1	7.1 : Cytoplasm
YP_001206103.1	1.3.7 : Anaerobic respiration
YP_001206103.1	1.3.4 : Tricarboxylic acid cycle
YP_001206104.1	1.6.3.3 : Lipid A
YP_001206104.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001206104.1	6.1 : Membrane
YP_001206104.1	7.1 : Cytoplasm
YP_001206106.1	1.6.3.3 : Lipid A
YP_001206106.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001206107.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206107.1	7.1 : Cytoplasm
YP_001206108.1	1.6.3.3 : Lipid A
YP_001206108.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001206110.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206111.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001206112.1	1.6.1 : Phospholipid
YP_001206113.1	1.6.3 : Lipopolysaccharide
YP_001206113.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001206113.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001206114.1	2.3.2 : Translation
YP_001206114.1	3.1.3.1 : Translation attenuation and efficiency
YP_001206114.1	7.1 : Cytoplasm
YP_001206115.1	1.5.2.4 : Pyrimidine ribonucleotide/ribonucleoside biosynthesis
YP_001206115.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001206115.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001206115.1	7.1 : Cytoplasm
YP_001206116.1	2.3.2 : Translation
YP_001206116.1	7.1 : Cytoplasm
YP_001206117.1	2.3.2 : Translation
YP_001206117.1	2.3.8 : Ribosomal proteins
YP_001206117.1	6.6 : Ribosome
YP_001206122.1	2.1.1 : DNA replication
YP_001206122.1	7.1 : Cytoplasm
YP_001206124.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001206126.1	4.1.B : Beta barrel porins (The Outer Membrane Porin (OMP) Functional Superfamily)
YP_001206128.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206129.1	4.3.A.1.a : ATP binding component
YP_001206129.1	7.1 : Cytoplasm
YP_001206130.1	4.3.A.1.m : membrane component
YP_001206130.1	6.1 : Membrane
YP_001206130.1	7.3 : Inner membrane
YP_001206131.1	2.3.1 : Amino acid-activation
YP_001206132.1	4.9.B :  uncharacterized transport protein
YP_001206132.1	5.6.4 : Drug resistance/sensitivity
YP_001206134.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001206134.1	5.5.7 : Fe aquisition
YP_001206140.1	4.3.A.1.p : periplasmic binding component
YP_001206140.1	4.S.48 : D-ribose
YP_001206141.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206141.1	4.3.A.1.a : ATP binding component
YP_001206141.1	4.S.48 : D-ribose
YP_001206141.1	7.1 : Cytoplasm
YP_001206142.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206142.1	4.3.A.1.m : membrane component
YP_001206142.1	4.S.48 : D-ribose
YP_001206143.1	1.5.1.9 : Methionine
YP_001206145.1	1.1.3.14 : Valine degradation
YP_001206147.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206147.1	1.5.3.1 : Biotin
YP_001206148.1	1.4.1 : Electron donor
YP_001206148.1	1.3.6 : Aerobic respiration
YP_001206148.1	1.3.7 : Anaerobic respiration
YP_001206148.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206148.1	6.1 : Membrane
YP_001206148.1	7.3 : Inner membrane
YP_001206149.1	1.4.1 : Electron donor
YP_001206149.1	1.3.6 : Aerobic respiration
YP_001206149.1	1.3.7 : Anaerobic respiration
YP_001206149.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206149.1	6.1 : Membrane
YP_001206149.1	7.3 : Inner membrane
YP_001206150.1	1.4.1 : Electron donor
YP_001206150.1	1.3.6 : Aerobic respiration
YP_001206150.1	1.3.7 : Anaerobic respiration
YP_001206150.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206150.1	6.1 : Membrane
YP_001206150.1	7.3 : Inner membrane
YP_001206151.1	1.4.1 : Electron donor
YP_001206151.1	1.3.6 : Aerobic respiration
YP_001206151.1	1.3.7 : Anaerobic respiration
YP_001206151.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206151.1	6.1 : Membrane
YP_001206151.1	7.3 : Inner membrane
YP_001206152.1	1.4.1 : Electron donor
YP_001206152.1	1.3.6 : Aerobic respiration
YP_001206152.1	1.3.7 : Anaerobic respiration
YP_001206152.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206152.1	6.1 : Membrane
YP_001206152.1	7.3 : Inner membrane
YP_001206153.1	1.4.1 : Electron donor
YP_001206153.1	1.3.6 : Aerobic respiration
YP_001206153.1	1.3.7 : Anaerobic respiration
YP_001206153.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206154.1	1.4.1 : Electron donor
YP_001206154.1	1.3.6 : Aerobic respiration
YP_001206154.1	1.3.7 : Anaerobic respiration
YP_001206154.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206154.1	6.1 : Membrane
YP_001206154.1	7.3 : Inner membrane
YP_001206155.1	1.4.1 : Electron donor
YP_001206155.1	1.3.6 : Aerobic respiration
YP_001206155.1	1.3.7 : Anaerobic respiration
YP_001206155.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206156.1	1.4.1 : Electron donor
YP_001206156.1	1.3.6 : Aerobic respiration
YP_001206156.1	1.3.7 : Anaerobic respiration
YP_001206156.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206156.1	7.1 : Cytoplasm
YP_001206158.1	1.4.1 : Electron donor
YP_001206158.1	1.3.6 : Aerobic respiration
YP_001206158.1	1.3.7 : Anaerobic respiration
YP_001206158.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206160.1	1.4.1 : Electron donor
YP_001206160.1	1.3.6 : Aerobic respiration
YP_001206160.1	1.3.7 : Anaerobic respiration
YP_001206160.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206161.1	1.4.1 : Electron donor
YP_001206161.1	1.3.6 : Aerobic respiration
YP_001206161.1	1.3.7 : Anaerobic respiration
YP_001206161.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206162.1	1.4.1 : Electron donor
YP_001206162.1	1.3.6 : Aerobic respiration
YP_001206162.1	1.3.7 : Anaerobic respiration
YP_001206162.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206163.1	1.4.1 : Electron donor
YP_001206163.1	1.3.6 : Aerobic respiration
YP_001206163.1	1.3.7 : Anaerobic respiration
YP_001206163.1	4.3.D.1 : The Proton- or sodium ion-translocating NADH Dehydrogenase (NDH) Family
YP_001206166.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206173.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206173.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001206173.1	7.1 : Cytoplasm
YP_001206174.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206174.1	2.3.4 : Chaperoning, folding
YP_001206174.1	7.1 : Cytoplasm
YP_001206175.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206175.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001206175.1	5.5.2 : Temperature extremes
YP_001206175.1	7.1 : Cytoplasm
YP_001206177.1	2.3.4 : Chaperoning, folding
YP_001206177.1	5.1 : Cell division
YP_001206177.1	7.1 : Cytoplasm
YP_001206179.1	1.1.3.8 : Tryptophan utilization
YP_001206181.1	1.5.1.2 : Glutamine
YP_001206181.1	1.8.3 : Nitrogen metabolism
YP_001206181.1	2.2.2 : Transcription related
YP_001206181.1	3.1.3.3 : Inhibition / activation of enzymes
YP_001206181.1	7.1 : Cytoplasm
YP_001206182.1	1.8.3 : Nitrogen metabolism
YP_001206182.1	1.5.1.2 : Glutamine
YP_001206182.1	7.1 : Cytoplasm
YP_001206186.1	1.7.32 : Putrescine catabolism
YP_001206186.1	1.1.4 : Amines
YP_001206187.1	4.9.B.22 : The  Permease (PerM) Family
YP_001206188.1	1.1 : Carbon compound utilization
YP_001206189.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206189.1	4.S.34 : citrate/succinate
YP_001206192.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001206193.1	2.3.2 : Translation
YP_001206193.1	2.3.8 : Ribosomal proteins
YP_001206193.1	6.6 : Ribosome
YP_001206194.1	2.3.2 : Translation
YP_001206194.1	2.3.8 : Ribosomal proteins
YP_001206194.1	6.6 : Ribosome
YP_001206194.1	7.1 : Cytoplasm
YP_001206195.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001206196.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001206198.1	1.5.1.9 : Methionine
YP_001206198.1	1.5.1.12 : Cysteine
YP_001206198.1	4.S.174 : sulfate
YP_001206205.1	1.6 : Macromolecules (cellular constituent) biosynthesis
YP_001206206.1	1.6 : Macromolecules (cellular constituent) biosynthesis
YP_001206207.1	1.6.2 : Colanic acid (M antigen)
YP_001206207.1	1.6.3 : Lipopolysaccharide
YP_001206207.1	1.6 : Macromolecules (cellular constituent) biosynthesis
YP_001206216.1	3 : Regulation
YP_001206219.1	4.3.A.1.p : periplasmic binding component
YP_001206220.1	4.3.A.1.m : membrane component
YP_001206221.1	4.3.A.1.m : membrane component
YP_001206223.1	4.3.A.1.a : ATP binding component
YP_001206230.1	3.1.2 : Transcriptional level
YP_001206241.1	8.3.1 : transposases
YP_001206242.1	8.3.1 : transposases
YP_001206244.1	1.8.2 : Sulfur metabolism
YP_001206244.1	4.3.A.1.m : membrane component
YP_001206245.1	1.8.2 : Sulfur metabolism
YP_001206245.1	4.3.A.1.a : ATP binding component
YP_001206245.1	7.1 : Cytoplasm
YP_001206246.1	4.3.A.1.p : periplasmic binding component
YP_001206249.1	1.5.1.12 : Cysteine
YP_001206252.1	4.3.A.1.p : periplasmic binding component
YP_001206259.1	4.3.A.1.p : periplasmic binding component
YP_001206259.1	6.1 : Membrane
YP_001206259.1	7.2 : Periplasmic space
YP_001206261.1	4.3.A.1.m : membrane component
YP_001206261.1	6.1 : Membrane
YP_001206261.1	7.3 : Inner membrane
YP_001206262.1	4.3.A.1.a : ATP binding component
YP_001206262.1	7.1 : Cytoplasm
YP_001206266.1	1.8.2 : Sulfur metabolism
YP_001206266.1	1.1.4 : Amines
YP_001206268.1	8.3.1 : transposases
YP_001206280.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206291.1	6.1 : Membrane
YP_001206296.1	3.1.2 : Transcriptional level
YP_001206303.1	1.3.6 : Aerobic respiration
YP_001206303.1	1.1.3.14 : Valine degradation
YP_001206306.1	2.2.2 : Transcription related
YP_001206309.1	4 : Transport
YP_001206314.1	3.1.2 : Transcriptional level
YP_001206315.1	2.3.4 : Chaperoning, folding
YP_001206315.1	5.1 : Cell division
YP_001206315.1	7.1 : Cytoplasm
YP_001206325.1	3.1.2 : Transcriptional level
YP_001206329.1	1.8.2 : Sulfur metabolism
YP_001206330.1	1.8.2 : Sulfur metabolism
YP_001206330.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001206332.1	1.8.2 : Sulfur metabolism
YP_001206332.1	4.3.A.1.a : ATP binding component
YP_001206332.1	7.1 : Cytoplasm
YP_001206333.1	4.3.A.1.m : membrane component
YP_001206334.1	4.3.A.1.p : periplasmic binding component
YP_001206356.1	8.1.6 : Structural component
YP_001206357.1	8.1.6 : Structural component
YP_001206358.1	1.7.1 : Unassigned reversible reactions
YP_001206359.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206359.1	4.3.A.1.a : ATP binding component
YP_001206359.1	7.1 : Cytoplasm
YP_001206360.1	4.3.A.1.m : membrane component
YP_001206361.1	4.3.A.1.m : membrane component
YP_001206362.1	4.3.A.1.p : periplasmic binding component
YP_001206363.1	3.1.2 : Transcriptional level
YP_001206366.1	4.3.A.1.p : periplasmic binding component
YP_001206366.1	7.2 : Periplasmic space
YP_001206368.1	4.3.A.1.a : ATP binding component
YP_001206368.1	7.1 : Cytoplasm
YP_001206369.1	4.3.A.1.a : ATP binding component
YP_001206369.1	7.1 : Cytoplasm
YP_001206370.1	4.3.A.1.m : membrane component
YP_001206370.1	6.1 : Membrane
YP_001206370.1	7.3 : Inner membrane
YP_001206371.1	4.3.A.1.m : membrane component
YP_001206371.1	6.1 : Membrane
YP_001206371.1	7.3 : Inner membrane
YP_001206376.1	3.1.2 : Transcriptional level
YP_001206377.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206377.1	5.6.4 : Drug resistance/sensitivity
YP_001206377.1	6.1 : Membrane
YP_001206377.1	7.3 : Inner membrane
YP_001206378.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206378.1	5.6.4 : Drug resistance/sensitivity
YP_001206378.1	6.1 : Membrane
YP_001206378.1	7.3 : Inner membrane
YP_001206380.1	7.1 : Cytoplasm
YP_001206380.1	8.1.4 : Integration, recombination
YP_001206381.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206381.1	7.1 : Cytoplasm
YP_001206382.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206382.1	1.6.1 : Phospholipid
YP_001206388.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001206389.1	2.2.2 : Transcription related
YP_001206389.1	7.1 : Cytoplasm
YP_001206390.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001206391.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001206392.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001206394.1	1.5.1.10 : Glycine
YP_001206394.1	1.5.2.1 : Purine biosynthesis
YP_001206394.1	1.5.3.2 : Folic acid
YP_001206394.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001206394.1	1.1.3.5 : Glycine cleavage
YP_001206394.1	7.1 : Cytoplasm
YP_001206398.1	3.1.2 : Transcriptional level
YP_001206400.1	1.5.3.12 : Heme, porphyrin
YP_001206402.1	2.3.2 : Translation
YP_001206403.1	4.2.A.55 : The Manganese (Nramp) Fam.
YP_001206405.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206406.1	5.6 : Protection
YP_001206408.1	5.6.4 : Drug resistance/sensitivity
YP_001206411.1	4.2.A.4 : The Cation Diffusion Facilitator (CDF) Family
YP_001206412.1	2.1.1 : DNA replication
YP_001206412.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001206412.1	7.1 : Cytoplasm
YP_001206419.1	3.1.2 : Transcriptional level
YP_001206422.1	2.1.3 : DNA recombination
YP_001206422.1	2.1.4 : DNA repair
YP_001206424.1	5.2 : Cell cycle physiology
YP_001206425.1	2.2.4 : RNA degradation
YP_001206426.1	2.3.5 : Export, signal peptide cleavage
YP_001206426.1	6.1 : Membrane
YP_001206426.1	7.3 : Inner membrane
YP_001206427.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206427.1	7.1 : Cytoplasm
YP_001206428.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001206428.1	7.1 : Cytoplasm
YP_001206429.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001206429.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001206429.1	5.5.3 : Starvation response
YP_001206430.1	2.2.2 : Transcription related
YP_001206433.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001206434.1	2.3.6 : Turnover, degradation
YP_001206435.1	4.1.A.22 : The Large Conductance Mechanosensitive Ion Channel (MscL) Family
YP_001206435.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001206435.1	6.1 : Membrane
YP_001206435.1	7.3 : Inner membrane
YP_001206436.1	1.5.1.7 : Lysine, diaminopimelate
YP_001206436.1	7.1 : Cytoplasm
YP_001206443.1	8 : extrachromosomal
YP_001206444.1	2.3.1 : Amino acid-activation
YP_001206444.1	2.2.5 : tRNA
YP_001206447.1	2.3.1 : Amino acid-activation
YP_001206447.1	2.2.5 : tRNA
YP_001206449.1	2.3.1 : Amino acid-activation
YP_001206449.1	2.2.5 : tRNA
YP_001206450.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001206451.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001206452.1	3.1.2 : Transcriptional level
YP_001206454.1	4.3.A.1.a : ATP binding component
YP_001206455.1	2.1.3 : DNA recombination
YP_001206455.1	2.1 : DNA related
YP_001206459.1	5.5 : Adaptation to stress
YP_001206460.1	1.5.2.4 : Pyrimidine ribonucleotide/ribonucleoside biosynthesis
YP_001206460.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001206461.1	1.5.2.4 : Pyrimidine ribonucleotide/ribonucleoside biosynthesis
YP_001206461.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001206464.1	1.2.2 : DNA
YP_001206464.1	5.11 : DNA uptake
YP_001206466.1	2.2.2 : Transcription related
YP_001206466.1	2.1.1 : DNA replication
YP_001206466.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001206467.1	1.2.1 : RNA
YP_001206467.1	2.2.4 : RNA degradation
YP_001206471.1	2.3.2 : Translation
YP_001206471.1	2.3.8 : Ribosomal proteins
YP_001206471.1	6.6 : Ribosome
YP_001206471.1	7.1 : Cytoplasm
YP_001206472.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206477.1	3.1.2.4 : Complex regulation
YP_001206478.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206480.1	2.1.1 : DNA replication
YP_001206480.1	5.8 : SOS response
YP_001206482.1	3.1.3 : Posttranscriptional
YP_001206483.1	1.7.6 : Glycerol metabolism
YP_001206486.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001206487.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001206488.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001206496.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001206497.1	3.1.2 : Transcriptional level
YP_001206500.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206500.1	6.1 : Membrane
YP_001206500.1	7.3 : Inner membrane
YP_001206502.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206502.1	7.1 : Cytoplasm
YP_001206503.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001206505.1	6.2 : Peptidoglycan (murein)
YP_001206510.1	1.5.3.5 : Coenzyme A
YP_001206510.1	7.1 : Cytoplasm
YP_001206517.1	1.1.1.2 : 2,5-ketogluconate metabolism
YP_001206517.1	7.1 : Cytoplasm
YP_001206518.1	3.1.2 : Transcriptional level
YP_001206519.1	4.S.121 : Mg2+/Ni2+/Co2+
YP_001206526.1	3.1.2 : Transcriptional level
YP_001206530.1	3.1.2 : Transcriptional level
YP_001206532.1	1.8.3 : Nitrogen metabolism
YP_001206532.1	1.1.4 : Amines
YP_001206533.1	1.8.3 : Nitrogen metabolism
YP_001206533.1	1.1.4 : Amines
YP_001206534.1	4.3.A.1.a : ATP binding component
YP_001206535.1	4.3.A.1.a : ATP binding component
YP_001206536.1	4.3.A.1.m : membrane component
YP_001206537.1	4.3.A.1.m : membrane component
YP_001206538.1	4.3.A.1.p : periplasmic binding component
YP_001206539.1	1.3 : Energy metabolism (carbon)
YP_001206540.1	1.3 : Energy metabolism (carbon)
YP_001206541.1	1.3 : Energy metabolism (carbon)
YP_001206542.1	3.1.2 : Transcriptional level
YP_001206548.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206548.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001206559.1	3.1.2 : Transcriptional level
YP_001206560.1	1.7.1 : Unassigned reversible reactions
YP_001206562.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206562.1	4.8.A.7 : The Phosphotransferase System Enzyme I (EI) Family
YP_001206563.1	4.8.A.8 : The Phosphotransferase System HPr (HPr) Family
YP_001206564.1	4.8.A.7 : The Phosphotransferase System Enzyme I (EI) Family
YP_001206565.1	1.7.1 : Unassigned reversible reactions
YP_001206566.1	4.3.A.1.a : ATP binding component
YP_001206567.1	4.3.A.1.a : ATP binding component
YP_001206569.1	4.3.A.1.m : membrane component
YP_001206570.1	4.3.A.1.m : membrane component
YP_001206571.1	4.3.A.1.p : periplasmic binding component
YP_001206573.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206573.1	5.6.4 : Drug resistance/sensitivity
YP_001206573.1	6.1 : Membrane
YP_001206573.1	7.3 : Inner membrane
YP_001206574.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206574.1	5.6.4 : Drug resistance/sensitivity
YP_001206574.1	6.1 : Membrane
YP_001206574.1	7.3 : Inner membrane
YP_001206578.1	5.6.4 : Drug resistance/sensitivity
YP_001206582.1	2.2 : RNA related
YP_001206586.1	3.1.2 : Transcriptional level
YP_001206591.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206594.1	3.1.2 : Transcriptional level
YP_001206599.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001206599.1	5.5.7 : Fe aquisition
YP_001206600.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001206600.1	5.5.7 : Fe aquisition
YP_001206601.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001206601.1	5.5.7 : Fe aquisition
YP_001206601.1	6.1 : Membrane
YP_001206601.1	7.3 : Inner membrane
YP_001206605.1	3.1.2 : Transcriptional level
YP_001206606.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206606.1	5.6.4 : Drug resistance/sensitivity
YP_001206606.1	6.1 : Membrane
YP_001206606.1	7.3 : Inner membrane
YP_001206607.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206607.1	5.6.4 : Drug resistance/sensitivity
YP_001206612.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001206615.1	3.1.2 : Transcriptional level
YP_001206618.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001206618.1	6.1 : Membrane
YP_001206618.1	7.3 : Inner membrane
YP_001206622.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206622.1	1.6.3.3 : Lipid A
YP_001206623.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206624.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206625.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206626.1	1.6.3.3 : Lipid A
YP_001206628.1	1.1.4 : Amines
YP_001206628.1	1.7.14 : Polyamine biosynthesis
YP_001206628.1	4.3.A.1.p : periplasmic binding component
YP_001206628.1	7.2 : Periplasmic space
YP_001206631.1	4.2.A.72 : The K+ uptake permease (KUP) family
YP_001206631.1	5.5.1 : Osmotic pressure
YP_001206632.1	4.2.A.72 : The K+ uptake permease (KUP) family
YP_001206632.1	5.5.1 : Osmotic pressure
YP_001206633.1	4.1.A.46 : The H+- or Na+-translocating Bacterial Flagellar Motor (Mot) Family
YP_001206634.1	4.1.A.46 : The H+- or Na+-translocating Bacterial Flagellar Motor (Mot) Family
YP_001206635.1	3.1.2.4 : Complex regulation
YP_001206636.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206638.1	1.6.1 : Phospholipid
YP_001206639.1	1.1.3.5 : Glycine cleavage
YP_001206639.1	1.1.3.7 : Threonine catabolism
YP_001206639.1	1.6.1 : Phospholipid
YP_001206639.1	1.1.3.2 : L-serine degradation
YP_001206640.1	4.3.A.1.am : ATP binding and membrane component
YP_001206646.1	2.3.1 : Amino acid-activation
YP_001206646.1	7.1 : Cytoplasm
YP_001206649.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001206650.1	1.6.1 : Phospholipid
YP_001206650.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206651.1	1.5.1.20 : Chorismate
YP_001206654.1	3.1.2 : Transcriptional level
YP_001206659.1	1.5.3.10 : Glutathione
YP_001206661.1	1.7.3 : Pentose phosphate shunt, non-oxidative branch
YP_001206661.1	1.1.1.22 : Ribose degradation
YP_001206662.1	1.7.25 : Glycolate metabolism
YP_001206664.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001206673.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206674.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206675.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206676.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206676.1	4.S.28 : cation
YP_001206677.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001206678.1	4.S.115 : mannitol
YP_001206679.1	4.S.115 : mannitol
YP_001206683.1	8.1 : Prophage genes and phage related functions
YP_001206686.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206690.1	2.2.5 : tRNA
YP_001206695.1	1.6.3 : Lipopolysaccharide
YP_001206697.1	1.6.3.2 : Core region
YP_001206701.1	1.6 : Macromolecules (cellular constituent) biosynthesis
YP_001206705.1	4.9.B :  uncharacterized transport protein
YP_001206706.1	4.9.B :  uncharacterized transport protein
YP_001206709.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001206710.1	3.1.2 : Transcriptional level
YP_001206710.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001206725.1	4.3.A.1.a : ATP binding component
YP_001206726.1	4.3.A.1.a : ABC superfamily ATP binding cytoplasmic component
YP_001206727.1	4.3.A.1.m : membrane component
YP_001206728.1	4.3.A.1.m : membrane component
YP_001206729.1	3.1.2 : Transcriptional level
YP_001206730.1	4.3.A.1.p : periplasmic binding component
YP_001206731.1	4.3.A.1.p : periplasmic binding component
YP_001206732.1	4.3.A.1.a : ATP binding component
YP_001206733.1	4.3.A.1.m : membrane component
YP_001206734.1	4.3.A.1.m : membrane component
YP_001206735.1	1.3.6 : Aerobic respiration
YP_001206735.1	1.4.1 : Electron donor
YP_001206735.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001206735.1	1.7.6 : Glycerol metabolism
YP_001206735.1	1.1.1.23 : Galactose degradation
YP_001206735.1	7.1 : Cytoplasm
YP_001206736.1	1.1.1.3 : D-arabinose catabolism
YP_001206736.1	1.1.1.11 : Fucose catabolism
YP_001206739.1	4.3.A.1.a : ATP binding component
YP_001206740.1	4.3.A.1.a : ATP binding component
YP_001206741.1	4.3.A.1.m : membrane component
YP_001206742.1	4.3.A.1.m : membrane component
YP_001206743.1	4.3.A.1.p : periplasmic binding component
YP_001206744.1	3.1.2 : Transcriptional level
YP_001206744.1	3.3.1 : Operon (regulation of one operon)
YP_001206752.1	4.3.A.1.p : periplasmic binding component
YP_001206754.1	3.1.2 : transcriptional level
YP_001206755.1	1.6.3 : Lipopolysaccharide
YP_001206758.1	1.6.3 : Lipopolysaccharide
YP_001206765.1	1.5.1.6 : Asparagine
YP_001206770.1	4.9.A.1 : The Polysaccharide Transporter (PST) Family
YP_001206773.1	1.6.3 : Lipopolysaccharide
YP_001206778.1	1.6.3 : Lipopolysaccharide
YP_001206779.1	1.6.3 : Lipopolysaccharide
YP_001206780.1	3 : Regulation
YP_001206782.1	6.7 : Capsule (M and K antigens)
YP_001206785.1	1.8.3 : Nitrogen metabolism
YP_001206787.1	4.3.A.1.a : ATP binding component
YP_001206788.1	4.3.A.1.a : ATP binding component
YP_001206789.1	4.3.A.1.m : membrane component
YP_001206790.1	4.3.A.1.m : membrane component
YP_001206801.1	3.1.2 : Transcriptional level
YP_001206802.1	1.8.2 : Sulfur metabolism
YP_001206802.1	4.3.A.1.p : periplasmic binding component
YP_001206802.1	7.2 : Periplasmic space
YP_001206803.1	1.8.3 : Nitrogen metabolism
YP_001206803.1	1.4.3 : Electron carrier
YP_001206804.1	1.5.1.9 : Methionine
YP_001206804.1	1.5.1.12 : Cysteine
YP_001206804.1	4.S.174 : sulfate
YP_001206809.1	1.4.2 : Electron acceptor
YP_001206809.1	1.3.6 : Aerobic respiration
YP_001206809.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001206809.1	6.1 : Membrane
YP_001206809.1	7.3 : Inner membrane
YP_001206811.1	1.6.12 : Flagella
YP_001206811.1	6.4 : Flagellum
YP_001206812.1	1.6.12 : Flagella
YP_001206812.1	6.4 : Flagellum
YP_001206815.1	1.6.12 : Flagella
YP_001206815.1	6.4 : Flagellum
YP_001206816.1	1.6.12 : Flagella
YP_001206816.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206816.1	6.4 : Flagellum
YP_001206819.1	1.6.12 : Flagella
YP_001206819.1	6.4 : Flagellum
YP_001206820.1	1.6.12 : Flagella
YP_001206820.1	6.4 : Flagellum
YP_001206821.1	1.6.12 : Flagella
YP_001206821.1	6.4 : Flagellum
YP_001206822.1	2.2.2 : Transcription related
YP_001206822.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001206825.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206826.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206827.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206828.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206830.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206831.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206832.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206833.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206834.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206835.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206836.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206840.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206841.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206841.1	7.1 : Cytoplasm
YP_001206842.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206843.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206844.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206846.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206847.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001206848.1	1.7.14 : Polyamine biosynthesis
YP_001206848.1	1.1.4.3 : Ornithine degradation
YP_001206848.1	4.S.171 : spermidine/putrescine
YP_001206848.1	4.S.164 : putrescine/ornithine
YP_001206849.1	5.6.4 : Drug resistance/sensitivity
YP_001206851.1	1.5.1.11 : Serine
YP_001206851.1	1.5.1.10 : Glycine
YP_001206862.1	1.5.3.10 : Glutathione
YP_001206866.1	1.7.1 : Unassigned reversible reactions
YP_001206866.1	7.1 : Cytoplasm
YP_001206867.1	1.1.5.2 : Ethanol degradation
YP_001206867.1	1.7.25 : Glycolate metabolism
YP_001206867.1	1.7.26 : Allantoin assimilation
YP_001206867.1	1.1.1.20 : Glycol degradation
YP_001206868.1	4.S.162 : purine/xanthine
YP_001206871.1	1.7.2 : Glyoxylate bypass
YP_001206871.1	2.2.2 : Transcription related
YP_001206871.1	3.1.2.3 : Repressor
YP_001206871.1	3.3.1 : Operon (regulation of one operon)
YP_001206871.1	7.1 : Cytoplasm
YP_001206873.1	3.1.2 : Transcriptional level
YP_001206874.1	1.7.1 : Unassigned reversible reactions
YP_001206874.1	1.7.21 : Glyoxylate degradation
YP_001206875.1	1.7.1 : Unassigned reversible reactions
YP_001206882.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206883.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001206886.1	4.2.A.4 : The Cation Diffusion Facilitator (CDF) Family
YP_001206888.1	8.3.1 : transposases
YP_001206892.1	3.1.2 : Transcriptional level
YP_001206893.1	1.4.3 : Electron carrier
YP_001206893.1	1.3.7 : Anaerobic respiration
YP_001206893.1	4.S.59 : formate
YP_001206894.1	1.4.3 : Electron carrier
YP_001206894.1	1.3.7 : Anaerobic respiration
YP_001206894.1	4.S.59 : formate
YP_001206895.1	1.4.3 : Electron carrier
YP_001206895.1	1.3.7 : Anaerobic respiration
YP_001206895.1	4.S.59 : formate
YP_001206896.1	1.3.7 : Anaerobic respiration
YP_001206896.1	1.4.3 : Electron carrier
YP_001206896.1	4.S.59 : formate
YP_001206897.1	1.4.3 : Electron carrier
YP_001206897.1	1.3.7 : Anaerobic respiration
YP_001206897.1	4.S.59 : formate
YP_001206898.1	4.1.A.1. : The Voltage-gated Ion Channel (VIC) Superfamily
YP_001206899.1	2.3.1 : Amino acid-activation
YP_001206900.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001206900.1	1.1.3.5 : Glycine cleavage
YP_001206901.1	1.1.3.5 : Glycine cleavage
YP_001206901.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001206902.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001206902.1	1.1.3.5 : Glycine cleavage
YP_001206903.1	2.1.3 : DNA recombination
YP_001206903.1	2.1.4 : DNA repair
YP_001206903.1	2.3.6 : Turnover, degradation
YP_001206903.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001206903.1	5.8 : SOS response
YP_001206903.1	7.1 : Cytoplasm
YP_001206915.1	2.3.3 : Posttranslational modification
YP_001206921.1	1.1.3.10 : Lysine cleavage
YP_001206921.1	4.S.111 : lysine
YP_001206923.1	3.1.2 : Transcriptional level
YP_001206925.1	5.1 : Cell division
YP_001206925.1	5.2 : Cell cycle physiology
YP_001206927.1	5.1 : Cell division
YP_001206927.1	5.2 : Cell cycle physiology
YP_001206931.1	1.3.5 : Fermentation
YP_001206931.1	1.3.4 : Tricarboxylic acid cycle
YP_001206934.1	1.5.3.10 : Glutathione
YP_001206938.1	1.6.12 : Flagella
YP_001206938.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206938.1	6.4 : Flagellum
YP_001206939.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206939.1	6.4 : Flagellum
YP_001206940.1	1.6.12 : Flagella
YP_001206940.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206940.1	6.4 : Flagellum
YP_001206941.1	1.6.12 : Flagella
YP_001206941.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206941.1	6.4 : Flagellum
YP_001206942.1	1.6.12 : Flagella
YP_001206942.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206942.1	6.4 : Flagellum
YP_001206943.1	1.6.12 : Flagella
YP_001206943.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206943.1	6.4 : Flagellum
YP_001206945.1	1.6.12 : Flagella
YP_001206945.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206945.1	6.4 : Flagellum
YP_001206949.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206949.1	6.4 : Flagellum
YP_001206950.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206950.1	6.4 : Flagellum
YP_001206951.1	1.6.12 : Flagella
YP_001206951.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206951.1	6.4 : Flagellum
YP_001206952.1	1.6.12 : Flagella
YP_001206952.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206952.1	6.4 : Flagellum
YP_001206953.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206953.1	6.4 : Flagellum
YP_001206954.1	1.6.12 : Flagella
YP_001206954.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206954.1	6.4 : Flagellum
YP_001206956.1	1.5.2 : Nucleotide
YP_001206956.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001206957.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001206958.1	2.2.2 : Transcription related
YP_001206961.1	3.1.2 : Transcriptional level
YP_001206962.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206962.1	6.4 : Flagellum
YP_001206963.1	1.6.12 : Flagella
YP_001206963.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206963.1	6.4 : Flagellum
YP_001206967.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206967.1	6.4 : Flagellum
YP_001206968.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206968.1	6.4 : Flagellum
YP_001206969.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206969.1	6.4 : Flagellum
YP_001206970.1	6.4 : Flagellum
YP_001206971.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001206971.1	6.4 : Flagellum
YP_001206972.1	1.1.3 : Amino acids
YP_001206977.1	1.6.12 : Flagella
YP_001206977.1	6.4 : Flagellum
YP_001206978.1	1.6.12 : Flagella
YP_001206978.1	6.4 : Flagellum
YP_001206979.1	2.3.6 : Turnover, degradation
YP_001206982.1	5.5 : Adaptation to stress
YP_001206983.1	8.3.1 : transposases
YP_001206993.1	1.4.3 : Electron carrier
YP_001206996.1	4.3.A.1.p : periplasmic binding component
YP_001206997.1	4.3.A.1.a : ATP binding component
YP_001206998.1	4.3.A.1.m : membrane component
YP_001206999.1	1.1 : Carbon compound utilization
YP_001207000.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207003.1	1.1.3.7 : Threonine catabolism
YP_001207005.1	1.3.1 : Glycolysis
YP_001207006.1	1.3.5 : Fermentation
YP_001207006.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207007.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207007.1	3.1.2 : Transcriptional level
YP_001207008.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207008.1	7.1 : Cytoplasm
YP_001207012.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207013.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207017.1	4.S.19 : arsenite
YP_001207017.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001207018.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001207019.1	3.1.2.3 : Repressor
YP_001207019.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001207020.1	3.1.2.3 : Repressor
YP_001207020.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001207022.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207025.1	3.1.2 : Transcriptional level
YP_001207026.1	3.1.2 : Transcriptional level
YP_001207027.1	1.1 : Carbon compound utilization
YP_001207028.1	1.1 : Carbon compound utilization
YP_001207029.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207030.1	1.1 : Carbon compound utilization
YP_001207031.1	8.3.1 : transposases
YP_001207032.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207032.1	5.6.4 : Drug resistance/sensitivity
YP_001207033.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207033.1	5.6.4 : Drug resistance/sensitivity
YP_001207043.1	3.1.2 : Transcriptional level
YP_001207045.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001207046.1	3.1.2 : Transcriptional level
YP_001207047.1	3.1.2 : Transcriptional level
YP_001207048.1	3 : Regulation
YP_001207049.1	4 : Transport
YP_001207050.1	1.4.3 : Electron carrier
YP_001207051.1	1.4.3 : Electron carrier
YP_001207054.1	4.1.B.14 : The Outer Membrane Receptor (OMR) Family
YP_001207056.1	5.13 : Virulence associated
YP_001207058.1	3.1.4 : Regulation level unknown
YP_001207063.1	1.6.2 : Colanic acid (M antigen)
YP_001207063.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207063.1	5.5.5 : Dessication
YP_001207063.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207063.1	6.7 : Capsule (M and K antigens)
YP_001207064.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207064.1	6.7 : Capsule (M and K antigens)
YP_001207064.1	6 : Cell structure
YP_001207065.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207065.1	6.7 : Capsule (M and K antigens)
YP_001207067.1	1.5.1.6 : Asparagine
YP_001207068.1	1.6.3.1 : O antigen
YP_001207070.1	1.6.3.1 : O antigen
YP_001207074.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207074.1	1.6.3 : Lipopolysaccharide
YP_001207075.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207076.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207077.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207078.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207078.1	1.6.3 : Lipopolysaccharide
YP_001207079.1	1.3 : Energy metabolism (carbon)
YP_001207079.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207080.1	1.3 : Energy metabolism (carbon)
YP_001207080.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207089.1	4.3.A.1.m : membrane component
YP_001207090.1	4.3.A.1.a : ATP binding component
YP_001207095.1	1.6.3 : Lipopolysaccharide
YP_001207095.1	3.1.4 : Regulation level unknown
YP_001207098.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001207098.1	1.6.3 : Lipopolysaccharide
YP_001207099.1	1.6.3.3 : Lipid A
YP_001207099.1	3.1.4 : Regulation level unknown
YP_001207100.1	1.8.2 : Sulfur metabolism
YP_001207101.1	1.8.2 : Sulfur metabolism
YP_001207105.1	1.6.3 : Lipopolysaccharide
YP_001207106.1	1.6.3 : Lipopolysaccharide
YP_001207108.1	1.6.3.1 : O antigen
YP_001207109.1	1.6.3.2 : Core region
YP_001207110.1	1.6.3.2 : Core region
YP_001207110.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001207110.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207111.1	1.6.3.2 : Core region
YP_001207111.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207112.1	1.6.3.2 : Core region
YP_001207113.1	1.5.1.16 : Histidine
YP_001207114.1	1.6.3.2 : Core region
YP_001207115.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001207115.1	1.6.2 : Colanic acid (M antigen)
YP_001207115.1	1.6.3 : Lipopolysaccharide
YP_001207115.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001207115.1	1.7.7 : Galactose metabolism
YP_001207115.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207115.1	5.5.5 : Dessication
YP_001207115.1	6.7 : Capsule (M and K antigens)
YP_001207115.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207115.1	7.1 : Cytoplasm
YP_001207116.1	4.3.A.1.am : ATP binding and membrane component
YP_001207118.1	8.1 : Prophage genes and phage related functions
YP_001207121.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001207122.1	1.6.3.3 : Lipid A
YP_001207122.1	5.10 : Defense/survival
YP_001207125.1	5.4 : Genetic exchange, recombination
YP_001207125.1	6.5 : Pilus
YP_001207126.1	5.4 : Genetic exchange, recombination
YP_001207126.1	6.5 : Pilus
YP_001207127.1	5.4 : Genetic exchange, recombination
YP_001207127.1	6.5 : Pilus
YP_001207128.1	5.4 : Genetic exchange, recombination
YP_001207128.1	6.5 : Pilus
YP_001207131.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207132.1	3.1.2 : Transcriptional level
YP_001207133.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207141.1	1.4.3 : Electron carrier
YP_001207143.1	1.5.1.12 : Cysteine
YP_001207144.1	1.7.20 : S-adenosyl methionine biosynthesis
YP_001207144.1	3.1.4 : Regulation level unknown
YP_001207144.1	7.1 : Cytoplasm
YP_001207153.1	1.5.1.9 : Methionine
YP_001207154.1	4.3.A.1.a : ATP binding component
YP_001207155.1	4.3.A.1.a : ATP binding component
YP_001207157.1	4.3.A.1.m : membrane component
YP_001207160.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001207160.1	1.5.2.3 : Purine ribonucleotide biosynthesis
YP_001207160.1	7.1 : Cytoplasm
YP_001207161.1	1.5.3.12 : Heme, porphyrin
YP_001207162.1	1.6.2 : Colanic acid (M antigen)
YP_001207162.1	5.5.5 : Dessication
YP_001207162.1	6.7 : Capsule (M and K antigens)
YP_001207162.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207162.1	7.1 : Cytoplasm
YP_001207163.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001207164.1	3.1.2 : Transcriptional level
YP_001207165.1	1.5.1.18 : Isoleucine/valine
YP_001207165.1	1.5.1.19 : Leucine
YP_001207165.1	1.1.3 : Amino acids
YP_001207165.1	4.3.A.1.a : ATP binding component
YP_001207165.1	7.1 : Cytoplasm
YP_001207166.1	1.5.3.5 : Coenzyme A
YP_001207166.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001207166.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001207167.1	4.3.A.1.m : membrane component
YP_001207168.1	1.1.3 : Amino acids
YP_001207168.1	4.3.A.1.m : membrane component
YP_001207169.1	1.1.3 : Amino acids
YP_001207170.1	1.5.1.18 : Isoleucine/valine
YP_001207170.1	1.5.1.19 : Leucine
YP_001207170.1	1.1.3 : Amino acids
YP_001207170.1	4.3.A.1.a : ATP binding component
YP_001207170.1	7.1 : Cytoplasm
YP_001207178.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001207179.1	1.5.3.6 : Pyridoxine (vitamin B6)
YP_001207180.1	3.1.2 : Transcriptional level
YP_001207188.1	1.7.22 : Carnitine metabolism
YP_001207188.1	1.1.4.2 : Carnitine degradation
YP_001207190.1	1.6.1 : Phospholipid
YP_001207190.1	2.3.3 : Posttranslational modification
YP_001207190.1	3.1.4 : Regulation level unknown
YP_001207190.1	6.1 : Membrane
YP_001207190.1	7.3 : Inner membrane
YP_001207192.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207193.1	3.1.2 : Transcriptional level
YP_001207194.1	4.9.B :  uncharacterized transport protein
YP_001207194.1	7.2 : Periplasmic space
YP_001207195.1	4.9.A : Transporters of Unknown Classification
YP_001207195.1	4.S.34 : citrate/succinate
YP_001207196.1	4.9.B :  uncharacterized transport protein
YP_001207196.1	4.S.34 : citrate/succinate
YP_001207196.1	6.1 : Membrane
YP_001207196.1	7.3 : Inner membrane
YP_001207199.1	1.4.3 : Electron carrier
YP_001207200.1	4.3.A.1.p : periplasmic binding component
YP_001207201.1	4.3.A.1.a : ATP binding component
YP_001207201.1	7.1 : Cytoplasm
YP_001207202.1	4.3.A.1.m : membrane component
YP_001207206.1	1.3.5 : Fermentation
YP_001207206.1	1.3.7 : Anaerobic respiration
YP_001207206.1	1.1.5.2 : Ethanol degradation
YP_001207208.1	1.3 : Energy metabolism (carbon)
YP_001207211.1	1.7.22 : Carnitine metabolism
YP_001207218.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207219.1	4.2.A.55 : The Manganese (Nramp) Fam.
YP_001207219.1	4.S.123 : Mn+/H+
YP_001207220.1	1.7.8 : Gluconeogenesis
YP_001207221.1	1.7.19 : Incorporation of metal ions
YP_001207221.1	1.1.3.3 : Arginine catabolism
YP_001207226.1	1.4.3 : Electron carrier
YP_001207237.1	2.1.4 : DNA repair
YP_001207237.1	3.1.2.3 : Repressor
YP_001207239.1	1.4.3 : Electron carrier
YP_001207241.1	4.2.A.7 : The Drug/Metabolite Transporter (DMT) Superfamily
YP_001207241.1	4.S.126 : multidrug
YP_001207241.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001207241.1	6.1 : Membrane
YP_001207241.1	7.3 : Inner membrane
YP_001207245.1	4.S.8 : alkylphosphonate
YP_001207246.1	4.S.8 : alkylphosphonate
YP_001207247.1	1.8.1 : Phosphorous metabolism
YP_001207247.1	4.S.8 : alkylphosphonate
YP_001207247.1	4.3.A.1.a : ATP binding component
YP_001207247.1	7.1 : Cytoplasm
YP_001207248.1	1.8.1 : Phosphorous metabolism
YP_001207248.1	4.S.8 : alkylphosphonate
YP_001207248.1	4.3.A.1.a : ATP binding component
YP_001207248.1	7.1 : Cytoplasm
YP_001207249.1	1.8.1 : Phosphorous metabolism
YP_001207249.1	4.S.8 : alkylphosphonate
YP_001207250.1	1.8.1 : Phosphorous metabolism
YP_001207250.1	4.S.8 : alkylphosphonate
YP_001207251.1	1.8.1 : Phosphorous metabolism
YP_001207251.1	4.S.8 : alkylphosphonate
YP_001207252.1	1.8.1 : Phosphorous metabolism
YP_001207252.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207252.1	4.S.8 : alkylphosphonate
YP_001207253.1	3.1.2 : Transcriptional level
YP_001207255.1	4.3.A.1.a : ATP binding component
YP_001207256.1	4.3.A.1.m : membrane component
YP_001207257.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207257.1	6.1 : Membrane
YP_001207259.1	1.8.1 : Phosphorous metabolism
YP_001207259.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207259.1	4.S.8 : alkylphosphonate
YP_001207259.1	6.1 : Membrane
YP_001207260.1	1.8.1 : Phosphorous metabolism
YP_001207260.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207260.1	4.S.8 : alkylphosphonate
YP_001207260.1	6.1 : Membrane
YP_001207261.1	1.8.1 : Phosphorous metabolism
YP_001207261.1	4.3.A.1.p : periplasmic binding component
YP_001207261.1	4.S.8 : alkylphosphonate
YP_001207261.1	7.2 : Periplasmic space
YP_001207262.1	1.8.1 : Phosphorous metabolism
YP_001207262.1	4.3.A.1.a : ATP binding component
YP_001207263.1	5.6 : Protection
YP_001207264.1	4.S.8 : alkylphosphonate
YP_001207267.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001207269.1	4.3.A.1.m : membrane component
YP_001207269.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207270.1	4.3.A.1.a : ATP binding component
YP_001207270.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207272.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001207275.1	4.3.A.1.p : periplasmic binding component
YP_001207276.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207277.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207278.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207279.1	1.4.3 : Electron carrier
YP_001207280.1	1.4.3 : Electron carrier
YP_001207281.1	1.4.3 : Electron carrier
YP_001207282.1	1.4.3 : Electron carrier
YP_001207284.1	1.5.1.12 : cysteine
YP_001207284.1	1.1.3 : Amino acids
YP_001207285.1	1.8.3 : Nitrogen metabolism
YP_001207285.1	1.5.1.7 : Lysine, diaminopimelate
YP_001207286.1	3.1.2 : Transcriptional level
YP_001207287.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207287.1	1.8.3 : Nitrogen metabolism
YP_001207288.1	1.8.3 : Nitrogen metabolism
YP_001207290.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207291.1	5.6.4 : Drug resistance/sensitivity
YP_001207292.1	1.4.3 : Electron carrier
YP_001207293.1	1.4.3 : Electron carrier
YP_001207294.1	3.1.4 : Regulation level unknown
YP_001207294.1	5.1 : Cell division
YP_001207294.1	5.5 : Adaptation to stress
YP_001207299.1	8.3.1 : transposases
YP_001207304.1	1.4.3 : Electron carrier
YP_001207305.1	1.6.3.3 : Lipid A
YP_001207305.1	3.1.4 : Regulation level unknown
YP_001207308.1	1.8.3 : Nitrogen metabolism
YP_001207309.1	1.8.3 : Nitrogen metabolism
YP_001207312.1	2.3.4 : Chaperoning, folding
YP_001207314.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207314.1	1.8.3 : Nitrogen metabolism
YP_001207316.1	1.8.3 : Nitrogen metabolism
YP_001207317.1	1.8.3 : Nitrogen metabolism
YP_001207317.1	1.5.1.17 : Alanine
YP_001207318.1	1.8.2 : Sulfur metabolism
YP_001207318.1	1.8.3 : Nitrogen metabolism
YP_001207319.1	1.7.19 : Incorporation of metal ions
YP_001207319.1	1.8.2 : Sulfur metabolism
YP_001207319.1	2.3.4 : Chaperoning, folding
YP_001207323.1	1.8.2 : Sulfur metabolism
YP_001207323.1	5.6 : Protection
YP_001207326.1	1.4.3 : Electron carrier
YP_001207326.1	1.8.3 : Nitrogen metabolism
YP_001207329.1	1.8.3 : Nitrogen metabolism
YP_001207330.1	1.8.3 : Nitrogen metabolism
YP_001207331.1	1.8.3 : Nitrogen metabolism
YP_001207332.1	1.8.3 : Nitrogen metabolism
YP_001207333.1	1.8.3 : Nitrogen metabolism
YP_001207334.1	1.8.3 : Nitrogen metabolism
YP_001207336.1	1.7.19 : Incorporation of metal ions
YP_001207336.1	1.8.2 : Sulfur metabolism
YP_001207337.1	1.8.2 : Sulfur metabolism
YP_001207337.1	1.7.19 : Incorporation of metal ions
YP_001207338.1	1.7.19 : Incorporation of metal ions
YP_001207338.1	1.8.2 : Sulfur metabolism
YP_001207339.1	1.8.2 : Sulfur metabolism
YP_001207339.1	4.3.A.1.a : ATP binding component
YP_001207339.1	7.1 : Cytoplasm
YP_001207340.1	1.8.2 : Sulfur metabolism
YP_001207340.1	2.3.4 : Chaperoning, folding
YP_001207341.1	1.4.3 : Electron carrier
YP_001207342.1	1.8.3 : Nitrogen metabolism
YP_001207343.1	1.8.3 : Nitrogen metabolism
YP_001207346.1	1 : Metabolism
YP_001207351.1	2.3.3 : Posttranslational modification
YP_001207351.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207351.1	6.1 : Membrane
YP_001207352.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207353.1	1.1 : Carbon compound utilization
YP_001207357.1	4.3.A.1.a : ATP binding component
YP_001207358.1	4.3.A.1.m : membrane component
YP_001207361.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207365.1	4.3.A.1.p : periplasmic binding component
YP_001207366.1	4.3.A.1.m : membrane component
YP_001207367.1	4.3.A.1.a : ATP binding component
YP_001207373.1	1.1.5.2 : Ethanol degradation
YP_001207374.1	1.4.3 : Electron carrier
YP_001207375.1	4.3.A.1.p : periplasmic binding component
YP_001207376.1	3.1.2 : Transcriptional level
YP_001207377.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207378.1	1.4.3 : Electron carrier
YP_001207379.1	1.1.5.2 : Ethanol degradation
YP_001207379.1	1.3.5 : Fermentation
YP_001207379.1	7.1 : Cytoplasm
YP_001207381.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207382.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207383.1	8.3.1 : transposases
YP_001207385.1	1.4.3 : Electron carrier
YP_001207386.1	1.1.3.8 : Tryptophan utilization
YP_001207386.1	1.1 : Carbon compound utilization
YP_001207390.1	1.5.1.15 : Tryptophan
YP_001207390.1	1.1 : Carbon compound utilization
YP_001207391.1	4.3.A.1.p : periplasmic binding component
YP_001207392.1	3.1.2 : Transcriptional level
YP_001207393.1	4.3.A.1 : The ATP-binding Cassette (ABC) Superfamily + ABC-type Uptake Permeases
YP_001207394.1	4.3.A.1.m : membrane component
YP_001207395.1	4.3.A.1.m : membrane component
YP_001207396.1	1.3.4 : Tricarboxylic acid cycle
YP_001207397.1	1.1.5 : Others
YP_001207398.1	1.5.1 : Amino acids
YP_001207399.1	1.5.1 : Amino acids
YP_001207400.1	1.1.2.3 : Propionate degradation
YP_001207400.1	7.1 : Cytoplasm
YP_001207401.1	1.5.1.18 : Isoleucine/valine
YP_001207401.1	1.5.1.19 : Leucine
YP_001207401.1	1.1.3 : Amino acids
YP_001207401.1	4.3.A.1.a : ATP binding component
YP_001207401.1	7.1 : Cytoplasm
YP_001207402.1	1.5.1.18 : Isoleucine/valine
YP_001207402.1	1.5.1.19 : Leucine
YP_001207402.1	1.1.3 : Amino acids
YP_001207402.1	4.3.A.1.a : ATP binding component
YP_001207402.1	7.1 : Cytoplasm
YP_001207403.1	1.5.1.18 : Isoleucine/valine
YP_001207403.1	1.5.1.19 : Leucine
YP_001207403.1	4.3.A.1.m : membrane component
YP_001207403.1	7.3 : Inner membrane
YP_001207404.1	1.5.1.18 : Isoleucine/valine
YP_001207404.1	1.5.1.19 : Leucine
YP_001207404.1	4.3.A.1.m : membrane component
YP_001207405.1	4.3.A.1.p : periplasmic binding component
YP_001207405.1	4.S.108 : L-leucine/L-valine/L-iso-leucine
YP_001207406.1	3.1.2 : Transcriptional level
YP_001207407.1	1.1 : Carbon compound utilization
YP_001207408.1	1.5.1.19 : Leucine
YP_001207408.1	7.1 : Cytoplasm
YP_001207409.1	1.5.1.19 : Leucine
YP_001207409.1	7.1 : Cytoplasm
YP_001207412.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207416.1	4.9.B :  uncharacterized transport protein
YP_001207416.1	4.S.34 : citrate/succinate
YP_001207417.1	4.9.B :  uncharacterized transport protein
YP_001207417.1	4.S.34 : citrate/succinate
YP_001207418.1	4.9.B :  uncharacterized transport protein
YP_001207418.1	4.S.34 : citrate/succinate
YP_001207419.1	1.5.1.19 : Leucine
YP_001207419.1	7.1 : Cytoplasm
YP_001207421.1	8.1 : Prophage genes and phage related functions
YP_001207421.1	8.3.1 : transposases
YP_001207423.1	5.10 : Defense/survival
YP_001207423.1	5.6.4 : Drug resistance/sensitivity
YP_001207429.1	3.1.2 : Transcriptional level
YP_001207432.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207432.1	5.6.4 : Drug resistance/sensitivity
YP_001207438.1	4.3.A.1.p : periplasmic binding component
YP_001207439.1	4.3.A.1.m : membrane component
YP_001207440.1	4.3.A.1.a : ATP binding component
YP_001207441.1	4.3.A.1.a : ATP binding component
YP_001207442.1	4.3.A.1.m : membrane component
YP_001207449.1	1.5.1.18 : Isoleucine/valine
YP_001207450.1	4.2.A.76 : The Resistance to Homoserine/Threonine (RhtB) Family
YP_001207452.1	1.5.1.18 : Isoleucine/valine
YP_001207453.1	1.5.1.18 : Isoleucine/valine
YP_001207453.1	1.1.3.7 : Threonine catabolism
YP_001207454.1	1.5.1.18 : Isoleucine/valine
YP_001207455.1	8.2.1 : replication and maintenance
YP_001207456.1	2.2.3 : RNA modification
YP_001207456.1	7.1 : Cytoplasm
YP_001207457.1	1.5.1.11 : Serine
YP_001207457.1	1.5.1.10 : Glycine
YP_001207459.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001207461.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207461.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001207461.1	5.5.2 : Temperature extremes
YP_001207461.1	7.2 : Periplasmic space
YP_001207463.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207463.1	8.1 : Prophage genes and phage related functions
YP_001207464.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207464.1	8.1 : Prophage genes and phage related functions
YP_001207465.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001207465.1	1.5.3.2 : Folic acid
YP_001207466.1	1.1 : Carbon compound utilization
YP_001207467.1	1.7.17 : Formyl-tetrahydrofolate biosynthesis
YP_001207467.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001207467.1	1.7.15 : 2'-deoxyribonucleotide/ribonucleoside metabolism
YP_001207467.1	7.1 : Cytoplasm
YP_001207470.1	5.6.4 : Drug resistance/sensitivity
YP_001207473.1	1.3.4 : Tricarboxylic acid cycle
YP_001207476.1	5.5.7 : Fe aquisition
YP_001207477.1	4.9.A.8 : The Ferrous Iron Uptake (FeoB) Family
YP_001207477.1	5.5.7 : Fe aquisition
YP_001207477.1	7.3 : Inner membrane
YP_001207478.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001207479.1	3.1.2 : Transcriptional level
YP_001207481.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001207482.1	4.3.A.1.a : ATP binding component
YP_001207483.1	4.3.A.1.a : ATP binding component
YP_001207484.1	4.3.A.1.m : membrane component
YP_001207485.1	4.3.A.1.m : membrane component
YP_001207486.1	4.3.A.1.p : periplasmic binding component
YP_001207487.1	1.5.1.20 : Chorismate
YP_001207488.1	3.1.2 : Transcriptional level
YP_001207490.1	1.4.3 : Electron carrier
YP_001207491.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207494.1	3.1.2 : Transcriptional level
YP_001207495.1	4.S.174 : sulfate
YP_001207498.1	1.7.35 : Lactate oxidation
YP_001207507.1	2.1.4 : DNA repair
YP_001207507.1	2.1.1 : DNA replication
YP_001207507.1	5.8 : SOS response
YP_001207507.1	7.1 : Cytoplasm
YP_001207516.1	4.3.A.1.a : ATP binding component
YP_001207516.1	7.1 : Cytoplasm
YP_001207517.1	4.3.A.1.m : membrane component
YP_001207517.1	6.1 : Membrane
YP_001207517.1	7.3 : Inner membrane
YP_001207521.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207521.1	4.3.A.1.m : membrane component
YP_001207521.1	4.S.10 : allose/ribose
YP_001207521.1	6.1 : Membrane
YP_001207521.1	7.3 : Inner membrane
YP_001207522.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207522.1	4.S.10 : allose/ribose
YP_001207522.1	4.3.A.1.a : ATP binding component
YP_001207522.1	7.1 : Cytoplasm
YP_001207523.1	4.S.10 : allose/ribose
YP_001207523.1	4.3.A.1.p : periplasmic binding component
YP_001207525.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001207525.1	1.5.3.5 : Coenzyme A
YP_001207528.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001207530.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001207531.1	6.5 : Pilus
YP_001207532.1	2.2.3 : RNA modification
YP_001207532.1	6.6 : Ribosome
YP_001207532.1	7.1 : Cytoplasm
YP_001207534.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207535.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207535.1	5.6.4 : Drug resistance/sensitivity
YP_001207535.1	7.3 : Inner membrane
YP_001207536.1	2.1.4 : DNA repair
YP_001207536.1	7.1 : Cytoplasm
YP_001207537.1	2.1.3 : DNA recombination
YP_001207537.1	2.1.4 : DNA repair
YP_001207537.1	5.8 : SOS response
YP_001207537.1	7.1 : Cytoplasm
YP_001207539.1	1.6.3.3 : Lipid A
YP_001207539.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207539.1	6.1 : Membrane
YP_001207539.1	7.1 : Cytoplasm
YP_001207540.1	5.1 : Cell division
YP_001207540.1	7.1 : Cytoplasm
YP_001207541.1	5.1 : Cell division
YP_001207541.1	6.1 : Membrane
YP_001207541.1	7.3 : Inner membrane
YP_001207542.1	5.1 : Cell division
YP_001207543.1	1.6.7 : Peptidoglycan (murein)
YP_001207543.1	5.1 : Cell division
YP_001207543.1	6.2 : Peptidoglycan (murein)
YP_001207543.1	7.1 : Cytoplasm
YP_001207544.1	1.6.7 : Peptidoglycan (murein)
YP_001207544.1	6.2 : Peptidoglycan (murein)
YP_001207545.1	1.6.7 : Peptidoglycan (murein)
YP_001207545.1	6.2 : Peptidoglycan (murein)
YP_001207546.1	1.6.7 : Peptidoglycan (murein)
YP_001207546.1	6.2 : Peptidoglycan (murein)
YP_001207546.1	6.1 : Membrane
YP_001207546.1	7.3 : Inner membrane
YP_001207547.1	4.9.B.3 : The  Bacterial Murein Precursor Exporter (MPE) Family
YP_001207547.1	5.1 : Cell division
YP_001207547.1	6.1 : Membrane
YP_001207547.1	7.3 : Inner membrane
YP_001207548.1	1.6.7 : Peptidoglycan (murein)
YP_001207548.1	6.2 : Peptidoglycan (murein)
YP_001207548.1	7.1 : Cytoplasm
YP_001207549.1	1.6.7 : Peptidoglycan (murein)
YP_001207549.1	6.2 : Peptidoglycan (murein)
YP_001207549.1	6.1 : Membrane
YP_001207549.1	7.3 : Inner membrane
YP_001207550.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001207550.1	1.6.7 : Peptidoglycan (murein)
YP_001207550.1	5.1 : Cell division
YP_001207550.1	6.2 : Peptidoglycan (murein)
YP_001207550.1	7.1 : Cytoplasm
YP_001207551.1	1.6.7 : Peptidoglycan (murein)
YP_001207551.1	6.2 : Peptidoglycan (murein)
YP_001207552.1	1.6.7 : Peptidoglycan (murein)
YP_001207552.1	5.6.4 : Drug resistance/sensitivity
YP_001207552.1	5.1 : Cell division
YP_001207552.1	6.2 : Peptidoglycan (murein)
YP_001207552.1	6.1 : Membrane
YP_001207554.1	1.6.10 : Lipoprotein
YP_001207556.1	2.2.2 : Transcription related
YP_001207558.1	4.3.A.1.am : ATP binding and membrane component
YP_001207559.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207559.1	5.6.4 : Drug resistance/sensitivity
YP_001207560.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207560.1	5.6.4 : Drug resistance/sensitivity
YP_001207561.1	3.1.2 : Transcriptional level
YP_001207562.1	2.2.2 : Transcription related
YP_001207562.1	3.1.2.3 : Repressor
YP_001207562.1	3.3.1 : Operon (regulation of one operon)
YP_001207562.1	7.1 : Cytoplasm
YP_001207568.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207569.1	2.2.2 : Transcription related
YP_001207569.1	3.1.2.2 : Activator
YP_001207569.1	3.1.2.3 : Repressor
YP_001207569.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207569.1	3.3.1 : Operon (regulation of one operon)
YP_001207569.1	6.1 : Membrane
YP_001207569.1	7.1 : Cytoplasm
YP_001207570.1	4.1.B.17 : The Outer Membrane Factor (OMF) Family
YP_001207571.1	5.6.4 : Drug resistance/sensitivity
YP_001207571.1	6.1 : Membrane
YP_001207571.1	7.3 : Inner membrane
YP_001207572.1	4.3.A.1.a : ATP binding component
YP_001207572.1	4.3.A.1.m : membrane component
YP_001207572.1	5.6.4 : Drug resistance/sensitivity
YP_001207572.1	6.1 : Membrane
YP_001207572.1	7.1 : Cytoplasm
YP_001207572.1	7.3 : Inner membrane
YP_001207574.1	4.2.A.7 : The Drug/Metabolite Transporter (DMT) Superfamily
YP_001207579.1	1.6.1 : Phospholipid
YP_001207587.1	6.5 : Pilus
YP_001207588.1	4.3.A.1.p : periplasmic binding component
YP_001207589.1	2.2.2 : Transcription related
YP_001207589.1	3.1.2.2 : Activator
YP_001207589.1	3.1.2.3 : Repressor
YP_001207589.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207589.1	3.3.1 : Operon (regulation of one operon)
YP_001207589.1	6.1 : Membrane
YP_001207589.1	7.1 : Cytoplasm
YP_001207590.1	2.2.2 : Transcription related
YP_001207590.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207595.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001207596.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001207597.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001207598.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001207599.1	1.5.3.8 : Thiamine (Vitamin B1)
YP_001207604.1	2.1.4 : DNA repair
YP_001207606.1	3.1.2 : Transcriptional level
YP_001207609.1	1.5.1.9 : Methionine
YP_001207613.1	4.9.B :  uncharacterized transport protein
YP_001207613.1	5.6.4 : Drug resistance/sensitivity
YP_001207614.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001207614.1	5.6.4 : Drug resistance/sensitivity
YP_001207616.1	5.5.7 : Fe aquisition
YP_001207617.1	5.5.7 : Fe aquisition
YP_001207621.1	1.7.34 : Peptidoglycan (murein) turnover, recycling
YP_001207624.1	4.3.A.1.a : ATP binding component
YP_001207626.1	1.5.1.11 : Serine
YP_001207629.1	1.8.2 : Sulfur metabolism
YP_001207634.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207635.1	2.2.2 : Transcription related
YP_001207635.1	3.1.2 : Transcriptional level
YP_001207636.1	3 : Regulation
YP_001207636.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207637.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207640.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207642.1	1.4 : Energy production/transport
YP_001207643.1	2.2.2 : Transcription related
YP_001207644.1	4.3.A.1.p : periplasmic binding component
YP_001207648.1	3.1.2 : Transcriptional level
YP_001207654.1	3.1.2 : Transcriptional level
YP_001207657.1	4.3.A.1.p : ABC superfamily, periplasmic binding component
YP_001207658.1	4.3.A.1.p : periplasmic binding component
YP_001207662.1	4.3.A.1.p : periplasmic binding component
YP_001207663.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207664.1	2.2.2 : Transcription related
YP_001207664.1	3.1.2 : Transcriptional level
YP_001207665.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001207671.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001207676.1	1.1.5 : Others
YP_001207677.1	1.1.5 : Others
YP_001207678.1	1.1.5 : Others
YP_001207679.1	1.1.5 : Others
YP_001207680.1	1.1.5 : Others
YP_001207681.1	3.1.3.4 : Proteases, cleavage of compounds
YP_001207690.1	1.3.1 : Glycolysis
YP_001207690.1	1.3.2 : Pentose phosphate shunt, oxidative branch
YP_001207691.1	1.7.3 : Pentose phosphate shunt, non-oxidative branch
YP_001207691.1	1.3.2 : Pentose phosphate shunt, oxidative branch
YP_001207692.1	1.3.2 : Pentose phosphate shunt, oxidative branch
YP_001207692.1	7.1 : Cytoplasm
YP_001207693.1	1.7.9 : Misc. glucose metabolism
YP_001207693.1	1.1.1.2 : 2,5-ketogluconate metabolism
YP_001207693.1	1.1.1.9 : L-idonate catabolism
YP_001207696.1	1.2.4 : Polysaccharides
YP_001207696.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207698.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001207698.1	7.1 : Cytoplasm
YP_001207699.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207699.1	7.1 : Cytoplasm
YP_001207707.1	2.2.2 : Transcription related
YP_001207707.1	3.1.2.2 : Activator
YP_001207707.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207707.1	3.3.1 : Operon (regulation of one operon)
YP_001207707.1	7.1 : Cytoplasm
YP_001207708.1	2.3.3 : Posttranslational modification
YP_001207708.1	3.1.3.2 : Covalent modification, demodification, maturation
YP_001207708.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207708.1	6.1 : Membrane
YP_001207708.1	7.3 : Inner membrane
YP_001207709.1	4.3.A.3 : The P-type ATPase (P-ATPase) Superfamily
YP_001207709.1	6.1 : Membrane
YP_001207709.1	7.3 : Inner membrane
YP_001207710.1	4.3.A.3 : The P-type ATPase (P-ATPase) Superfamily
YP_001207710.1	6.1 : Membrane
YP_001207710.1	7.3 : Inner membrane
YP_001207711.1	4.3.A.3 : The P-type ATPase (P-ATPase) Superfamily
YP_001207711.1	6.1 : Membrane
YP_001207711.1	7.3 : Inner membrane
YP_001207717.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207719.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207720.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207721.1	4.2.A.4 : The Cation Diffusion Facilitator (CDF) Family
YP_001207722.1	4.3.A.1.p : periplasmic binding component
YP_001207728.1	1.1.3.14 : Valine degradation
YP_001207728.1	1.1.3.12 : Leucine degradation
YP_001207729.1	4.S.20 : benzoate
YP_001207730.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207731.1	1.1.3 : amino acids
YP_001207731.1	4.3.A.1.a : ABC superfamily ATP binding cytoplasmic component
YP_001207732.1	4.3.A.1.p : periplasmic binding component
YP_001207733.1	1.1.3 : Amino acids
YP_001207733.1	4.3.A.1.m : membrane component
YP_001207734.1	4.3.A.1.m : membrane component
YP_001207735.1	4.3.A.1.a : ATP binding component
YP_001207740.1	1.8.3 : Nitrogen metabolism
YP_001207741.1	1.8.3 : Nitrogen metabolism
YP_001207742.1	1.8.3 : Nitrogen metabolism
YP_001207743.1	1.8.3 : Nitrogen metabolism
YP_001207744.1	1.8.3 : Nitrogen metabolism
YP_001207745.1	1.8.3 : Nitrogen metabolism
YP_001207746.1	1.8.3 : Nitrogen metabolism
YP_001207747.1	1.8.3 : Nitrogen metabolism
YP_001207748.1	1.8.2 : Sulfur metabolism
YP_001207748.1	1.5.1.9 : Methionine
YP_001207750.1	1.5.1.15 : Tryptophan
YP_001207750.1	1.5.1.3 : Arginine
YP_001207750.1	1.5.1.4 : Proline
YP_001207750.1	1.5.1.13 : Phenylalanine
YP_001207750.1	4.S.20 : benzoate
YP_001207751.1	4.3.A.1.a : ATP binding component
YP_001207752.1	4.3.A.1.a : ATP binding component
YP_001207753.1	4.3.A.1.m : membrane component
YP_001207754.1	4.3.A.1.m : membrane component
YP_001207758.1	3.1. : Type of regulation
YP_001207759.1	1.5.1.11 : Serine
YP_001207759.1	1.5.1.8 : Threonine
YP_001207759.1	1.5.1.10 : Glycine
YP_001207760.1	1.5.1.11 : Serine
YP_001207760.1	1.5.1.8 : Threonine
YP_001207760.1	1.5.1.10 : Glycine
YP_001207761.1	1.5.1.11 : Serine
YP_001207761.1	1.5.1.8 : Threonine
YP_001207761.1	1.5.1.10 : Glycine
YP_001207762.1	1.5.1.11 : Serine
YP_001207762.1	1.5.1.8 : Threonine
YP_001207762.1	1.5.1.10 : Glycine
YP_001207763.1	1.8.3 : Nitrogen metabolism
YP_001207763.1	1.5.1.2 : Glutamine
YP_001207764.1	1.8.3 : nitrogen metabolism
YP_001207764.1	1.5.1.1 : glutamate
YP_001207765.1	1.5.1.1 : Glutamate
YP_001207766.1	4.S.76 : glutamine
YP_001207767.1	3.1.2 : Transcriptional level
YP_001207773.1	2.2.5 : tRNA
YP_001207774.1	1.6.12 : Flagella
YP_001207774.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207774.1	6.4 : Flagellum
YP_001207775.1	1.6.12 : Flagella
YP_001207775.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207775.1	6.4 : Flagellum
YP_001207777.1	1.6.12 : Flagella
YP_001207777.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207777.1	6.4 : Flagellum
YP_001207777.1	7.3 : Inner membrane
YP_001207778.1	1.6.12 : Flagella
YP_001207778.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207778.1	6.4 : Flagellum
YP_001207779.1	1.6.12 : Flagella
YP_001207779.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207779.1	6.4 : Flagellum
YP_001207780.1	1.6.12 : Flagella
YP_001207780.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207780.1	6.4 : Flagellum
YP_001207781.1	1.6.12 : Flagella
YP_001207781.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207781.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207781.1	6.4 : Flagellum
YP_001207786.1	1.8.2 : Sulfur metabolism
YP_001207786.1	4.3.A.1.a : ATP binding component
YP_001207787.1	1.8.2 : Sulfur metabolism
YP_001207787.1	4.3.A.1.m : membrane component
YP_001207788.1	1.8.2 : Sulfur metabolism
YP_001207788.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001207789.1	1.8.2 : Sulfur metabolism
YP_001207789.1	4.3.A.1.p : periplasmic binding component
YP_001207792.1	1.4.2 : Electron acceptor
YP_001207792.1	1.3.7 : Anaerobic respiration
YP_001207793.1	1.3.7 : Anaerobic respiration
YP_001207793.1	1.4.2 : Electron acceptor
YP_001207793.1	1.6.15.1 : Cytochromes
YP_001207794.1	1.3.7 : Anaerobic respiration
YP_001207794.1	1.4.2 : Electron acceptor
YP_001207794.1	1.6.15.1 : Cytochromes
YP_001207797.1	8.3.1 : transposases
YP_001207800.1	2.3.6 : Turnover, degradation
YP_001207801.1	2.3.6 : Turnover, degradation
YP_001207804.1	3.1.2 : Transcriptional level
YP_001207809.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001207809.1	1.5.2.1 : Purine biosynthesis
YP_001207810.1	4.3.A.1.a : ATP binding component
YP_001207811.1	4.3.A.1.m : membrane component
YP_001207813.1	4.3.A.3 : The P-type ATPase (P-ATPase) Superfamily
YP_001207817.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001207818.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207821.1	1.5.1.11 : Serine
YP_001207822.1	1.5.1.11 : Serine
YP_001207829.1	1.6.7 : Peptidoglycan (murein)
YP_001207829.1	1.7.12 : Amino sugar conversions
YP_001207829.1	1.7.9 : Misc. glucose metabolism
YP_001207829.1	1.6.4 : Enterobacterial common antigen (surface glycolipid)
YP_001207830.1	1.7.35 : Lactate oxidation
YP_001207830.1	1.4.3 : Electron carrier
YP_001207832.1	1.5.1.20 : Chorismate
YP_001207834.1	4.S.174 : sulfate
YP_001207836.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207841.1	2.3.2 : Translation
YP_001207844.1	1.5.1 : Amino acids
YP_001207846.1	1.5.3.10 : Glutathione
YP_001207849.1	2.2.2 : Transcription related
YP_001207858.1	3.1.2 : Transcriptional level
YP_001207859.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001207860.1	1.5.3.10 : Glutathione
YP_001207863.1	3.1.2 : Transcriptional level
YP_001207866.1	2.1.4 : DNA repair
YP_001207869.1	1.5.2.4 : Pyrimidine ribonucleotide/ribonucleoside biosynthesis
YP_001207869.1	1.5.2.3 : Purine ribonucleotide biosynthesis
YP_001207873.1	1.6.10 : Lipoprotein
YP_001207873.1	1.6.1 : Phospholipid
YP_001207875.1	2.3.2 : Translation
YP_001207876.1	2.3.2 : Translation
YP_001207876.1	2.3.1 : Amino acid-activation
YP_001207889.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001207890.1	4.3.A.1.p : periplasmic binding component
YP_001207891.1	4.3.A.1.m : membrane component
YP_001207892.1	4.3.A.1.m : membrane component
YP_001207893.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207894.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207894.1	1.3 : Energy metabolism (carbon)
YP_001207895.1	1.3 : Energy metabolism (carbon)
YP_001207896.1	1.3 : Energy metabolism (carbon)
YP_001207897.1	1.3 : Energy metabolism (carbon)
YP_001207898.1	1.3 : Energy metabolism (carbon)
YP_001207899.1	1.3 : Energy metabolism (carbon)
YP_001207900.1	3 : Regulation
YP_001207901.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001207903.1	1.5.1.4 : Proline
YP_001207903.1	7.1 : Cytoplasm
YP_001207905.1	1.1 : Carbon compound utilization
YP_001207906.1	2.3.1 : Amino acid-activation
YP_001207907.1	1.5.1.18 : Isoleucine/valine
YP_001207907.1	1.5.1.19 : Leucine
YP_001207907.1	1.5.1.17 : Alanine
YP_001207908.1	3.1.2 : Transcriptional level
YP_001207909.1	2.2.2 : Transcription related
YP_001207909.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207910.1	2.2.2 : Transcription related
YP_001207910.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207911.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207912.1	2.2.2 : Transcription related
YP_001207913.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207914.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207915.1	4.3.A.1.p : periplasmic binding component
YP_001207919.1	1.2.1 : RNA
YP_001207921.1	2.2.2 : Transcription related
YP_001207921.1	3.1.2.2 : Activator
YP_001207921.1	3.3.1 : Operon (regulation of one operon)
YP_001207921.1	5.5.2 : Temperature extremes
YP_001207921.1	7.1 : Cytoplasm
YP_001207922.1	7.4 : Outer membrane
YP_001207923.1	1.2.2 : DNA
YP_001207923.1	2.1.4 : DNA repair
YP_001207923.1	2.1.5 : DNA degradation
YP_001207923.1	5.6.1 : Radiation
YP_001207923.1	7.1 : Cytoplasm
YP_001207925.1	1.6.1 : Phospholipid
YP_001207925.1	6.1 : Membrane
YP_001207925.1	7.3 : Inner membrane
YP_001207926.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207927.1	1.5.3.4 : Molybdenum (molybdopterin)
YP_001207928.1	3.1.1.2 : Methylation
YP_001207929.1	1.5.1 : Amino acids
YP_001207933.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001207934.1	1.5.3.9 : Riboflavin (Vitamin B2), FAD, FMN
YP_001207934.1	7.1 : Cytoplasm
YP_001207935.1	2.3.1 : Amino acid-activation
YP_001207935.1	7.1 : Cytoplasm
YP_001207936.1	2.3.5 : Export, signal peptide cleavage
YP_001207936.1	6.1 : Membrane
YP_001207936.1	7.3 : Inner membrane
YP_001207938.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207939.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001207940.1	2.3.2 : Translation
YP_001207942.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001207946.1	2.1.4 : DNA repair
YP_001207948.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001207948.1	2.3.2 : Translation
YP_001207949.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001207951.1	1.4.3 : Electron carrier
YP_001207954.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001207955.1	1.5.2.1 : Purine biosynthesis
YP_001207955.1	7.1 : Cytoplasm
YP_001207956.1	3.1.2 : Transcriptional level
YP_001207959.1	1.2.2 : DNA
YP_001207959.1	2.1.5 : DNA degradation
YP_001207959.1	2.1.4 : DNA repair
YP_001207962.1	1.6.3.3 : Lipid A
YP_001207963.1	1.6.3.3 : Lipid A
YP_001207963.1	1.6.5 : K antigen
YP_001207963.1	1.6.3.2 : Core region
YP_001207963.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001207963.1	6.7 : Capsule (M and K antigens)
YP_001207963.1	6.1 : Membrane
YP_001207966.1	3.1.4 : Regulation level unknown
YP_001207973.1	2.3.1 : Amino acid-activation
YP_001207974.1	1.5.1.16 : Histidine
YP_001207981.1	2.3.4 : Chaperoning, folding
YP_001207981.1	5.1 : Cell division
YP_001207981.1	7.1 : Cytoplasm
YP_001207982.1	2.3.4 : Chaperoning, folding
YP_001207982.1	5.1 : Cell division
YP_001207982.1	7.1 : Cytoplasm
YP_001207985.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207985.1	4.2.A.14 : The Lactate Permease (LctP) Family
YP_001207985.1	6.1 : Membrane
YP_001207985.1	7.3 : Inner membrane
YP_001207986.1	4.3.A.1.am : ATP binding and membrane component
YP_001207986.1	7.3 : Inner membrane
YP_001207989.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207996.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001207997.1	1.4.3 : Electron carrier
YP_001208002.1	2.3.2 : Translation
YP_001208002.1	2.3.8 : Ribosomal proteins
YP_001208002.1	6.6 : Ribosome
YP_001208002.1	7.1 : Cytoplasm
YP_001208004.1	3 : Regulation
YP_001208005.1	3.1.2 : Transcriptional level
YP_001208007.1	1.5.1.15 : Tryptophan
YP_001208007.1	3.1.4 : Regulation level unknown
YP_001208007.1	7.1 : Cytoplasm
YP_001208009.1	1.7.13 : Amino acid conversion
YP_001208009.1	1.5.1 : Amino acids
YP_001208010.1	1.5.1.5 : Aspartate
YP_001208010.1	1.5.1.1 : Glutamate
YP_001208010.1	4.S.75 : glutamate/aspartate
YP_001208010.1	4.3.A.1.a : ATP binding component
YP_001208010.1	7.1 : Cytoplasm
YP_001208011.1	1.5.1.1 : Glutamate
YP_001208011.1	1.5.1.5 : Aspartate
YP_001208011.1	4.3.A.1.m : membrane component
YP_001208011.1	4.S.75 : glutamate/aspartate
YP_001208011.1	6.1 : Membrane
YP_001208011.1	7.3 : Inner membrane
YP_001208012.1	1.5.1.1 : Glutamate
YP_001208012.1	1.5.1.5 : Aspartate
YP_001208012.1	4.3.A.1.m : membrane component
YP_001208012.1	4.S.75 : glutamate/aspartate
YP_001208012.1	6.1 : Membrane
YP_001208012.1	7.3 : Inner membrane
YP_001208013.1	1.5.1.1 : Glutamate
YP_001208013.1	4.3.A.1.p : periplasmic binding component
YP_001208013.1	4.S.75 : glutamate/aspartate
YP_001208013.1	7.2 : Periplasmic space
YP_001208014.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001208016.1	1.7.1 : Unassigned reversible reactions
YP_001208017.1	3.1.2 : Transcriptional level
YP_001208018.1	1.4.3 : Electron carrier
YP_001208023.1	3.1.2 : Transcriptional level
YP_001208024.1	4.3.A.1.p : periplasmic binding component
YP_001208026.1	3.1.2 : Transcriptional level
YP_001208027.1	1.6.15.4 : Acyl carrier protein
YP_001208028.1	1.7.1 : Unassigned reversible reactions
YP_001208030.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001208031.1	4 : Transport
YP_001208032.1	4 : Transport
YP_001208035.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208036.1	3.1.2 : Transcriptional level
YP_001208037.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001208037.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001208037.1	5.6.4 : Drug resistance/sensitivity
YP_001208037.1	6.1 : Membrane
YP_001208037.1	7.3 : Inner membrane
YP_001208038.1	4.2.A.6 : The Resistance-Nodulation-Cell Division (RND) Superfamily
YP_001208038.1	5.6.4 : Drug resistance/sensitivity
YP_001208038.1	6.1 : Membrane
YP_001208038.1	7.3 : Inner membrane
YP_001208041.1	3.1.2 : Transcriptional level
YP_001208042.1	4.3.A.1.p : periplasmic binding component
YP_001208042.1	4.S.171 : spermidine/putrescine
YP_001208042.1	7.2 : Periplasmic space
YP_001208043.1	1.7.14 : Polyamine biosynthesis
YP_001208043.1	1.1.4 : Amines
YP_001208043.1	4.S.171 : spermidine/putrescine
YP_001208043.1	4.3.A.1.a : ATP binding component
YP_001208043.1	7.1 : Cytoplasm
YP_001208044.1	4.3.A.1.m : membrane component
YP_001208044.1	4.S.171 : spermidine/putrescine
YP_001208045.1	4.3.A.1.m : membrane component
YP_001208045.1	4.S.171 : spermidine/putrescine
YP_001208046.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001208050.1	5.10 : Defense/survival
YP_001208050.1	5.6.4 : Drug resistance/sensitivity
YP_001208051.1	4 : Transport
YP_001208052.1	3.1.2 : Transcriptional level
YP_001208053.1	1.7.1 : Unassigned reversible reactions
YP_001208063.1	4 : Transport
YP_001208063.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001208064.1	4.3.A.1.am : ATP binding and membrane component
YP_001208067.1	8.3.1 : transposases
YP_001208068.1	5.4 : Genetic exchange, recombination
YP_001208069.1	5.4 : Genetic exchange, recombination
YP_001208070.1	8.2.2 : plasmid transfer
YP_001208071.1	2.2.2 : Transcription related
YP_001208071.1	3.1.2.2 : Activator
YP_001208071.1	8.1.3 : Regulation
YP_001208072.1	8.1.4 : Integration, recombination
YP_001208073.1	3.1.4 : Regulation level unknown
YP_001208074.1	1.5.1.1 : Glutamate
YP_001208074.1	1.1.3.11 : Histidine degradation
YP_001208076.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208077.1	3.1.2 : transcriptional level
YP_001208079.1	4.2.A.75 : The L-lysine exporter (LysE) family
YP_001208080.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208081.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208084.1	1.4.3 : Electron carrier
YP_001208085.1	3.1.2 : Transcriptional level
YP_001208087.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208091.1	3.1.2 : Transcriptional level
YP_001208092.1	4.3.A.1.p : periplasmic binding component
YP_001208093.1	1.8.1 : Phosphorous metabolism
YP_001208094.1	5.5.2 : Temperature extremes
YP_001208094.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001208096.1	1.5.1.2 : Glutamine
YP_001208096.1	1.8.3 : Nitrogen metabolism
YP_001208096.1	1.5.1.1 : Glutamate
YP_001208097.1	1.5.1.2 : Glutamine
YP_001208097.1	1.8.3 : Nitrogen metabolism
YP_001208097.1	1.5.1.1 : Glutamate
YP_001208098.1	1 : Metabolism
YP_001208099.1	1 : Metabolism
YP_001208100.1	3.1.2 : Transcriptional level
YP_001208102.1	1.6.3 : Lipopolysaccharide
YP_001208102.1	3.1.4 : Regulation level unknown
YP_001208102.1	6.7 : Capsule (M and K antigens)
YP_001208106.1	1.5.3.12 : Heme, porphyrin
YP_001208108.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208111.1	3.1.2 : Transcriptional level
YP_001208112.1	4.S.143 : Ni++
YP_001208114.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001208116.1	1.7.14 : Polyamine biosynthesis
YP_001208116.1	1.1.4.3 : Ornithine degradation
YP_001208120.1	1.7.32 : Putrescine catabolism
YP_001208123.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001208124.1	4.3.A.1.p : periplasmic binding component
YP_001208125.1	4.3.A.1.m : membrane component
YP_001208125.1	6.1 : Membrane
YP_001208125.1	7.3 : Inner membrane
YP_001208126.1	4.3.A.1.a : ATP binding component
YP_001208127.1	5.6.4 : Drug resistance/sensitivity
YP_001208128.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001208128.1	5.5.6 : Other stresses (mechanical, nutritional, oxidative)
YP_001208128.1	7.1 : Cytoplasm
YP_001208134.1	4.S.121 : Mg2+/Ni2+/Co2+
YP_001208136.1	1.4.3 : Electron carrier
YP_001208137.1	1.4.3 : Electron carrier
YP_001208138.1	4.1.B.17 : The Outer Membrane Factor (OMF) Family
YP_001208138.1	7.4 : Outer membrane
YP_001208139.1	1.4.3 : Electron carrier
YP_001208140.1	1.4.3 : Electron carrier
YP_001208141.1	3.1.2 : Transcriptional level
YP_001208142.1	1.3.8 : ATP proton motive force interconversion
YP_001208142.1	4.3.A.3 : The P-type ATPase (P-ATPase) Superfamily
YP_001208142.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001208143.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208144.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208144.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001208146.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208148.1	2.3.4 : Chaperoning, folding
YP_001208149.1	3.1.2 : Transcriptional level
YP_001208150.1	1.1 : Carbon compound utilization
YP_001208150.1	5.6.4 : Drug resistance/sensitivity
YP_001208151.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001208155.1	4.9.B.4 : The  Efflux Transporter (PET) Family
YP_001208155.1	5.6.4 : Drug resistance/sensitivity
YP_001208156.1	4.9.B.4 : The  Efflux Transporter (PET) Family
YP_001208156.1	5.6.4 : Drug resistance/sensitivity
YP_001208161.1	1.4.3 : Electron carrier
YP_001208164.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001208164.1	5.5.7 : Fe aquisition
YP_001208165.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001208165.1	5.5.7 : Fe aquisition
YP_001208165.1	7.3 : Inner membrane
YP_001208166.1	4.2.C.1 : TonB Family of Auxiliary Proteins for Energization of OMR-mediated Transport
YP_001208166.1	5.5.7 : Fe aquisition
YP_001208166.1	6.1 : Membrane
YP_001208166.1	7.3 : Inner membrane
YP_001208168.1	5.5.7 : Fe aquisition
YP_001208168.1	7.4 : Outer membrane
YP_001208169.1	5.5.7 : Fe aquisition
YP_001208169.1	7.4 : Outer membrane
YP_001208170.1	1.1 : Carbon compound utilization
YP_001208170.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001208175.1	1.1.3.8 : Tryptophan utilization
YP_001208180.1	1.7.14 : Polyamine biosynthesis
YP_001208188.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208189.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208189.1	4.9.B :  uncharacterized transport protein
YP_001208190.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208190.1	4.9.B :  uncharacterized transport protein
YP_001208191.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208191.1	4.9.B :  uncharacterized transport protein
YP_001208192.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208192.1	4.9.B :  uncharacterized transport protein
YP_001208193.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208193.1	4.9.B :  uncharacterized transport protein
YP_001208194.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208194.1	4.9.B :  uncharacterized transport protein
YP_001208195.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208195.1	4.9.B :  uncharacterized transport protein
YP_001208196.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208196.1	4.9.B :  uncharacterized transport protein
YP_001208197.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208197.1	4.9.B :  uncharacterized transport protein
YP_001208198.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208198.1	4.9.B :  uncharacterized transport protein
YP_001208199.1	4.3.A.5 : The Type II (General) Secretory Pathway (IISP) Family
YP_001208199.1	4.9.B :  uncharacterized transport protein
YP_001208203.1	1.7.28 : Pyruvate catabolism
YP_001208207.1	4.1.B.3 : The Sugar Porin (SP) Family
YP_001208207.1	7.4 : Outer membrane
YP_001208208.1	4.2.A.45 : The Metal Ion Transporter (MIT) Family
YP_001208209.1	1.8.1 : Phosphorous metabolism
YP_001208209.1	4.2.A.20 : The Inorganic Phosphate Transporter (PiT) Family
YP_001208209.1	6.1 : Membrane
YP_001208209.1	7.3 : Inner membrane
YP_001208210.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208211.1	1.7.29 : Acetate catabolism
YP_001208211.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208211.1	7.1 : Cytoplasm
YP_001208213.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208213.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001208213.1	7.1 : Cytoplasm
YP_001208214.1	5.10 : Defense/survival
YP_001208214.1	5.6.4 : Drug resistance/sensitivity
YP_001208221.1	8 : extrachromosomal
YP_001208221.1	8.2.2 : plasmid transfer
YP_001208226.1	8.1.2 : Replication
YP_001208230.1	8 : extrachromosomal
YP_001208233.1	1.8.3 : Nitrogen metabolism
YP_001208235.1	8.1 : Prophage genes and phage related functions
YP_001208241.1	8.3 : Transposon related
YP_001208246.1	8.1.4 : Integration, recombination
YP_001208249.1	8.2.1 : replication and maintenance
YP_001208250.1	2.1.1 : DNA replication
YP_001208252.1	4.3.A.1.a : ATP binding component
YP_001208254.1	2.1 : DNA related
YP_001208254.1	8.1 : Prophage genes and phage related functions
YP_001208256.1	2.1.3 : DNA recombination
YP_001208256.1	8.1.4 : Integration, recombination
YP_001208258.1	1.4.3 : Electron carrier
YP_001208260.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208262.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208265.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001208266.1	1.5.3.10 : Glutathione
YP_001208268.1	2.1.4 : DNA repair
YP_001208273.1	8.3.1 : transposases
YP_001208275.1	8.3.1 : transposases
YP_001208279.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001208279.1	2.3.4 : Chaperoning, folding
YP_001208279.1	7.1 : Cytoplasm
YP_001208282.1	1.1 : Carbon compound utilization
YP_001208283.1	3.1.2 : Transcriptional level
YP_001208288.1	1.5.1.9 : Methionine
YP_001208289.1	1.5.1.9 : Methionine
YP_001208290.1	1.5.1.14 : Tyrosine
YP_001208290.1	1.5.1.13 : Phenylalanine
YP_001208291.1	1.5.1.16 : Histidine
YP_001208292.1	1.5.1.14 : Tyrosine
YP_001208295.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208295.1	1.4.3 : Electron carrier
YP_001208297.1	4.3.A.1.m : membrane component
YP_001208298.1	4.3.A.1.a : ATP binding component
YP_001208298.1	5.1 : Cell division
YP_001208298.1	7.1 : Cytoplasm
YP_001208300.1	3.1.4 : Regulation level unknown
YP_001208301.1	2.2.2 : Transcription related
YP_001208301.1	3.1.2 : Transcriptional level
YP_001208306.1	8 : extrachromosomal
YP_001208307.1	8 : extrachromosomal
YP_001208308.1	8 : extrachromosomal
YP_001208309.1	8.3.1 : transposases
YP_001208310.1	2.1.1 : DNA replication
YP_001208310.1	8.3.1 : transposases
YP_001208312.1	1.5.1.3 : Arginine
YP_001208312.1	7.1 : Cytoplasm
YP_001208313.1	1.5.1.7 : Lysine, diaminopimelate
YP_001208315.1	1.5.1.3 : Arginine
YP_001208315.1	7.1 : Cytoplasm
YP_001208316.1	1.4.3 : Electron carrier
YP_001208318.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208319.1	1.4.3 : Electron carrier
YP_001208320.1	1.4.3 : Electron carrier
YP_001208321.1	1.5.3.13 : Cobalamin (Vitamin B12)
YP_001208323.1	2.2.3 : RNA modification
YP_001208324.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208329.1	2.1.2 : DNA restriction/modification
YP_001208329.1	3.1.1.1 : DNA bending, supercoiling, inversion
YP_001208330.1	4.3.A.1.a : ATP binding component
YP_001208331.1	4.3.A.1.m : membrane component
YP_001208332.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208333.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208334.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208335.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208335.1	7.1 : Cytoplasm
YP_001208336.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208336.1	7.1 : Cytoplasm
YP_001208341.1	2.3.2 : Translation
YP_001208342.1	2.3.4 : Chaperoning, folding
YP_001208348.1	3.1.2 : Transcriptional level
YP_001208352.1	1 : Metabolism
YP_001208352.1	3.1.2 : Transcriptional level
YP_001208353.1	1.1 : Carbon compound utilization
YP_001208369.1	1.4.3 : Electron carrier
YP_001208369.1	2.3.4 : Chaperoning, folding
YP_001208369.1	7.3 : Inner membrane
YP_001208377.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001208379.1	3.1.2 : Transcriptional level
YP_001208390.1	5.1 : Cell division
YP_001208390.1	7.1 : Cytoplasm
YP_001208391.1	5.1 : Cell division
YP_001208391.1	6.1 : Membrane
YP_001208391.1	7.3 : Inner membrane
YP_001208392.1	5.1 : Cell division
YP_001208392.1	7.1 : Cytoplasm
YP_001208394.1	4.3.A.1.p : periplasmic binding component
YP_001208394.1	4.S.12 : amino acid
YP_001208395.1	4.3.A.1.p : periplasmic binding component
YP_001208396.1	4.3.A.1.p : periplasmic binding component
YP_001208396.1	4.S.12 : amino acid
YP_001208400.1	1.5.1.16 : Histidine
YP_001208405.1	1.1.2.1 : Degradation of short-chain fatty acids
YP_001208405.1	6.1 : Membrane
YP_001208407.1	1.2.1 : RNA
YP_001208407.1	2.3.6 : Turnover, degradation
YP_001208407.1	2.1.1 : DNA replication
YP_001208407.1	7.1 : Cytoplasm
YP_001208408.1	1.5.1.8 : Threonine
YP_001208409.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208409.1	5.6.4 : Drug resistance/sensitivity
YP_001208413.1	1.7.29 : Acetate catabolism
YP_001208413.1	1.1.2.3 : Propionate degradation
YP_001208413.1	7.1 : Cytoplasm
YP_001208417.1	4.S.46 : dicarboxylate
YP_001208418.1	4.9.B :  uncharacterized transport protein
YP_001208427.1	1.1.3 : Amino acids
YP_001208428.1	3.1.2 : Transcriptional level
YP_001208429.1	1.1.3 : Amino acids
YP_001208431.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001208431.1	7.1 : Cytoplasm
YP_001208432.1	1.6.9 : Polysaccharides, cytoplasmic
YP_001208432.1	7.1 : Cytoplasm
YP_001208433.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001208434.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001208436.1	4.3.A.1.a : ATP binding component
YP_001208437.1	4.3.A.1.m : membrane component
YP_001208438.1	4.3.A.1.m : membrane component
YP_001208439.1	4.3.A.1.p : periplasmic binding component
YP_001208440.1	3.1.2 : Transcriptional level
YP_001208443.1	6.4 : Flagellum
YP_001208446.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001208446.1	1.3.6 : Aerobic respiration
YP_001208450.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208453.1	5.1 : Cell division
YP_001208454.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001208456.1	1.5.1.16 : Histidine
YP_001208458.1	1.6.7 : Peptidoglycan (murein)
YP_001208458.1	6.2 : Peptidoglycan (murein)
YP_001208461.1	1.7.28 : Pyruvate catabolism
YP_001208461.1	1.4.1 : Electron donor
YP_001208461.1	7.1 : Cytoplasm
YP_001208468.1	4.3.A.1.p : periplasmic binding component
YP_001208469.1	4.9.A.17 : The Metal Ion Transporter (MIT) Family
YP_001208470.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208471.1	3.1.2 : Transcriptional level
YP_001208472.1	3.1.2 : Transcriptional level
YP_001208475.1	1.8.3 : Nitrogen metabolism
YP_001208475.1	1.5.1.2 : Glutamine
YP_001208476.1	5.6.2 : Detoxification (xenobiotic metabolism)
YP_001208477.1	3.1.2 : Transcriptional level
YP_001208481.1	3.1.2 : Transcriptional level
YP_001208483.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208485.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208486.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208489.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208491.1	1.5.3.12 : Heme, porphyrin
YP_001208492.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208493.1	3.1.2 : Transcriptional level
YP_001208495.1	3.1.2 : Transcriptional level
YP_001208499.1	2.2.2 : Transcription related
YP_001208499.1	3.1.2 : Transcriptional level
YP_001208499.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208500.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001208501.1	5.1 : Cell division
YP_001208504.1	1.3.8 : ATP proton motive force interconversion
YP_001208504.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001208504.1	7.3 : Inner membrane
YP_001208505.1	1.3.8 : ATP proton motive force interconversion
YP_001208505.1	2.3.4 : Chaperoning, folding
YP_001208505.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001208505.1	7.3 : Inner membrane
YP_001208506.1	1.3.8 : ATP proton motive force interconversion
YP_001208506.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001208507.1	1.3.8 : ATP proton motive force interconversion
YP_001208507.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001208508.1	1.3.8 : ATP proton motive force interconversion
YP_001208508.1	4.3.A.2 : The H+/Na+-translocating F-, V- and A-type ATPase (F-ATPase) Superfamily
YP_001208510.1	2.3.3 : Posttranslational modification
YP_001208510.1	6.6 : Ribosome
YP_001208512.1	1.5.1.8 : Threonine
YP_001208516.1	3.1.2 : Transcriptional level
YP_001208517.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001208520.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001208521.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001208523.1	1.5.3.12 : Heme, porphyrin
YP_001208523.1	6.1 : Membrane
YP_001208523.1	7.3 : Inner membrane
YP_001208524.1	1.4.2 : Electron acceptor
YP_001208524.1	1.3.6 : Aerobic respiration
YP_001208524.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001208525.1	1.4 : Energy production/transport
YP_001208525.1	1.4.2 : Electron acceptor
YP_001208525.1	1.3.6 : Aerobic respiration
YP_001208525.1	4.3.D.4 : The Proton-translocating Cytochrome Oxidase (COX) Superfamily
YP_001208526.1	5.13 : Virulence associated
YP_001208528.1	2.3.5 : Export, signal peptide cleavage
YP_001208528.1	5.10 : Defense/survival
YP_001208529.1	2.3.5 : Export, signal peptide cleavage
YP_001208529.1	7.3 : Inner membrane
YP_001208531.1	1.4 : Energy production/transport
YP_001208534.1	1.5.3.10 : Glutathione
YP_001208535.1	3.1.2 : Transcriptional level
YP_001208536.1	1.5.3.10 : Glutathione
YP_001208539.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001208543.1	3.1.2 : Transcriptional level
YP_001208549.1	2.2.2 : Transcription related
YP_001208549.1	3.1.2 : Transcriptional level
YP_001208551.1	2.1.1 : DNA replication
YP_001208552.1	4.3.A.1.p : periplasmic binding component
YP_001208557.1	2.1.4 : DNA repair
YP_001208557.1	4.2.A.66 : The Multi Antimicrobial Extrusion (MATE) Family
YP_001208557.1	5.6.1 : Radiation
YP_001208557.1	5.8 : SOS response
YP_001208557.1	7.3 : Inner membrane
YP_001208558.1	1.5.2.2 : Pyrimidine biosynthesis
YP_001208558.1	7.1 : Cytoplasm
YP_001208560.1	1.7.24 : Cyanate catabolism
YP_001208561.1	1.5.1.7 : Lysine, diaminopimelate
YP_001208562.1	4.3.A.1.p : periplasmic binding component
YP_001208563.1	1.4 : Energy production/transport
YP_001208568.1	3.1.2 : Transcriptional level
YP_001208569.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001208569.1	4.3.A.1.a : ATP binding component
YP_001208569.1	7.1 : Cytoplasm
YP_001208570.1	4.3.A.1.m : membrane component
YP_001208571.1	4.3.A.1.p : periplasmic binding component
YP_001208574.1	1.7.25 : Glycolate metabolism
YP_001208574.1	1.1.1.20 : Glycol degradation
YP_001208575.1	1.1.1.9 : L-idonate catabolism
YP_001208575.1	1.1.1.2 : 2,5-ketogluconate metabolism
YP_001208575.1	7.1 : Cytoplasm
YP_001208577.1	2.1.4 : DNA repair
YP_001208582.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208582.1	1.7.15 : 2'-deoxyribonucleotide/ribonucleoside metabolism
YP_001208583.1	1.5.1.9 : Methionine
YP_001208588.1	2.3.4 : Chaperoning, folding
YP_001208590.1	1.5.1.3 : Arginine
YP_001208591.1	1.5.1.3 : Arginine
YP_001208591.1	1.5.1.7 : Lysine, diaminopimelate
YP_001208591.1	7.1 : Cytoplasm
YP_001208593.1	1.8.1 : Phosphorous metabolism
YP_001208593.1	2.3.3 : Posttranslational modification
YP_001208593.1	3.1.3.2 : Covalent modification, demodification, maturation
YP_001208593.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208593.1	6.1 : Membrane
YP_001208593.1	7.3 : Inner membrane
YP_001208599.1	1.1.5 : Others
YP_001208600.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208600.1	1.1.2 : Fatty acids (fatty acid oxidation)
YP_001208603.1	1.5.1.20 : Chorismate
YP_001208606.1	1.5.1.4 : Proline
YP_001208606.1	1.8.3 : Nitrogen metabolism
YP_001208606.1	1.5.1.3 : Arginine
YP_001208607.1	4.3.A.1.a : ATP binding component
YP_001208608.1	4.3.A.1.m : membrane component
YP_001208609.1	4.3.A.1.p : periplasmic binding component
YP_001208612.1	4.3.A.1.a : ATP binding component
YP_001208613.1	4.3.A.1.a : ATP binding component
YP_001208614.1	4.3.A.1.m : membrane component
YP_001208615.1	4.3.A.1.m : membrane component
YP_001208619.1	1.4.3 : Electron carrier
YP_001208620.1	1.4.3 : Electron carrier
YP_001208621.1	3.1.2 : Transcriptional level
YP_001208623.1	1.4.3 : Electron carrier
YP_001208624.1	2.3.2 : Translation
YP_001208625.1	8.3.1 : transposases
YP_001208626.1	3.1.2 : Transcriptional level
YP_001208628.1	2.3.2 : Translation
YP_001208630.1	4.3.A.1.a : ATP binding component
YP_001208631.1	4.3.A.1.m : membrane component
YP_001208632.1	4.3.A.1.m : membrane component
YP_001208633.1	4.3.A.1.p : periplasmic binding component
YP_001208640.1	4.3.A.1.p : periplasmic binding component
YP_001208641.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208642.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208643.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208644.1	2.2.2 : Transcription related
YP_001208645.1	1.4.3 : Electron carrier
YP_001208645.1	1.3.6 : Aerobic respiration
YP_001208646.1	1.4.3 : Electron carrier
YP_001208646.1	1.3.6 : Aerobic respiration
YP_001208648.1	4.3.A.1.p : periplasmic binding component
YP_001208650.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208651.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208653.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001208656.1	1.4.3 : Electron carrier
YP_001208661.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208663.1	1.4.3 : Electron carrier
YP_001208668.1	4.3.A.1.a : ATP binding component
YP_001208670.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001208671.1	1.5.1 : Amino acids
YP_001208672.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001208673.1	4.3.A.1.a : ATP binding component
YP_001208676.1	1.5.3.10 : Glutathione
YP_001208677.1	4.3.A.1.p : periplasmic binding component
YP_001208678.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208680.1	1.4.3 : Electron carrier
YP_001208682.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208683.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208686.1	3.1.2 : Transcriptional level
YP_001208687.1	1.5.3.10 : Glutathione
YP_001208688.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208689.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208690.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001208691.1	4.3.A.1.p : periplasmic binding component
YP_001208698.1	1.8.3 : Nitrogen metabolism
YP_001208698.1	1.4 : Energy production/transport
YP_001208699.1	4.3.A.1.a : ATP binding component
YP_001208700.1	4.3.A.1.a : ATP binding component
YP_001208701.1	4.3.A.1.m : membrane component
YP_001208702.1	4.3.A.1.m : membrane component
YP_001208703.1	4.3.A.1.p : periplasmic binding component
YP_001208704.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208705.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208706.1	1.1.1 : Carbohydrates/Carbon compounds
YP_001208709.1	1.7.38 : Methionine salvage pathway
YP_001208710.1	1.7.38 : Methionine salvage pathway
YP_001208710.1	1.7.14 : Polyamine biosynthesis
YP_001208711.1	1.5.4 : Fatty acid and phosphatidic acid
YP_001208713.1	2.3.2 : Translation
YP_001208715.1	1.5.1.18 : Isoleucine/valine
YP_001208715.1	1.5.1.19 : Leucine
YP_001208715.1	1.5.1.17 : Alanine
YP_001208717.1	1.5.1.9 : Methionine
YP_001208717.1	1.5.1.12 : Cysteine
YP_001208717.1	4.S.174 : sulfate
YP_001208718.1	1.5.1.9 : Methionine
YP_001208719.1	1.5.1.4 : Proline
YP_001208719.1	1.5.1.1 : Glutamate
YP_001208719.1	1.5.1.3 : Arginine
YP_001208719.1	3.1.2 : Transcriptional level
YP_001208722.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208723.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001208726.1	3.1.2 : Transcriptional level
YP_001208727.1	1.4.3 : Electron carrier
YP_001208730.1	4 : Transport
YP_001208730.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001208731.1	4.3.A.1.am : ATP binding and membrane component
YP_001208737.1	8.3.1 : transposases
YP_001208754.1	1.7.9 : Misc. glucose metabolism
YP_001208754.1	5.5.5 : Dessication
YP_001208755.1	1.7.9 : Misc. glucose metabolism
YP_001208755.1	5.5.5 : Dessication
YP_001208756.1	4.2.A.1 : The Major Facilitator Superfamily (MFS)
YP_001208757.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208759.1	1.3 : Energy metabolism (carbon)
YP_001208760.1	1.3 : Energy metabolism (carbon)
YP_001208761.1	1.3 : Energy metabolism (carbon)
YP_001208763.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001208764.1	3.1.2 : Transcriptional level
YP_001208766.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001208767.1	1.1.3.15 : Phenylalanine, tyrosine degradation
YP_001208768.1	5.6.4 : Drug resistance/sensitivity
YP_001208768.1	5.10 : Defense/survival
YP_001208770.1	1.1 : Carbon compound utilization
YP_001208771.1	3.1.2 : Transcriptional level
YP_001208772.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208774.1	3.1.2.2 : Activator
YP_001208776.1	4.2.A.7 : The Drug/Metabolite Transporter (DMT) Superfamily
YP_001208777.1	4.9.A : Transporters of Unknown Classification
YP_001208779.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001208783.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001208785.1	1.2.2 : DNA
YP_001208787.1	1.2.3 : Proteins/peptides/glycopeptides
YP_001208788.1	1.5.3.11 : Menaquinone (MK), ubiquinone (Q)
YP_001208789.1	1.5.1.18 : Isoleucine/valine
YP_001208790.1	4.3.A.1.m : membrane component
YP_001208791.1	4.3.A.1.a : ATP binding component
YP_001208792.1	4.3.A.1.p : periplasmic binding component
YP_001208793.1	3.1.2 : Transcriptional level
YP_001208794.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208795.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208796.1	8.1.3 : Regulation
YP_001208797.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208798.1	3.1.2 : Transcriptional level
YP_001208799.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208801.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208802.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208803.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208804.1	5.3 : Motility (incl. chemotaxis, energytaxis, aerotaxis, redoxtaxis)
YP_001208808.1	3.1.4 : Regulation level unknown
YP_001208809.1	3.1.4 : Regulation level unknown
YP_001208810.1	3.1.4 : Regulation level unknown
YP_001208811.1	3.1.2.4 : Complex regulation
YP_001208813.1	3.1.2 : Transcriptional level
YP_001208827.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001208827.1	1.6.3.1 : O antigen
YP_001208827.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001208827.1	6.1 : Membrane
YP_001208827.1	7.1 : Cytoplasm
YP_001208828.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001208828.1	1.6.3.1 : O antigen
YP_001208828.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001208828.1	6.1 : Membrane
YP_001208828.1	7.1 : Cytoplasm
YP_001208829.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001208829.1	1.6.3.1 : O antigen
YP_001208829.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001208829.1	6.1 : Membrane
YP_001208829.1	7.1 : Cytoplasm
YP_001208830.1	1.6.3.1 : O antigen
YP_001208830.1	1.6.4 : Enterobacterial common antigen (surface glycolipid)
YP_001208830.1	1.5.3.7 : Nicotinamide adenine dinucleotide (NAD)
YP_001208830.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001208830.1	6.1 : Membrane
YP_001208835.1	4 : Transport
YP_001208835.1	4.8.A.1 : The Membrane Fusion Protein (MFP) Family
YP_001208836.1	4.3.A.1.am : ATP binding and membrane component
YP_001208846.1	1.7.10 : Sugar nucleotide biosynthesis, conversions
YP_001208846.1	1.6 : Macromolecules (cellular constituent) biosynthesis
YP_001208850.1	4.9.A.1 : The Polysaccharide Transporter (PST) Family
YP_001208851.1	1.6.3 : Lipopolysaccharide
YP_001208855.1	1.6.3 : Lipopolysaccharide
YP_001208857.1	1.6.3.1 : O antigen
YP_001208858.1	4.9.A.1 : The Polysaccharide Transporter (PST) Family
YP_001208863.1	1.6.3 : Lipopolysaccharide
YP_001208870.1	1.6.3 : Lipopolysaccharide
YP_001208871.1	1.6.3 : Lipopolysaccharide
YP_001208872.1	1.6.3 : Lipopolysaccharide
YP_001208875.1	1.6.3 : Lipopolysaccharide
YP_001208876.1	1.6.3 : Lipopolysaccharide
YP_001208877.1	1.6.3 : Lipopolysaccharide
YP_001208885.1	3 : Regulation
YP_001208888.1	1.1.4 : Amines
YP_001208888.1	1.7.14 : Polyamine biosynthesis
YP_001208888.1	4.3.A.1.m : membrane component
YP_001208888.1	4.S.166 : putrescine/spermidine
YP_001208888.1	7.3 : Inner membrane
YP_001208889.1	1.1.4 : Amines
YP_001208889.1	1.7.14 : Polyamine biosynthesis
YP_001208889.1	4.3.A.1.m : membrane component
YP_001208889.1	4.S.166 : putrescine/spermidine
YP_001208889.1	6.1 : Membrane
YP_001208889.1	7.3 : Inner membrane
YP_001208890.1	1.1.4 : Amines
YP_001208890.1	1.7.14 : Polyamine biosynthesis
YP_001208890.1	4.3.A.1.a : ATP binding component
YP_001208890.1	4.S.166 : putrescine/spermidine
YP_001208890.1	7.1 : Cytoplasm
YP_001208891.1	1.1.4 : Amines
YP_001208891.1	1.7.14 : Polyamine biosynthesis
YP_001208891.1	4.3.A.1.p : periplasmic binding component
YP_001208891.1	4.S.166 : putrescine/spermidine
YP_001208891.1	7.2 : Periplasmic space
YP_001208892.1	3.1.2 : Transcriptional level
YP_001208893.1	1.7.33 : Nucleotide and nucleoside conversions
YP_001208906.1	3.1.2.1 : Sigma factors, anti-sigmafactors
YP_001208908.1	3.1.2 : Transcriptional level
YP_001208910.1	1.8.3 : Nitrogen metabolism
YP_001208911.1	3.1.2 : Transcriptional level
YP_001208913.1	3.1.2.4.3 : Two-component regulatory systems (external signal)
YP_001208916.1	7.4 : Outer membrane
YP_001208917.1	4.3.A.1.m : membrane component
YP_001208917.1	6.1 : Membrane
YP_001208917.1	7.3 : Inner membrane
YP_001208918.1	4.3.A.1.am : ATP binding and membrane component
YP_001208919.1	6.1 : Membrane
YP_001208919.1	7.3 : Inner membrane
YP_001208921.1	1.5.3.19 : Isoprenoid biosynthesis
YP_001208921.1	6.3 : Surface antigens (ECA, O antigen of LPS)
YP_001208921.1	7.1 : Cytoplasm
YP_001208922.1	3.1.2 : Transcriptional level
YP_001208929.1	1.1.4 : Amines
YP_001208931.1	1.1 : Carbon compound utilization
YP_001208933.1	1.1 : Carbon compound utilization
YP_001208934.1	1.1 : Carbon compound utilization
YP_001208938.1	2.3.6 : Turnover, degradation
YP_001208940.1	2.3.2 : Translation
YP_001208940.1	2.3.8 : Ribosomal proteins
YP_001208940.1	6.6 : Ribosome
YP_001208940.1	7.1 : Cytoplasm